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Abstract 
The worldwide demand for prosthetic heart valve (PHV) replacements is increasing 
rapidly. Although developing countries have the largest demand due to the high incidence 
of rheumatic heart disease, the mismatch between the available resources and the cost 
of PHVs often renders them inaccessible in these locations. This raises the need for lower 
cost PHVs which calls for reduced development costs. A cardiac pulse duplicator (CPD) 
plays a crucial role in the PHV design process and CPDs built in-house can represent large 
savings over commercial alternatives. However, they are complex devices and without the 
appropriate level of expertise their development can result in a time consuming, 
expensive process which offsets any benefits derived from building it in-house. This thesis 
documents the redevelopment of a PHV testing device and the methods used to evaluate 
its performance, providing guidelines to assist those interested in developing a CPD. This 
was also done to enable the Biomedical Engineering Research Group at Stellenbosch 
University to test, in accordance to the ISO5840 standard, the PHV it developed. 
 
A literature survey confirmed the increasing importance of CPDs in PHV development and 
in a variety of other cardiovascular research topics but also indicated that there are no 
established guidelines to quantify or directly assess a CPD’s performance. Due to the 
difficulty of distinguishing between the hydrodynamic performance of the PHV and that 
of the device used to test it, the standardisation of methods to assess the performance of 
CPDs is proposed. The concept of fidelity is presented as a first step towards a means of 
quantifying CPD performance which can improve the quality of PHV test data. 
 
A high performance system was designed and implemented to control the motion of the 
pump used to generate pulsatile flow. Various other aspects of the CPD were designed 
and implemented or manufactured. This included control, acquisition and analysis 
software as well as a number of connected hydraulic elements making up a flexible 
platform for testing PHVs. Rigorous tests were devised to assess the performance of the 
CPD’s control system. Commercially available PHVs were tested to evaluate the electrical 
and hydrodynamic performance of the CPD. To compare the overall performance of the 
CPD to that of a widely cited counterpart, further tests were carried out so that the results 
obtained could be compared directly against those found in the literature. 
 
Analysis of the results showed the control system to be highly dynamic, accurate 
(0.019 ±0.006 mm deviation from setpoint at 70 bpm) and repeatable (2.426 
±1.335 mmHg RMSE cycle-to-cycle). The hydrodynamic performance achieved with the 
hydraulic components that were designed was satisfactory. The measured pressure data 
showed good agreement with published data for the available reference PHV, although 
some deviations were noted. These deviations were used to investigate some phenomena 
that ought to be taken into consideration during the design phase of CPDs. 
 
Some shortcomings present in the final implementation of the CPD were identified and 
recommendations made to address them. Despite its limitations and a cost of R 160 951, 
the CPD offers similar performance to a commercial system eight times this cost.  
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Opsomming 
Die wêreldwye aanvraag na prostetiese hartklep (PHK) plaasvervangers neem vinnig toe. 
Alhoewel ontwikkelende nasies die grootste aanvraag het as gevolg van die hoë voorkoms 
van rumatiese hartsiekte, veroorsaak die wanverhouding tussen die beskikbare 
hulpbronne en die koste van PHKs dat hulle dikwels ontoeganklik in hierdie lande is. Dit 
gee aanleiding tot die behoefte aan 'n goedkoper PHK wat verminderde 
ontwikkelingskostes vereis. ‘n Hartpolsnabootser (HPN) speel 'n belangrike rol in die PHK 
ontwerpsproses en HPNe wat plaaslik gebou word kan grooter besparings inhou as 
kommersiële alternatiewe. Hulle is egter ingewikkelde toestelle en sonder die toepaslike 
kundigheid kan hul ontwikkeling tot 'n tydrowende, duur proses lei wat enige voordele 
wat uit die plaaslike proses voortspruit neutraliseer. Dié tesis dokumenteer die 
herontwikkeling van 'n PHK toetsapparaat en die metodes wat gebruik is om die 
werkverrigting te evalueer, om sodoende riglyne te verskaf aan diegene wat belangstel in 
die ontwikkeling van 'n HPN. Bowendien, is die Biomediese Ingenieurswese Navorsings 
Groep aan die Universiteit van Stellenbosh in staat gestel om die HPN wat daar ontwikkel 
is in ooreenstemming met die ISO5840 standaard te toets. 
 
'n Literatuur studie bevestig die toenemende belangrikheid van HPNe in PHK 
ontwikkeling, sowel as in 'n verskeidenheid van ander kardiovaskulêre-
navorsingsonderwerpe, maar het ook aangedui dat daar geen gevestigde riglyne om die 
werkvirrigting van ‘n HPN te kwantifiseer of direk te evalueer bestaan nie. As gevolg van 
die probleme om te onderskei tussen die hidrodinamiese prestasie van die PHK en dié van 
die toestel gebruik om dit te toets, is die standaardisering van metodes om die prestasie 
van HPNe te evalueer voorgestel. Die konsep van getrouheid word aangebied as 'n eerste 
stap na 'n wyse om die prestasie van ‘n HPN te kwantifiseer, wat die gehalte van PHK 
toetsdata kan verbeter. 
 
'n Hoë-prestasie stelsel is ontwerp en geïmplementeer om die beweging van die pomp 
wat gebruik word om polsmatige vloei te genereer te beheer. Verskeie ander aspekte van 
die HPN is ontwerp en geïmplementeer of vervaardig. Dit sluit in beheer-, verkryging- en 
analisesagteware, sowel as 'n aantal gekoppelde hidrouliese elemente wat 'n buigsame 
omgewing vir die toets van HPNe skep. Streng toetse is ontwerp om die werkverrigting 
van die HPN se beheerstelsel te evalueer. Komersiële PHKs is getoets om die elektriese en 
hidrodinamiese werkverrigting van die HPN te evalueer. Om die algehele werkverrigting 
van die HPN met dié van 'n wyd aangehale ewebeeld te vergelyk, is verdere toetse 
uitgevoer sodat die resultate wat verkry is direk teen dié wat in die literatuur voorkom 
vergelyk kon word. 
 
Ontleding van die resultate het getoon dat die beheerstelsel hoogs dinamies en akkuraat 
is (0.019 ±0.006 mm afwyking om ‘n stelpunt teen 70 spm) met herhaalbare uitkomste 
(2.426 ±1.335 mmHg WGKF siklus-tot-siklus). Die hidrodinamieseprestasie behaal met die 
hidrouliese komponente wat ontwerp is was bevredigend. Die data vir die gemete druk 
het goeie ooreenkoms getoon met gepubliseerde data vir die beskikbare verwysings PHK, 
hoewel sommige afwykings opgemerk is. Hierdie afwykings is gebruik om 'n paar 
verskynsels wat tydens die ontwerpsfase van HPNe in ag geneem behoort te word te 
ondersoek. 
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Sommige tekortkominge teenwoordig in die finale implementering van die HPN is 
geïdentifiseer en aanbevelings is gemaak om hulle aan te spreek. Ten spyte van sy 
beperkinge en koste van R160 951, is die werkverigting van die HPN soortgelyk aan 
kommersiële stelsels wat agt keer duurder is. 
 
 
  
Stellenbosch University  https://scholar.sun.ac.za
v 
 
 
 
 
 
 
 
To Cris, 
for keeping my heart beating. 
 
To my parents, 
for the gift of education. 
  
Stellenbosch University  https://scholar.sun.ac.za
vi 
 
Acknowledgements 
This project could not have been completed without the help and support of numerous 
people. A few of them deserve to be acknowledged in a special way and therefore I would 
like to express my sincere gratitude to: 
 
 The late Prof Cornie Scheffer, my initial supervisor, for providing me with this 
unique opportunity and accepting me as his student, and Prof Anton Basson, who 
also played a crucial role in facilitating this opportunity. Their support and 
understanding as employers enabled me to pursue this project. 
 
 Dr Kiran Dellimore, my co-supervisor, for encouraging me to embark on this 
academic undertaking. His enthusiasm for this project, passion for research and 
mentoring were essential to my academic development. 
 
 Dr Cobus Müller, my supervisor, for willingly taking over this project after Prof 
Scheffer’s tragic passing and having the ability to calm me down during times of 
panic. He provided the necessary guidance to find direction again and facilitated 
equipment that proved critical to the successful completion of this project. 
 
 All the staff in the workshop, for welcoming me into their domain as one of their 
own. Mr Anton van den Berg deserves special mention not only for his excellent 
workmanship but also for taking the time to mentor me in his art. Being able to 
manufacture my own designs brought me great satisfaction and ultimately played 
a key role in this highly practical project. 
 
 My close friends, Kevin Neaves and Kobus Hoffman, who took up this challenge 
with me, and Melody van Rooyen, for all the encouragement and interest in my 
work. This endeavour would have been far more difficult without their friendship. 
 
 My parents, for the financial and emotional support, the interest in my project 
and always believing in me. 
 
 Cris, the shoulder I leaned on all these years, for the incredible patience and 
constant encouragement; for sharing the experience, celebrating the highs and 
getting me through the lows; for always being positive and giving me hope. 
 
 God, for this undertaking would neither have started nor finished had He not 
moved so many people along the way to help me and opened so many doors. 
 
  
Stellenbosch University  https://scholar.sun.ac.za
vii 
 
Table of contents 
 
Declaration ....................................................................................... i 
Abstract ........................................................................................... ii 
Opsomming .................................................................................... iii 
Acknowledgements ........................................................................ vi 
Table of contents ........................................................................... vii 
List of figures ................................................................................... x 
List of tables .................................................................................. xii 
List of abbreviations ..................................................................... xiii 
List of symbols .............................................................................. xiv 
1 Introduction .............................................................................. 1 
 Background and motivation ...................................................................... 1 
 Aim ............................................................................................................ 3 
 Thesis overview ......................................................................................... 4 
2 Literature Review ...................................................................... 5 
 The human heart and overview of CPDs ................................................... 5 
 Types of CPDs and circulatory system simulation .................................... 7 
2.2.1 Wave propagation model............................................................................ 7 
2.2.2 Lump parameter model .............................................................................. 8 
 Evolution of CPDs and the state of the art.............................................. 10 
 Significance and applications of CPDs ..................................................... 13 
 The development of CPDs and challenges .............................................. 14 
 Guidelines for the assessment of CPDs ................................................... 16 
3 Materials and Methods ........................................................... 18 
 Existing apparatus ................................................................................... 18 
3.1.1 Apparatus description ............................................................................... 18 
3.1.2 Problems identified ................................................................................... 19 
 System development .............................................................................. 23 
3.2.1 Requirements and constraints .................................................................. 23 
3.2.2 Mechanical design ..................................................................................... 23 
3.2.2.1 Pump drive system ................................................................................ 23 
3.2.2.2 Aortic root compliance chamber and optical access ............................ 26 
Stellenbosch University  https://scholar.sun.ac.za
viii 
 
3.2.2.3 Resistor .................................................................................................. 27 
3.2.2.4 Fluid isolation and ventricular compliance ........................................... 28 
3.2.3 Mechanical overview ................................................................................ 29 
3.2.4 Control strategy and software .................................................................. 31 
3.2.4.1 Software Overview ................................................................................ 32 
3.2.4.2 Ventricle pump control ......................................................................... 32 
3.2.4.3 Data acquisition..................................................................................... 41 
 Reproduction of cam profile ................................................................... 42 
 Calibration and testing ............................................................................ 43 
3.4.1 Ventricular motion control........................................................................ 43 
3.4.1.1 MoviDrive servomotor speed controller ............................................... 43 
3.4.1.2 LabVIEW position controller ................................................................. 44 
3.4.1.3 Ventricle pump accuracy and resolution .............................................. 45 
3.4.2 Hydrodynamic verification ........................................................................ 46 
3.4.2.1 Adjustment and effect of compliance and resistance controls ............ 48 
3.4.2.2 Effect of changes in control waveform on pressure ............................. 49 
3.4.2.3 Repeatability and fidelity ...................................................................... 49 
3.4.2.4 ISO testing ............................................................................................. 51 
3.4.3 Comparative tests ..................................................................................... 53 
3.4.3.1 Comparison to original CPD .................................................................. 53 
3.4.3.2 Comparison to published data .............................................................. 54 
4 Results ..................................................................................... 56 
 Cylinder and controller performance ..................................................... 56 
4.1.1 Speed controller ........................................................................................ 56 
4.1.2 Position controller ..................................................................................... 56 
4.1.3 Accuracy and resolution ............................................................................ 57 
4.1.4 Tracking ..................................................................................................... 58 
 Cam profiling ........................................................................................... 59 
 Hydrodynamic results ............................................................................. 60 
4.3.1 Adjustment of lump parameter controls .................................................. 60 
4.3.2 Response to changes in a single control point .......................................... 62 
4.3.3 Tuning the pressure profile ....................................................................... 63 
 Repeatability and fidelity tests ............................................................... 64 
4.4.1 Repeatability ............................................................................................. 64 
4.4.2 Fidelity ....................................................................................................... 64 
Stellenbosch University  https://scholar.sun.ac.za
ix 
 
 ISO5840:2005 tests ................................................................................. 66 
4.5.1 Pressure drop ............................................................................................ 66 
4.5.2 Regurgitation ............................................................................................. 68 
 Comparative results ................................................................................ 69 
4.6.1 Comparison to original CPD ...................................................................... 69 
4.6.2 Results used for comparison to published data ........................................ 71 
5 Discussion ................................................................................ 73 
 Hydrodynamic analysis............................................................................ 73 
5.1.1 The sinuses of Valsalva .............................................................................. 75 
5.1.2 Pulse wave velocity ................................................................................... 76 
5.1.3 Nature and operation of the CPD ............................................................. 77 
 Limitations affecting system performance ............................................. 78 
5.2.1 Mechanical ................................................................................................ 78 
5.2.2 Motion control .......................................................................................... 78 
 Cost overview .......................................................................................... 80 
6 Conclusion and Recommendations .......................................... 81 
 Conclusion ............................................................................................... 81 
 Recommendations .................................................................................. 82 
7 References ............................................................................... 83 
Appendix A: Calibration data ................................................................ 92 
Appendix B: Cam’s numerical profile ................................................... 100 
Appendix C: ISO test data .................................................................... 103 
Appendix D: Cost details ..................................................................... 110 
Appendix E: Graphical user interfaces ................................................. 112 
  
Stellenbosch University  https://scholar.sun.ac.za
x 
 
List of figures 
Figure 1.1: Stenosis of heart valves caused by RHD. .......................................................... 1 
Figure 1.2: Prevalence of worldwide RHD. ......................................................................... 2 
Figure 1.3: BERG valve. ....................................................................................................... 3 
Figure 2.1: Anatomic model of the heart in coronal section view. ..................................... 5 
Figure 2.2: Events and physiological values of the cardiac cycle. ....................................... 6 
Figure 2.3: Hydraulic loop (a) and functional diagram (b) for a generic CPD. .................... 7 
Figure 2.4: Wave propagation model CPD. ......................................................................... 8 
Figure 2.5: 2, 3 and 4 element Windkessel models (adapted from [41]). .......................... 9 
Figure 2.6: The ViVitro pulse duplicator system. .............................................................. 10 
Figure 2.7: Effect of ventricular compliance. .................................................................... 15 
Figure 3.1: BERG CPD at the start of this project. ............................................................. 18 
Figure 3.2: Original aortic valve chamber and inlet. ......................................................... 22 
Figure 3.3: Swash plate pump drive system concept........................................................ 24 
Figure 3.4: Lead screw pump drive system concept. ........................................................ 25 
Figure 3.5: SEW CMS50M (150mm stroke) electric cylinder. ........................................... 25 
Figure 3.6: Section view of the new left ventricular outflow tract and aortic root 
compliance chamber. ..................................................................................... 27 
Figure 3.7: Optical effect of the corrective lens. ............................................................... 27 
Figure 3.8: Resistor assembly. ........................................................................................... 28 
Figure 3.9: Ventricle dimensions. ...................................................................................... 28 
Figure 3.10: View of the ventricular section of the CPD. .................................................. 29 
Figure 3.11: Physical layout of the CPD. ........................................................................... 30 
Figure 3.12: Final state of the redesigned CPD. ................................................................ 30 
Figure 3.13: Information flow between the physical components of the system. ........... 32 
Figure 3.14: Data exchange pertinent to motion control. ................................................ 33 
Figure 3.15: Main user interface showing motion design controls. ................................. 34 
Figure 3.16: Flow diagram for waveform generation in the CPD. .................................... 35 
Figure 3.17: Values used in the determination of the optimal performance gradient for  
  constants Kp and Ti. ....................................................................................... 38 
Figure 3.18: Flow diagram for the PIDloop VI. .................................................................. 39 
Figure 3.19: Flow diagram for the stroke volume controller’s algorithm. ........................ 40 
Figure 3.20: Experimental setup used to obtain cam profile. ........................................... 42 
Figure 3.21: The concept used to evaluate repeatability of the CPD. .............................. 50 
Figure 3.22: Heart valve events. ....................................................................................... 52 
Figure 4.1: Dynamic speed tracking error. ........................................................................ 56 
Figure 4.2: Position controller response at HR = 70 bpm and SV = 71.43 mL. .................. 57 
Figure 4.3: Position controller response at HR = 189bpm and SV = 128mL. .................... 57 
Figure 4.4. a) Extract of the measured positions plotted as the difference to the  
baseline. b) Overview of the baseline measured position ............................. 58 
Figure 4.5: Interface of the processing program used to extract the cam profile. ........... 59 
Figure 4.6: Pressure response to lump parameter adjustments. ..................................... 60 
Figure 4.7: Pressure response to ventricular compliance adjustments for test 1. ........... 61 
Figure 4.8: Pressure response to ventricular compliance adjustments for test 2. ........... 62 
Figure 4.9: a) Control waveform used for each heartbeat. b): Corresponding  
ventricular pressure. ....................................................................................... 63 
Stellenbosch University  https://scholar.sun.ac.za
xi 
 
Figure 4.10: Measurements before tuning (black) and after tuning (red) for  
  a) ventricular pressure, b) aortic  pressure and c) control waveform. ......... 64 
Figure 4.11: a) Surface plot of arterial pressure for 100 heartbeats. b) XY plane view  
  (with contour lines) of the surface plot showing the location of highest  
  pressure (red) and lowest pressure (purple) for 100 heartbeats. ................ 65 
Figure 4.12: Graphical results for the variables of interest. ............................................. 65 
Figure 4.13: Representative waves showing ventricular, aortic and atrial pressures,  
  as well as aortic flow rate. ............................................................................. 67 
Figure 4.14: a) Pressure measurements obtained by Krynauw (adopted from [28]).  
  b) Pressure measurements obtained with the original CPD configuration. . 70 
Figure 4.15: Pressure measurements obtained using the new compliance chamber  
  and LVOT. ...................................................................................................... 70 
Figure 4.16: Results obtained from the system in its final state ...................................... 71 
Figure 5.1: Graphical comparison between measured and published hydrodynamic  
data. ................................................................................................................ 74 
Figure 5.2: The sinuses of Valsalva. ................................................................................... 75 
Figure 5.3: a) Pressure components of the arterial pressure curve. b) Effect of  
reduced compliance on  arterial pressure due to age. ................................... 76 
Figure 5.4: Controller response when writing setpoints using (a) fixed time 
resolution and (b) fixed number of positions. ................................................ 79 
Figure 6.1: a) Ventricle mold to be manufactured and resultant silicone model.  
b) Current  ventricular compliance setup; c) proposed ventricular  
compliance setup. ........................................................................................... 82 
 
  
Stellenbosch University  https://scholar.sun.ac.za
xii 
 
List of tables 
Table 2.1: Commercially available CPDs. .......................................................................... 12 
Table 2.2: ISO5840:2005 requirements for cardiac pulse duplicators.............................. 17 
Table 2.3: Operational environment parameters for aortic PHVs. ................................... 17 
Table 3.1: Summary of problems and solutions to improve the original CPD. ................. 19 
Table 3.2: Summary of concept comparison. ................................................................... 26 
Table 3.3: Operating points tested during speed calibration. .......................................... 44 
Table 3.4: Cardiovascular response to exercise in adults. ................................................ 44 
Table 3.5: Commercially available aortic PHVs used for the verification of the CPD’s  
  hydrodynamic performance. ............................................................................ 47 
Table 3.6: Test conditions for the ventricular compliance experiment. ........................... 48 
Table 3.7: Test matrix for the assessment of valve hydrodynamic performance............. 52 
Table 3.8: Tests for comparison to published data. .......................................................... 54 
Table 4.1: Tuning parameters used in the PI position controller. .................................... 56 
Table 4.2: Results for overall tracking tests. ..................................................................... 58 
Table 4.3: Control points used to describe the original cam’s profile. ............................. 59 
Table 4.4: Effect of aortic root compliance and peripheral resistance on pressure. ........ 60 
Table 4.5: Effect of ventricular compliance controls on pressure. ................................... 61 
Table 4.6: Effect of ventricular compliance controls on pressure. HR = 90 bpm,  
  CO = 7.5 L/min. ................................................................................................. 62 
Table 4.7: Control points used for tuning the pressure profile. ....................................... 63 
Table 4.8: Hydrodynamic repeatability results. All values are in mmHg. ......................... 64 
Table 4.9: Statistical results to supplement Figure 4.12. .................................................. 65 
Table 4.10: Fidelity description of the CPD. ...................................................................... 66 
Table 4.11: Statistical results for Test 1. ........................................................................... 67 
Table 4.12: Statistical results for Test 2. ........................................................................... 68 
Table 4.13: Statistical results for Test 3. ........................................................................... 68 
Table 4.14: Statistical results for Test 4. ........................................................................... 68 
Table 4.15: Statistical results for Test 5. ........................................................................... 69 
Table 4.16: Statistical results for Test 6. ........................................................................... 69 
Table 4.17: Statistical results for Test 7. ........................................................................... 69 
Table 4.18: Control points used to eliminate the ventricular pressure spike during 
systole. ............................................................................................................ 71 
Table 4.19: Statistical results for SJME 23 mm PHV.......................................................... 72 
Table 5.1: Comparison of waveform accuracy for BERG CPD and ViVitro Labs  
  SuperPump at SV = 75 mL. ............................................................................... 73 
Table 5.2: Measured and published pressure data for the SJME 23 mm PHV. ................ 74 
Table 5.3: Summary of hardware and manufacturing costs. ............................................ 80 
 
  
Stellenbosch University  https://scholar.sun.ac.za
xiii 
 
List of abbreviations 
AC Alternating current 
BERG Biomedical Engineering Research Group 
bpm beats per minute 
CNC Computer numerically controlled 
CO Cardiac output 
CPD Cardiac pulse duplicator 
DAQ Data acquisition 
EOA Effective orifice area 
FDA Food and Drug Administration 
FPGA Field programmable gate array 
HR Heart rate 
ISO International Organization for Standardization 
LVDT Linear variable differential transformer 
LVOT Left ventricular outflow tract 
MAP Mean arterial pressure 
PC Personal computer 
PHV Prosthetic heart valve 
PID Proportional-Integral-Derivative 
PIV Particle image velocimetry 
PWV Pulse wave velocity 
RF Rheumatic fever 
RHD Rheumatic heart disease 
RMS Root mean square 
RMSE RMS error 
RT Real time 
RTD Resistance temperature detector 
SD Standard deviation 
SJM St Jude Medical 
SUN Stellenbosch University 
SV Stroke volume 
SVE Shared Variable Engine 
SWL Stroke work loss 
VI Virtual instrument 
 
  
Stellenbosch University  https://scholar.sun.ac.za
xiv 
 
List of symbols 
C Compliance 
e Measured positioning error 
Pdias Diastolic pressure 
Psys Systolic pressure 
Psys_mean_art  Mean systolic arterial pressure 
Psys_mean_vent  Mean systolic ventricular pressure 
ΔP Differential pressure across the open test valve 
ΔPmean  Mean systolic pressure difference 
ΔPpeak  Peak systolic pressure difference 
-ΔPmean  Mean back pressure 
Qmean  Mean flow rate 
𝑞𝑣𝑅𝑀𝑆  Root mean square forward flow 
qv(t) Instantaneous flow rate 
R Resistance 
ρ Test fluid density 
Td Derivative action time constant of the position controller 
Ti  Integral action time constant of the position controller 
Kp  Proportional gain of the position controller 
Tsys  Duration of systole 
u Position controller output 
Vclosing Closing regurgitant volume of the test valve 
Vleakage Leakage volume of the test valve 
Vreg_total Total regurgitant volume of the test valve 
ℱ Fidelity metric 
 
 
Stellenbosch University  https://scholar.sun.ac.za
1 
1 Introduction 
 Background and motivation 
Rheumatic heart disease (RHD)1 is the most serious complication of childhood rheumatic 
fever (RF) and it is a major health problem in developing countries such as South Africa. 
Together, RF and RHD represent a major source of cardiovascular diseases across the 
globe, although their effect is most evident in developing countries [1]. It has been shown 
that previous diagnostic techniques may have underestimated the incidence of RHD by 
almost 10 times [2] and while thought to be primarily a childhood disease, a South African 
study reported newly diagnosed RHD in an adult population with an incidence of 23.5 
cases per 100 000 per annum for patients above 14 years of age [3]. The resultant chronic 
RHD leads to the development of aortic and/or mitral valve stenosis (see Figure 1.1) and 
varying degrees of regurgitation (backward flow of blood through the closed valve), often 
presenting the need for heart valve replacement as was the case for 22% of the South 
African study’s cohort. But while RHD is the main reason for valvular replacements, there 
are various other pathologies that may lead to severe heart valve dysfunction and the 
subsequent need for replacement. These include but are not limited to endocarditis2, 
congenital defects, calcific stenosis3, heart attack and valvular damage or degeneration 
arising from chronic high blood pressure, radiation and atherosclerosis4, among others [4, 
5]. 
 
 
Figure 1.1: Stenosis of heart valves caused by RHD.  Mitral valve (a) (adapted from [6 pp329]) and aortic 
valve (b) (adapted from [7 pp15]) showing characteristic RHD pathology. Insets: healthy valves, respectively. 
(Adopted from [8] and [9]). 
 
It is widely documented that RHD is most prevalent in developing regions of the world 
and particularly Africa [1, 2, 3, 10, 11, 12, 13, 14], as shown in Figure 1.2. This not only 
makes it difficult to control and treat RF in order to prevent RHD but it also means that 
                                                          
1  An inflammation of the heart leading to fibrotic repair of tissue and subsequent valvular 
 dysfunction. 
2 The inflammation of the endocardium (the heart chambers’ inner walls). 
3 The progressive narrowing of a valve’s orifice due to calcium deposits on its leaflets. 
4 The thickening of an arterial wall as a result of a lesion. 
Thickened leaflets and 
fused commissures 
Narrowed orifice 
Narrowed 
orifice 
a) b) Thickened leaflets and 
fused commissures 
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2 
regions with the highest demand for valvular replacements have very limited resources 
available to use in alleviating the burden of the disease and reducing RHD mortality rate. 
This is compounded by the fact that the prosthetic heart valve (PHV) replacement market 
is expensive when compared to limited health budgets and per capita income: the cost of 
a single prosthetic device can range from 2 000 USD to 10 000 USD for surgical valves and 
up to 25 000 USD (2010) for transcatheter5 valves [15]. These costs are dependent on 
location, as is the procedure and related hospitalisation costs. In South Africa, the average 
cost of a transcatheter aortic valve implantation procedure in 2011 was estimated to be 
ZAR 335 500 (46 255 USD) [16]. This situation, together with an increasing as well as older 
world population, advances in diagnostic techniques and new prosthetics technologies all 
contribute to a large demand for heart valve replacement systems that are more 
accessible to the resource constrained areas of the world where they are most needed. 
Indeed, it is estimated that by 2050, over 850 000 patients will need a heart valve 
replacement per annum. This is nearly 3 times more than in 2003 [17]. 
 
 
Figure 1.2: Prevalence of worldwide RHD. (Adopted from [14]). 
 
The field of PHV replacements has grown dramatically over the last 60 years after the first 
successful valve implant attempts in the late 1950s and early 1960s [18]. Since then, 
thanks to advancements in technology and high demand, heart valve replacements have 
been the focus of great interest with much research and development resulting in more 
than 70 different mechanical and tissue PHV designs [19]. Currently, over 10 well known 
manufacturers produce a range of PHVs, including surgically implantable mechanical and 
tissue valves as well as transcatheter designs. 
 
An important aspect of prostheses development is the equipment used to test the 
prostheses’ functionality and durability. Such equipment is crucial to the iterative design 
process, providing real world test data that are used to further develop, optimize and 
verify the performance of the prosthetic device. This includes, among others, cardiac 
                                                          
5  Transcatheter PHVs differ from their surgical counterparts in that their implantation procedure 
 is minimally invasive, requiring only a few small incisions. Implantation of surgical PHVs  
 requires open heart surgery. 
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pulse duplicators, echocardiographic machines, high speed cameras, flow visualisation 
systems (such as particle image velocimetry (PIV) and laser Doppler anemometry) and 
accelerated valve fatigue testers. Acquisition of these devices can prove prohibitively 
expensive for many academic institutions with the expertise and interest in the 
development and testing of PHVs as well as phenomena surrounding their operation. In 
line with this, the Biomedical Engineering Research Group (BERG) at Stellenbosch 
University (SUN) built a cardiac pulse duplicator (CPD) to study the performance of the 
transcatheter PHV replacement that it developed (Figure 1.3) [20, 21, 22, 23, 24, 25, 26, 
27]. This CPD was based on Krynauw’s design [28] and suffered from several drawbacks 
which will be described in detail Section 3.1.2. Further, Krynauw’s design was conceived 
as a dual purpose rig with fatigue testing as the primary mode of operation which posed 
several challenges for hemodynamic tests. Since then the BERG developed a stronger 
interest in hemodynamic testing and in order to use this CPD for the desired purposes, 
several modifications and upgrades were required for the system as described in the 
following section. 
 
 
Figure 1.3: BERG valve. 
 
 Aim 
The aim of this project was to upgrade an existing CPD that was developed in house so 
that it could be used to test PHVs according to the International Organization for 
Standardization in the International Standard ISO5840:2005 (Cardiovascular implants – 
Cardiac valve prostheses)6 [29]. As a means of evaluating the performance of the 
upgraded CPD and ensuring it is capable of producing the required quality of data, it was 
established that a reference PHV needed to be tested. Lastly, an important goal was to 
document the challenges and solutions related to the development of CPDs so as to 
enable easier, faster and more cost effective in-house development at other institutions. 
In order to achieve the above aims, the following objectives were identified: 
 Redesign the CPD’s left ventricular outflow tract (LVOT) and compliance chamber 
to encourage good laminar flow and allow reliable pressure and flow 
measurements while providing good optical access to the test valve. 
                                                          
6  ISO5840-1:2015 (Cardiovascular implants – Cardiac valve prostheses) became available during 
 the later stages of this project. Given the status of the project at that point in time it was 
 decided to keep to the testing conventions stipulated in ISO5840:2005. 
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 Design and manufacture a mechanism to reliably control the peripheral resistance 
of the CPD with good repeatability. 
 Replace the ventricle drive system to provide flexibility in terms of stroke volume 
(SV) and ventricular flow rate during testing. 
 Create a new control and acquisition program with a user friendly interface. 
 Establish and verify adequate operating and performance parameters for the CPD. 
 
 Thesis overview 
This chapter has framed the context of the project, explaining the needs that motivate 
this undertaking. The key aims and the related objectives that guided the project were 
outlined in no particular order of importance. 
 
Chapter 2 (Literature review), presents the knowledge required to understand the 
project. It includes basic cardiac anatomy and function (in the context of this project) as 
well as an introduction to CPDs, their increasing importance, development and 
evaluation. Importantly, it also states the typical working envelope for CPDs. 
 
Chapter 3 (Materials and methods) begins by describing the state of the existing 
apparatus prior to the start of the project and identifies the most prominent problems 
related to it. Details of the hardware and software that were developed to fulfil the aims 
stated in Section 1.2 are then discussed. The last part of the chapter presents a series of 
tests and techniques that were devised to evaluate the performance of the new CPD. 
Chapter 4 (Results) closely follows the structure of the testing section from Chapter 3, 
presenting results for all the tests either in graphical or tabular form. Statistical 
information is given where applicable. 
 
Chapter 5 (Discussion) reports the limitations of the design, explaining how they affect 
the functioning of the CPD. The second part of the chapter focuses on analysing and 
comparing the data acquired to data found in the literature, produced by a well cited CPD. 
A few important aspects of CPD design which directly affect PHV performance were 
investigated and are discussed in this chapter which also presents the need for a 
standardised approach to evaluating a CPD’s performance. 
 
Chapter 6 (Conclusion and Recommendations) ends this document summarising the work 
done, stating the outcomes of the project and highlighting the contributions that were 
made to the field. The recommendations section outlines the most important aspects of 
the machine that could be improved, offering solutions where necessary. 
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2 Literature Review 
 The human heart and overview of CPDs 
The human heart consists of four chambers: the right and left atria, and the right and left 
ventricles (Figure 2.1). Functionally, the heart can be divided into two separate pumps: 
the right heart and the left heart. The right side pumps blood through the pulmonary 
circulation while the left circulates blood through the systemic circulation. The right 
atrium accepts blood from the systemic circulatory system and delivers it to the right 
ventricle which pumps it to the lungs. Once oxygenated, blood from the lungs returns to 
the heart at the left atrium. As the left ventricle starts to relax, the diastolic phase of the 
cardiac cycle begins and the mitral valve opens allowing blood in the left atrium to fill the 
expanding left ventricular cavity. Shortly after the left ventricle is fully relaxed it begins to 
contract, signalling the start of the systolic phase, and the mitral valve closes. This creates 
pressure inside the ventricle, causing the aortic valve to open and blood to be ejected 
through the aorta which distributes it to the rest of the body using the systemic circulatory 
system. As soon as the ventricle starts to relax, the pressure in the aorta becomes larger 
than inside the ventricle causing the aortic valve to close preventing any blood flow from 
the aorta into the ventricle and as the ventricle continues to relax the mitral valve opens, 
starting a new cycle. This entire process occurs for every heartbeat. In a normal, healthy 
heart the valves open quickly, allowing blood to flow through them with minimal 
resistance. They also close very quickly, staying tightly shut until the next heartbeat. 
 
 
 
 
 
 
 
Figure 2.1: Anatomic model of the heart in coronal section view. (Adapted from [30]). 
 
Modern CPDs are electromechanical devices that replicate the above process so they 
must be capable of reproducing the range of pressure and flow patterns observed in and 
around a healthy heart. This involves creating pulsatile flow, as can be seen in Figure 2.2 
6: From systemic 
circulation 
5: Aorta 
4: Aortic valve 
To lungs 
From lungs 
1: Left atrium 
2: Mitral valve 
3: Left ventricle 
Right heart 
6: To systemic 
circulation 
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which graphically summarises this process with normal cardiac values. Since the right and 
left hearts have the same function of independent pumps, in practice only one of them 
needs to be implemented. The left heart has to pump blood through the entire body (as 
opposed to just the lungs) so it is stronger and operates at higher pressures. As a result, 
normally only the left heart is implemented because it can also replicate the function of 
the right heart. Figure 2.3 shows a CPD’s hydraulic loop and functional diagram. The 
numbered items and labels relate the mechanical components to their anatomical 
counterparts, accordingly numbered in Figure 2.1. 
 
 
Figure 2.2: Events and physiological values of the cardiac cycle. (Adapted from [31]). 
 
Cardiac preload and afterload determine the amount of work the heart does and thus the 
pressures at which it operates. Preload is related to the ventricle’s ability to relax. The 
more the ventricle relaxes (or stretches), the more blood volume it can accept and the 
higher the preload so preload refers to the end diastolic volume of a ventricle. Afterload 
is the pressure that the ventricle must generate to eject blood while contracting. Afterload 
is determined by a number of parameters dependent on the conditions of the arterial tree 
[32] which are discussed in detail in Section 2.2.2. The effects of preload and afterload on 
the muscular (compliant) nature of the ventricles and their ability to relax and contract 
determine the characteristic pressure curves shown in Figure 2.2. Therefore, besides 
generating the pulsatile flow, CPDs must also mimic these properties. This is achieved by 
simulating the circulation system. The following section explains the different circulatory 
system simulation models, diagrammatically represented in Figure 2.3 as a separate 
system. 
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Figure 2.3: Hydraulic loop (a) and functional diagram (b) for a 
generic CPD.  See Figure 2.1 for anatomical reference. 
 
 Types of CPDs and circulatory system simulation 
CPDs are broadly classified in accordance to the method used to simulate cardiac load 
which to an extent also determines the roles they are intended to play in cardiovascular 
research. Cardiac load is generated primarily by the arterial system (afterload) with large 
and small arteries affecting two basic variables of hemodynamics, respectively: 
compliance and resistance [33]. The elastic nature of vessels is most prominent in large 
arteries causing these to store a fraction of the blood ejected during systole and release 
it during diastole, acting as a filter. This has the effect of smoothing flow, which is pulsatile 
close the heart but becomes steady as it approaches the venous system [34], allowing 
capillaries to receive continuous flow even during diastole.  The small arteries offer 
resistance to flow, which combined with the action of the large arteries helps maintain 
systemic pressure [35]. Taking this into consideration, two basic types of arterial system 
simulations exist: the wave propagation model and the lump parameter model. 
 
2.2.1 Wave propagation model 
The wave propagation model simulates afterload by physically replicating the circulatory 
system. This is achieved by arranging compliant pipes (usually made of latex rubber or 
silicone) of different diameters in an anatomically correct manner [36]. The wave 
propagation model is useful for investigating pressure and flow as they develop through 
the main arteries and propagate down the circulation system [36, 37]. Figure 2.4 depicts 
a wave propagation setup (left) and the arterial tree used showing the descending aorta 
and main arterial branches (right). 
 
Since this type of CPD physically replicates the circulatory system it can be quite large, 
complex and difficult to manufacture. However, it allows pressure to be measured at 
nearly any point in the system and provides a realistic environment to test the 
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deployment of valves designed for transcatheter delivery. Since almost any point of the 
circulation system can be studied, this type of CPD can be used to test not only valve 
prostheses but also vascular grafts (prosthetic arteries or veins). However, their main 
purpose remains to develop and validate mathematical models of the arterial system [38]. 
Since such a complete representation of the circulatory system is not necessary to study 
heart valve behaviour, it will not be considered further. 
 
 
Figure 2.4: Wave propagation model CPD. (a): diagrammatic representation;  
(b) physical arterial tree used in this setup. (Adopted from [37]). 
 
2.2.2 Lump parameter model 
The lump parameter model (also known as the Windkessel model), based on the 
Windkessel effect and first described mathematically by Frank [39] in 1899 for the 
purposes of modelling hemodynamics, simulates afterload by applying the sum of the 
circulatory system effects on the ventricle and aortic valve. For example, the elasticity of 
all vessels and its effect on blood pressure at the aortic valve is simulated by a volume of 
air enclosed in a chamber after the aortic valve. This volume of air is compressed during 
the systolic phase of each heart beat while the fluid pressure is higher than the pressure 
of the entrapped air. When the ventricle goes into diastole and the aortic valves closes, 
the arterial pressure falls below the pressure of the air allowing the air to expand and 
gradually force the fluid through the next section of the system. Similarly, the resistance 
to blood flow created by the narrowing and length of all arteries can be achieved by a 
single flow restrictor located after the chamber that simulates compliance [40]. The 
gradual pressure applied by the expanding air causes the fluid to slowly flow through the 
restrictor giving the arterial pressure waveform its characteristic shape. This combination 
results in a compact, simplified system that has the same effect on the heart and aortic 
valve as a full wave propagation model. Therefore the lump parameter model is ideally 
suited to studying pressure and flow waveforms around PHVs [41]. 
 
Flow and pressure perceived by the left ventricle is determined by afterload which in turn 
is characterised by a number of parameters related to the state of the arterial tree. The 
body can regulate some of these parameters to affect flow and modify pressure at 
different areas of the body. Lump parameter model CPDs have discrete components that 
b
) 
a 
Stellenbosch University  https://scholar.sun.ac.za
9 
simulate the effect of such parameters enabling them to create a realistic pressure and 
flow environment corresponding to the specific area of the body to be studied. These 
parameters are characteristic resistance (Rc), peripheral resistance (Rp), inertance (L) and 
compliance (C). The lumped parameter model is an approximation of the vascular system 
effects, mathematically representing each of these parameters with a passive electrical 
element (Rc = resistor, Rp = resistor, L = inductor, C = capacitor) which makes it possible to 
create an electrical circuit representative of the vascular system. By using electrical laws 
and the corresponding formulas for each element, the system’s current and voltage can 
be calculated at any point in time, predicting values for flow and pressure respectively 
[40]. This approach has helped greatly to understand and simulate the effects of each 
parameter on pressure and flow as well as to establish appropriate physical values for the 
simulating components [38]. 
 
Frank’s original model, however, only used one resistance and compliance making it a two 
element Windkessel model. Since then, several types of Windkessel models have been 
proposed [38, 42, 43, 44, 45] according to the number of elements that they include. The 
number of elements determines the accuracy of the model, although the improvements 
offered by the three and four element models are only perceivable during the systolic 
phase [41]. Figure 2.5 shows the analogy between a selection of 2, 3 and 4 element 
electrical Windkessel models and their equivalent hydraulic system. 
 
 
Figure 2.5: 2, 3 and 4 element Windkessel models (adapted from [41]). 
 
The lump parameter model is not without limitations: any study related to the distributed 
nature of the circulation system cannot be undertaken. While the lump parameter model 
can be used to represent any part of the arterial system, it still cannot account for localised 
changes or effects within a larger system model, wave travel and transmission or the 
distribution of blood flow throughout the arterial tree [41]. However, because the physical 
implementation of the lump parameter model is compact and can simulate physiological 
conditions in the vicinity of the heart with sufficient accuracy, it is widely implemented by 
CPDs as a load to the heart and valve prostheses [41]. It offers the advantage that it can 
yield figures for compliance or resistance if the value of the other parameter is known [41, 
45]; this is useful, for example, to determine the resistance or compliance of a specific 
vessel. Figure 2.6 shows the commercially available ViVitro Pulse Duplicator System 
(Vivitro Labs Inc., Victoria, BC, Canada), implementing the lump parameter model and the 
components used to regulate cardiac load. 
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Figure 2.6: The ViVitro pulse duplicator system.  a) Physical location (adapted from [46]) and b) 
diagrammatic representation (adopted from [47]) of lump parameter components. 
 
 Evolution of CPDs and the state of the art 
The first documented CPDs appeared in the mid-1950s and were intended to gain insights 
into physiological cardiac and valvular function as well as studying the effects of heart 
valve pathologies [48, 49, 50, 51]. Most of these studies centred on acquiring pressure 
and visualising valve movement seeking to understand the fluid dynamics within the heart 
and around valves. Shortly thereafter, with the developments in surgical valve 
replacements in the early 1960s, a growing interest in CPDs was sparked to test valve 
replacements [52, 53]. Owing to a deeper understanding of the factors and phenomena 
affecting cardiac valve performance and emerging regulations for PHV testing, the 
following years saw the use of CPDs focus on studying more complex issues related to 
pressure and fluid dynamics around heart valves [54, 55, 56]. 
 
The pumps in these CPDs were driven pneumatically or by simple motors actuating either 
a lever arm or cam system. While some of these had the capability of adjusting the systolic 
fraction to some extent, this approach did not provide much flexibility in terms of 
ventricular control. The first commercially available CPD, developed by ViVitro Systems 
Inc., appeared in 1984 and used a reciprocal piston pump to implement the function of 
the left ventricle [57]. This year also saw the publication of the first edition of the ISO5840 
standard, which provided the requirements for commercialisation of cardiac valve 
prostheses. From this point onwards commercial CPDs evolved alongside the design 
requirements of PHV replacements. The intense activity in this field meant significant 
research and effort was undertaken to improve the performance of CPDs and a greater 
focus was applied on user friendliness. With respect to performance, the efforts of 
Westerhhof’s and Noordergraaf’s groups [58, 59, 60, 61], related to the development of 
mathematical models, facilitated major advancements in the design and implementation 
of physical circulatory system simulators for CPDs. 
 
The current embodiment of commercial CPDs has changed dramatically since the time 
they were first conceived and most modern implementations rely on a piston pump driven 
by a servomotor via a ball screw to simulate the ventricular action. This approach requires 
Remote aortic root and 
systemic compliance 
chambers 
Peripheral 
resistance 
Characteristic 
resistance 
a) b) 
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advanced control techniques but provides the user with great flexibility. Pump control is 
achieved by sophisticated software that allows the discretisation of ventricular volume 
into as many as 2000 points [46, 62]. This would not be possible with the simple drive 
systems utilised by the early CPDs and is useful for simulating pathologies of the heart and 
studying their effects on circulation. 
 
Since both pump control and acquisition of the data generated by the CPD has become 
computerised, users have come to expect all variables such as pressures, flow rate, fluid 
temperature and pump parameters to be monitored in real time and easily logged. Due 
to the complexity of the requirements dictated by PHV testing standards, it has further 
become necessary to process this data using computers. As a result, many manufacturers 
integrate software to perform automated analysis of the data and produce the necessary 
statistical reports into the control software. Typically, the analysis software performs the 
necessary calculations and displays valve performance indicators on a cycle to cycle basis. 
These include mean and root mean square (RMS) flow rates, mean arterial pressure 
(MAP), mean pressure difference across the valve, effective orifice area (EOA) and 
regurgitant volume, among others [46, 62]. Thus, a large part of the functionality of 
modern CPDs lies in the monitoring, analysis and reporting software that has come to 
form a standard part of CPD systems. 
 
Table 2.1 shows commercially available CPD systems and their general capabilities. All the 
models shown provide the user with the ability to program and execute custom 
waveforms. While all of the systems are modular to some extent, some manufacturers 
(not included in Table 2.1) such as Shelley (Shelley CardioFlow 5000 MR) and Harvard 
Apparatus (Harvard Apparatus 1400 Series) only provide the pump and the user must 
supply the mock circulatory system. Some manufacturers listed in Table 2.1 produce 
several models of CPDs which are more focused on the development of certain devices. 
BDC Laboratories, for example, provides three different models of CPDs and pumps, each 
tailored to the development of a specific range of technologies: the PD-1100 (employed 
in the flagship HDT-500 CPD) is used for driving cardiovascular networks for the purpose 
of device testing and validation (pressure or flow measuring catheters, for example), the 
PD-0750 is intended for cardiac valve development and the PD-0500 for endovascular and 
vascular devices (balloons and stents, for instance) [63]. Besides the commercial CPD 
systems shown in Table 2.1, there are a few prominent academic projects which are often 
cited in published studies: the Sheffield University CPD, the RWTH Aachen Cardiovascular 
Engineering Pulse Duplicator and the Yoganathan-FDA pulse duplicator. Chew et al 
provide a description of each of these systems [47]. 
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Table 2.1: Commercially available CPDs. 
 
ViVitro Pulse Duplicator System 
Circulatory 
simulation 
Lump parameter 
Heart rate (bpm) 3-200 
Flow rate (L/min) 0-15 
Stroke volume (mL) 0-180 
Drive technology Servomotor driven piston 
pump 
Special features  Preinstalled physiological 
waveforms 
 
 
BDC HDT-500 
Circulatory simulation Lump parameter 
Heart rate (bpm) 2-240 
Flow rate (L/min) 0-10 
Stroke volume (mL) 0-300 
Drive technology Not reported 
Special features  No need to empty system 
to change test valves 
 
 
Dynatek Labs MP3 
Circulatory simulation Lump parameter, 
Wave propagation 
Heart rate (bpm) Not reported 
Flow rate (L/min) 1-10 
Stroke volume (mL) Not reported 
Drive technology Servomotor or stepper-motor 
driven piston pump 
Special features  No need to empty system 
to change test valves 
 
 
MITL Modular Pulse Duplicator 
Circulatory simulation Lump parameter 
Wave propagation 
Heart rate (bpm) 30-240 
Flow rate (L/min) Not reported 
Stroke volume (mL) 100mL 
Drive technology Linear voice coil actuator 
Special features  Complete modularity and 
customisability 
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 Significance and applications of CPDs 
From their crude beginnings CPDs have played a crucial role in cardiovascular research. 
Over six decades ago they opened the window to the heart by allowing researchers to 
observe its internal components in action. Since then, they have been a vital tool that has 
deepened the understanding of the circulatory system and facilitates the development of 
most cardiovascular devices. Despite the extensive knowledge they facilitated in this 
subject since their use began, CPDs are still in widespread use for studying physiological 
phenomena [64] and the effects of pathologies [65] in the cardiovascular system. The 
effort to better predict and analyse the response of the cardiovascular system is on-going 
and CPDs are extensively used in order to develop, improve and validate mathematical 
models [66, 67, 68]. 
 
The main application of CPDs is in PHV development and testing. Areas of use in this field 
include validation and optimisation of the design as well as approval and certification of 
the final PHV design [22, 26, 69, 70], studies of leaflet kinematics [27, 71, 72] and 
generation of data for numerical simulations [23]. Further aspects of valve development 
in which CPDs play a role include valve leaflet tissue engineering and assessment. There 
is a growing interest in tissue engineered valves because they combine the best features 
of mechanical and bioprosthetic heart valves. Using this approach entails producing a 
valve leaflet scaffold which is seeded with stem cells and then placed in a bioreactor that 
stimulates the cells’ development by exposing them to the target physiological 
environment (a CPD) for a period of time before being implanted [73, 74, 75, 76]. Besides 
leaflets, vascular grafts (prosthetic arteries or veins) are also grown in a similar fashion 
[77]. 
 
Furthermore, CPDs play a critical role in the field of implantable device development other 
than valves. An example is the development of ventricular assist devices and artificial 
vasculature devices. The former works by helping the ventricle to pump blood into the 
aorta while the latter is inserted in the aorta and actively modifies the afterload perceived 
by the ventricle. CPDs are used to help develop and test both the algorithms that control 
these devices and the operation of the device [78, 79]. 
 
Less frequently reported uses for CPDs include the development of non-invasive 
cardiovascular monitoring devices [80] and exploring new endovascular procedures [81]. 
Segers et al [36] sum up the potential uses of a CPD as testing valve prostheses, 
cardiovascular grafts, stents, cardiac assist devices, as well as performing valve studies 
and the validation and calibration of medical technology and measurement methods. The 
key point is that, through their various applications, CPDs have made enormous 
contributions to the field of cardiovascular research and medical technology which 
ultimately have led to a great improvement in the life expectancy and quality of life of 
millions of people around the world. 
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 The development of CPDs and challenges 
CPD design will always be a compromise between a simulation of the ideal physiological 
environment and the practicality of testing. However, there are three basic requirements 
for a CPD to recreate a realistic environment in which to test valves [47]. A CPD must:  
1. generate physiological flow waveforms through the valves. 
2. have an appropriately shaped representation of the left heart and aortic root. 
3. use a test fluid (blood analogue) which has the same viscosity as blood. 
The first requirement above is fulfilled by accurately replicating the action of the ventricle 
(by means of, for example, a servo motor driven piston pump as mentioned in Section 
2.3) and the simulation of the effects of the arterial tree (using a lump parameter model, 
for example, as explained in Section 2.2) respectively. The second requirement must be 
built into the geometric design of the system. The third requirement dictates that the 
elements in the second requirement (left ventricle, left atrium and aortic root) must be 
to a scale of approximately 1:1. Since blood is non-Newtonian, its behaviour differs when 
flowing in small diameter vessels compared to when it flows within the heart. However, 
due to their size, it behaves as a Newtonian fluid in the heart and aorta. It is therefore 
important to maintain this scale so that its non-Newtonian effects can be ignored [47]. 
 
Noting the above conditions should pave the way for a good CPD design. However, despite 
doing so problems can still arise due to the large number of secondary design variables. 
The most common challenges in creating a realistic physiological environment are related 
to the generation of the correct flow waveform through the valves and obtaining the 
appropriate afterload conditions [82]. Krynauw [28] reported that building a system to 
serve the purposes of both a hydrodynamic and a high speed fatigue tester is not 
practically achievable. The parameters of the physical implementation that leads to good 
pressure and flow waveforms at physiological heart rates diverge from those that would 
work for testing at high speeds. Part of the reason for this is that to minimise 
uncontrollable resistance for hemodynamic testing, the use of large diameter pipes is an 
attractive alternative. However, this has the effect of increasing inertance which plays an 
increasing role as heart rate increases. The extra inertance created by the large volume of 
fluid in the pipes is not controllable and is undesirable for accelerated fatigue testing. As 
can be seen in Table 2.1, most commercial CPD systems intended for hydrodynamic 
testing limit the heart rate to a maximum of 240 beats per minute (bpm). Krynauw also 
noted that pressure measurements are highly sensitive to changes in peripheral 
resistance. This means that the peripheral resistance must be controlled in a very fine, 
accurate and repeatable manner, which may require the design and manufacture of a 
specialised device for this purpose. 
 
Another important design consideration with a significant effect on the pressure and flow 
waveforms is ventricular compliance. Ventricular compliance refers to the elastic nature 
of the ventricles which not only helps absorb pressure spikes but also slows down the rate 
of change of pressure [28, 83]. Pressure spikes are caused by pressure wave reflection, 
water hammer and resonance but can be controlled by compliance [44]. Besides pressure 
spikes, the rigidity of the components in modern CPDs causes pressures to oscillate after 
rapid movement of the ventricle. These effects are most noticeable during valve opening 
and closing, particularly if the ventricle and its outflow tract are stiff [83]; the stiffer the 
system the higher the frequency of the pressure oscillations. Figure 2.7 clearly shows the 
Stellenbosch University  https://scholar.sun.ac.za
15 
effects of ventricular compliance: reduced high frequency pressure oscillations and a less 
steep pressure gradient without changing the basic morphology of the waveform. 
 
 
Figure 2.7: Effect of ventricular compliance.  a) Ventricular and aortic pressures with ventricular 
compliance; b) ventricular and aortic pressures without ventricular compliance. The circled regions  
highlight the damping effect of ventricular compliance. (Adapted from [84]). 
 
Most successful CPD systems implement some form of ventricular compliance. This is 
normally achieved by using an enclosed volume of air, similar to the way that aortic root 
compliance is implemented. Ventricular compliance is closely related to fluid isolation and 
they are often implemented together. Fluid isolation refers to the separation of the fluid 
to which the test sample is exposed and the fluid with which the pump components are 
in contact. There are various advantages to fluid isolation which usually takes the form of 
a flexible diaphragm: 
 The working fluid does not need to be a saline solution. This reduces the 
possibilities of corrosion of the pump components which in turn leads to more 
relaxed requirements for material selection of these components. 
 The amount of test fluid, which must be monitored more closely and replaced 
more often, is reduced. 
 Seeding of the test fluid for PIV measurements poses no risks to pump seals and 
components subjected to friction. 
 Using a flexible diaphragm to achieve isolation provides the perfect opportunity to 
create an anatomically correct shape for more natural flow within the ventricle. 
 
Since CPDs are complex systems with so many design variables, their successful 
development requires experience and expertise. Fraser, of Vivitro Labs Inc., cites ten 
reasons to obtain a commercially available CPD instead of developing one in-house [85]: 
i) ease of use, ii) reliability, iii) availability of spares, iv) reputation, v) qualification, vi) 
training, vii) cost, viii) flexibility, ix) consistency and x) aesthetics. Each of these reasons 
can be taken as a point of advice to help shape the final product. Of these, reliability, 
flexibility, consistency and ease of use should be of primary importance as they will 
facilitate qualification (trustworthiness of calibration and device accreditation) and 
reputation (extensive use of the device and positive reports from the research 
community). Since they are critical to the success of a CPD design, they are further 
explained below: 
 Reliability: CPDs are often operated with saline solution, which is corrosive. All 
the materials employed should take this into consideration to limit unexpected 
failures. Software should be built robustly and operated within a stable 
Aortic 
Ventricular 
Atrial 
a) b) 
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environment as there may be a need to record repeatability many hours apart. 
Data acquisition and control systems should have good noise immunity. 
 Flexibility: Ideally, a CPD should be built in a modular fashion so that more 
capabilities can be added in future if needed. This may include accessories for 
simulating valve delivery for transcatheter designs. The design of the test valve 
section should allow for a variety of valve types to be tested. 
 Consistency: This refers to the ability of a system to produce repeatable results. 
This also applies to different systems of the same design. In other words, two 
different CPDs using the same theory of operation or circulatory system 
simulation should be able to produce the same pressure and flow waveforms for 
a given valve even if their implementation differs. 
 Ease of use: This does not only refer to the hardware but also to the software. It 
should be easy to set up tests and swap test valves. The software should clearly 
display the relevant monitoring and control parameters as well as provide safety 
measures throughout the test. 
A design that overlooks the above will likely result in a product with reduced service life, 
frequent modifications, unexpected costs or lack of credibility. 
 
 Guidelines for the assessment of CPDs 
Given that the primary role of CPDs is PHV testing, their design requirements have been 
broadly described by the ISO5840:2005, Annex L.4 (Pulsatile-flow testing) [29]. While the 
Food and Drug Administration (FDA) had its own recommendations concerning in vitro, 
animal and clinical testing requirements for heart valve replacements, it now invokes the 
relevant ISO5840 standard with regards to all in vitro testing, which includes the 
guidelines for test apparatuses [86]. Annex L.4 indicates that the performance of a CPD 
should be evaluated by testing a reference PHV. As a result, while it is possible to evaluate 
certain components of the CPD individually from a technical point of view (discussed in 
Chapter 3), the overall performance of the device must be assessed by testing a reference 
valve and comparing the results obtained to those available in literature. A valve’s 
hydrodynamic performance is assessed at three phases of the cycle: forward flow, closing 
phase and closed phase. The main parameters of interest are the pressure difference 
across the open valve for the duration of the forward flow phase and regurgitation volume 
for the closing and closed phases [47]. The following valve performance parameters help 
describe the operation of the valve and are normally reported: peak systolic pressure 
difference, mean systolic pressure difference, total regurgitant volume, valve leakage 
volume and effective orifice area [87, 88]. They can be used to compare a CPD’s ability to 
recreate physiological conditions to an ISO5840 certified CPD. 
 
Annex L.4 of the ISO5840:2005 standard also explains the functional requirements for the 
CPD, provides accuracy limits for the measuring equipment and suggests test conditions 
and parameters. A summary of the contents that should be included in the test report for 
cardiac valve prostheses offers information on features that should form part of the CPD’s 
control and analysis software. The most important requirements are summarised below, 
in Table 2.2. Table 2.3 details the pressures and other cardiac parameters that the CPD 
should be capable of achieving while fulfilling the requirements described in Table 2.2. 
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Table 2.2: ISO5840:2005 requirements for cardiac pulse duplicators. 
Accuracy 
Pressure ±2 mmHg 
Flow ±2 mL 
Other ±5 % of full-scale 
Functionality 
Produce pressure and flow waveforms that approximate physiological 
conditions over the required physiological range. 
Permit measurement of time-dependent pressures, volumetric flow 
rates, velocity fields and turbulent shear stress fields. 
Allow the repeatability of the test system to be evaluated and 
documented. 
Simulate the relevant dimensions of the cardiac chambers and vessels. 
Allow the observer to view and photograph the PHV at all stages of the 
cycle. 
Simulate relevant cardiac chamber compliances. 
 
 
Table 2.3: Operational environment parameters for aortic PHVs. (Adapted from [29]). 
Parameter Values 
Temperature 34-42 ºC 
Heart rate 30 – 200 bpm 
Cardiac output 3 – 15 L/min 
Stroke volume 25 – 100 mL 
Blood pressure 
according to condition 
Arterial peak 
systolic 
pressure 
(mmHg) 
Arterial minimum 
diastolic pressure 
(mmHg) 
Differential 
pressure across 
closed aortic valve 
(mmHg) 
Hypotensive 60 40 50 
Normotensive 100 – 130 65 - 85 95 
Hypertensive 
   Stage 1 (mild) 140 - 159 90 – 99 123 
   Stage 2 (moderate) 160 - 179 100 – 109 138 
   Stage 3 (severe) 180 – 209 110 - 119 155 
   Stage 4 (very severe) > 210 > 120 185 
Extreme (expected 
maximum for single 
cycle) 
300 160 230 
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3 Materials and Methods 
 Existing apparatus 
3.1.1 Apparatus description 
The BERG CPD was based on a modified version of Krynauw’s design which was extended, 
by replicating the test lines, to test up to four valves simultaneously. In-depth details 
related to the design of this CPD can be found in Knynauw’s thesis [28] but a brief 
description of the basic physical layout and function follows. 
 
The CPD used a lump parameter model for simulating afterload with pulsatile flow 
generated by a piston pump driven by a cam. The piston rod interacted with the cam via 
a roller follower which was kept in contact with the cam by means of a strong spring. The 
shaft carried four cams (one for each test line) and was connected to a standard 4-pole 
alternating current (AC) induction motor by a belt with a 2:1 reduction ratio. A variable 
speed drive was used to adjust the speed of the motor which controlled heart rate. Each 
test line consisted of a cam, the piston pump assembly, a mitral valve in the inlet side of 
the pump (coming from the fluid reservoir) and a test section (at the outlet of the pump) 
comprising the aortic valve test chamber, compliance chamber, the fluid return line and 
peripheral resistance control in the form of a ball valve. Figure 3.1 and the following labels 
supplement this description. a: motor; b: pulley and belt; c: cam, follower and spring of 
piston pump; d: piston pump; e: pump inlet with mitral valve; f: aortic valve chamber 
(providing optical access and pressure measurement points); g: peripheral resistance 
control; h: compliance chamber; i: fluid reservoir. 
 
 
Figure 3.1: BERG CPD at the start of this project. a) Test section; b) pump section. 
The test fluid used is a blood analogue consisting of 48% glycerol and 52% water by mass 
with sodium chloride added to form a 0.9% final saline solution. This mixture is kept at a 
constant temperature of 37 ºC (+-0.2 ºC) using a Delta DTA (Delta Electronics, Taiwan) 
proportional-integral-derivative (PID) temperature controller, a resistance temperature 
detector (RTD) PT100 sensor and two 300W RS Components (RS Components, Corby, 
United Kingdom) submersible heaters mounted among five HT HJ-541 submersible pumps 
to maintain even temperature distribution in the reservoir. When the system is at a steady 
state temperature of 37 ºC this blood analogue results in a viscosity of 3.57x10-3 Ns/m2 
and specific gravity of 1 050 kg/m3. 
a c 
e b 
d 
Flow 
g 
f 
h 
i 
Flow 
a) b) 
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The software received at the commencement of this project provided a unified interface 
for machine control, acquisition and display of data. Controls let users set heart rate 
(motor speed), a time or number of cycles limit for a test, logging settings and safety 
pressures. Acquisition of pressures, cycle count (via an optical switch counting shaft 
revolutions) and fluid level (by use of a float switch mounted inside the reservoir) took 
place whenever the motor run. The interface also provided visual feedback for the 
ventricular and aortic pressures of all testing lines as well as maximum and minimum 
pressures of each line. 
 
3.1.2 Problems identified 
The system described had several limitations. The most relevant of those are summarised 
in Table 3.1 and discussed in the following paragraphs. 
 
Table 3.1: Summary of problems and solutions to improve the original CPD. 
Limitation Consequence Resolution 
Rudimentary drive 
system. 
Lack of adjustability, unreliable 
ventricular discharge. 
Design a new drive system that 
would allow full ventricular 
motion control. 
(Sections 3.2.4.2 and 3.2.2.4) 
Unknown cam 
design. 
Difficulty in diagnosing 
measurement artefacts, 
inability to report parameters 
such as systolic duration, 
unknown ventricular discharge 
profile. 
Obtain numerical cam profile 
by means of an experiment, 
design a new drive system that 
would allow full ventricular 
motion control. 
(Sections 3.3 and 3.2.4.2) 
Inadequate data 
acquisition 
parameters. 
Masking of real process 
conditions. 
Acquire data at 1 kHz without 
any filtering. 
(Section 3.2.4.3) 
Awkward lump 
parameter 
controls. 
Difficulty in achieving the 
required test conditions, lack 
of repeatability. 
Design a new resistive 
element, install a hand pump 
for aortic root compliance 
control. 
(Section 3.2.2.3) 
Flawed test 
section geometry. 
Non physiological flow and 
pressure phenomena 
Design a new test section and 
LVOT. 
(Section 3.2.2.2) 
Poor pressure tap 
design. 
Unreliable pressure readings, 
Masking of real process 
conditions. 
Design a new test section and 
LVOT, install pressure taps 
further from the test sample. 
(Section 3.2.2.2) 
 
Drive system 
The most evident limitation was the cam drive system. Because the piston was driven by 
a cam, not only was the stroke volume fixed but it was also impossible to control the 
ventricle outflow curve. This prevented any fine tuning to eliminate pressure spikes or 
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adjustments to the systolic fraction. However, the biggest drawback of having a 
predetermined stroke volume is the limitation imposed on the size of valves that can be 
tested. A stroke volume that is too large (for a healthy valve at a normal heart rate) 
produces uncontrollable pressure spikes and a strong stenotic effect manifested as a 
misleading high transvalvular pressure gradient. A further problem of the drive system 
was uneven rotational speed due to the sharp cam profile. Even though the cams were 
phased at 90º from each other, there was a large variation in the torque requirements 
through one revolution of the shaft resulting in uneven rotational speed as the motor 
speed control was not a closed loop system and there was no flywheel. This was 
exacerbated by the motor operating at its torque limit while testing at physiological heart 
rates. Since the cam profile represents a time dependent process, the uneven speed 
defeated the purpose of the profile design causing a slower systole (larger systolic 
fraction) and a very abrupt diastolic phase. It was also found that at heart rates above 
160 bpm the cam follower would lose contact with the cam at the beginning of the 
diastolic phase, knocking against it when it eventually caught up. To address all of these 
drawbacks it was decided that a new system, allowing customisable ventricular motion, 
should be employed. The design and implementation of the final system are detailed in 
Section 3.2.2.1. 
 
Cam 
The cams used to actuate the ventricle pumps were replicated from Krynauw’s design but 
there was no detailed information (a mathematical model or numerical data) available to 
accurately establish their displacement profile. One of the hypotheses for the sharp 
pressure spike at the beginning of systole was that the slope of the cam profile was too 
steep (especially for a system without ventricular compliance) but there was no way of 
knowing the instantaneous velocity or acceleration of the piston. To establish these 
parameters, the experiment in Section 3.3 was set up to measure the cam’s displacement. 
The experiment produced a numerical profile that could be used to analyse the operation 
of the cam and as a starting point to the user generated ventricular volume waveform 
used by the system above. 
 
Sampling rate 
The pressure sampling rate was too slow. The original data acquisition software used the 
following equation to determine the sampling rate: 
 𝒏𝑺/𝒔 =
𝑺𝒑𝒆𝒆𝒅𝒃𝒑𝒎
𝟔𝟎
× 𝟑𝟎𝟎    if   𝑺𝒑𝒆𝒆𝒅
𝒃𝒑𝒎
< 𝟐𝟎𝟎𝒃𝒑𝒎 ( 1 ) 
For testing at the ISO5840:2005 recommended heart rate of 70 bpm, this equation yields 
a sampling rate of 350 Hz. Also, a low pass filter with a cut-off frequency of 15 Hz was 
applied to the acquired data before being displayed and logged. Though the acquisition 
rate was similar to the rate of 400 Hz reported by Liu et al [89], the low pass filter cut-off 
frequency is very low when compared to the value of 60 Hz used by Liu. Further, it was 
found that among the modifications made to the software after the CPD was expanded 
to three testing lines the calculation for the sampling rate was bypassed and a fixed rate 
of 250 Hz used for all heart rates. The combination of slow sampling speed and strong 
filter masked several features of the physical process. Sampling at a 1000 Hz without any 
filters revealed many non-physiological characteristics present in the data as well as high 
frequency oscillations superimposed on the pressure waveforms. Through this process 
the real amplitude of the ventricular pressure spike was found to be much higher than 
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reported. It was thus decided that a sampling rate of 1000 Hz would be used to acquire 
data, and a low pass filter with a minimum cut of frequency of 60 Hz to display and 
perform any numerical analysis on the data, where necessary. Some results pertinent to 
the original configuration are included in Section 4.6. 
 
Lump parameter controls 
As can be seen in Figure 3.1, the return line which connects the compliance chamber and 
the peripheral resistance control is a 1m long, two inch diameter hydraulic pipe. Because 
this pipe precedes the peripheral resistance in the hydraulic loop, it introduces a large 
inertance component at higher speeds when peripheral resistance is decreased. Since 
there is no way of varying the amount of fluid inside the pipe, there is no way of adjusting 
the inertance. Another problem in this configuration was the choice of peripheral 
resistance control. The large ball valve proved to be difficult to operate in that it was 
impossible to finely adjust its opening. These two problems were overcome by designing 
a precision resistance valve which was mounted directly onto the new compliance 
chamber (discussed in Section 3.2.2). Moving the resistance control to the compliance 
chamber means that the fluid return to the tank is on the venous part of the circulatory 
system so it does not have a significant influence on the pressures measured in the arterial 
section. 
 
The compliance chamber did not provide a means to reintroduce air once it was released. 
This made it extremely difficult to tune the compliance because if too much air was 
released the system had to be stopped and air reintroduced into the chamber by means 
of pressure equalisation after moving the plunger all the way to the top of the chamber. 
This was solved by the simple addition of a hand pump tapped into the plunger. 
 
Test section geometry 
The design of the aortic valve chamber was the source of a number of flow and pressure 
problems. Figure 3.2 shows the configuration of the valve chamber with blue arrows 
indicating the direction of flow and the red arrow showing the path the pressure wave 
must follow to reach the aortic pressure transducer. With a normal cardiac output of 
5 L/min, this setup will cause the test fluid to crash into the viewing window at a right 
angle at approximately 1.5 m/s during systole. This will lead to highly turbulent flow into 
the outlet to the compliance chamber. However, the pressure wave that arrives at the 
window will be reflected into the test valve tube and interfere with the pressure readings 
and valve leaflet operation. This is primarily due to the short distance between the valve 
tube and the viewing window. 
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Figure 3.2: Original aortic valve chamber and inlet. 
 
Pressure taps 
Besides the problems associated with the flow characteristics of the chamber, the choice 
of location for the pressure taps was poor for several reasons: 
 Given the inlet geometry (diameter reduction and 45º bend), the flow velocity 
profile at the ventricular pressure tap will not be symmetrical and turbulent flow 
will be experienced. 
 The ventricular tap was too close to the valve. If a valve slightly smaller than the 
valve tube diameter is used then the tap is in the turbulent region of a sudden 
contraction, producing unreliable pressure measurements. 
 The aortic tap was too close to the end of the test valve tube. The end of the tube 
represents a sudden expansion and with the flow behaviour previously described 
this tap is in a highly turbulent location. Also, it is likely that this section will 
experience bidirectional flow due to valve regurgitation (especially with a valve that 
is being developed) and under these circumstances the interfering effects of the 
sudden contraction and nearby turbulence outside the tube will be more 
prominent than with forward flow. 
 The path from the aortic pressure tap to the transducer is too convoluted and 
contains sharp bends. Since the valve tube can be rotated within its bore in the 
valve chamber, should it not be perfectly aligned the pressure may have to be 
transferred to the port via the channel (refer to Figure 3.2), potentially along half 
the circumference of the valve tube. Therefore, pressure waves generated by the 
highly dynamic process of pulsatile flow and valve operation are attenuated along 
this tortuosity, masking the high pressure spikes and oscillations to which the test 
valve is really being subjected. This was proven by tapping directly on the opposite 
side of the valve tube through the wall of the valve chamber (shown as alternative 
pressure tap in Figure 3.2). 
It should be noted that this valve chamber and inlet design is not Krynauw’s. The CPD is 
known to have gone through two major revisions between the time that Krynauw’s 
project was concluded and the start of this project. The valve chamber described above 
was implemented during the first revision in which two test lines were added to the CPD. 
To compliance 
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This arrangement is not representative of normal anatomy, as required by the ISO5840 
[29], and given the various problems it presented it was decided to change it. A new 
ventricle outflow tract, valve test section and compliance chamber were designed and 
manufactured. The particulars of this new setup can be found in Section 3.2.2. 
 
 System development 
3.2.1 Requirements and constraints 
Apart from the requirements set out by the ISO5840:2005 (discussed in Chapter 2.6) and 
in line with the aims stated in Section 1.2, a number of other features were desired. Of 
primary importance were independent control of heart rate and cardiac output, as well 
as immediate presentation of raw data and valve performance indicators. Addressing the 
existing issues identified in the previous section such as the precision of the peripheral 
resistance, inertance control and sampling rate was also deemed essential. 
 
Before any conceptualisation work was done, a number of design decisions were taken: 
 Only one test line would be implemented, in line with commercial CPDs. 
 The piston pump assembly would be reused but without the cam follower section. 
 The control, monitoring and logging software would be completely rewritten. 
 All the instrumentation from the existing setup (sensors, heaters and temperature 
controller) would be reused. 
 
3.2.2 Mechanical design 
3.2.2.1 Pump drive system 
One of the most important aspects of this project was to redesign the ventricle pump 
system; as a result, a number of concepts were devised and explored. Three of them were 
chosen for final consideration. To objectively select the best concept, six criteria were 
identified to assess each concept and a weight was associated to each criterion. Each 
concept received a rating from 1 to 3 for each criterion (1 = low, 2 = medium, 3 = high) 
and the weight associated to each criterion was also assigned a value between 1 and 3 (1 
= light, 2 = medium, 3 = heavy). The actual score for a criterion was the product of the 
rating and the weight. The final score for a concept was the sum of the weighted score of 
each criterion. The criteria (and weights) were: 
1. Flexibility (3): Flexibility was a measure of how easily the system could reproduce 
different ventricular conditions. This was the main objective of the new drive 
system so it carries a heavy weight. 
2. Efficiency (1): Efficiency considered the entire drive system: the source of power 
and power conversion. The rationale for assigning a low weight to efficiency was 
that CPDs, unlike durability testers, do not run for long periods of time.  
3. Accuracy (3): Accuracy contemplated not only the smallest change the system was 
capable of achieving but also the ability to validate its effect. These are two 
important aspects of a device used for laboratory tests so it received a heavy weight 
value.  
4. Ease of implementation (2): This is an indication of the difficulty and total amount 
of time required to design, build and control the system. 
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5. Ease of manufacture (2): This refers to the overall manufacturing effort, not only 
how easy it is to machine a part. Therefore, a concept with a large number of parts, 
even if they were easy to make, would have scored a low value. 
6. Overall cost (3): This includes the cost of manufacture and raw materials. As the 
project had very limited financial resources cost carried a heavy weight. 
 
Only solutions with rotary motors as their source of power were included in this analysis. 
Obtaining the resolution, accuracy and speed required for this application using 
pneumatics could have proven unachievable as shown by a similar application [90] and 
compressed air is often not readily available at many locations limiting the availability of 
the CPD itself. This decision was reinforced by the fact that no commercially available CPD 
system could be found that uses pneumatics. The preferred choice would have been a 
linear voice coil actuator, as utilised by the commercial MITL Modular Pulse Duplicator 
[91], but such a system was not within the financial reach of the project, especially after 
accounting for power source requirements and a feedback device. 
 
Swash plate 
This concept was the cheapest because it is run with a standard motor controlled by a 
simple and inexpensive variable speed drive, both of which were part of the existing 
system. However, the manufacturing effort was great and it had a high component count. 
This meant that although it only required a motor to rotate in one direction (resulting in 
high efficiency and a low cost source of power) overall cost was medium due to 
manufacturing expenses. The flexibility of the system was low because it would only have 
been possible to generate sinusoidal waves and although the SV could be adjusted it 
would have required stopping the motor and making manual adjustments with screws 
and counter nuts. Accuracy was compromised due to the difficulty of making precise 
changes to the SV and implementing a feedback system to measure pump position. While 
only very basic programming would have been necessary, the detailed mechanical design 
and construction required significant effort so ease of implementation was average. A 
model of this concept can be seen in Figure 3.3.  
 
 
Figure 3.3: Swash plate pump drive system concept. 
 
Ball screw 
This concept provided full flexibility through the use of a servomotor. Using the 
servomotor’s shaft encoder as position feedback in combination with a ball screw and 
Rotating plate 
Stroke volume 
adjustment 
Shaft (connected 
to motor)  
Bearing block  
Pivot block (connected 
to pump’s piston rod) 
Non rotating plate 
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anti-backlash nut ensured excellent accuracy. Since the ball screw drive (shown in Figure 
3.4) is made up of basic components, manufacturing and assembly was simple and quick. 
On the other hand, implementing a highly dynamic motion controller to accurately control 
the servomotor required careful software design and complex, efficient programming. 
This offset the advantages of an easy build so the ease of implementation was medium. 
While the efficiency of this setup can be improved by careful selection of the ball screw 
pitch, it will never be high because the servomotor is constantly changing direction with 
high accelerations. This also meant a highly dynamic servomotor and controller was 
required which represented a much greater cost than a simple variable speed drive as 
required by the swash plate concept. However, the ability to make small adjustments to 
the system’s operating parameters on the fly made this the concept of choice. 
 
 
Figure 3.4: Lead screw pump drive system concept. 
 
Electric cylinder 
Very similar to the ball screw concept, an electric cylinder (e-cylinder), shown in Figure 
3.5, is a high end servomotor and ball screw packaged as a compact and robust linear 
actuator. It presents the same characteristics of the ball screw concept but with only 
minimal manufacturing required for mounting. The cost, however, is the highest of all 
concepts. 
 
Figure 3.5: SEW CMS50M (150mm stroke) electric cylinder. 
Summary 
Table 3.2 summarises the evaluation of the different concepts considered for the pump 
drive system. Based on this assessment the ball screw was the better choice. However, 
when an electric cylinder together with a suitable motor controller became available to 
Nut block 
Ball screw  
(connected to motor) 
Thrust bearing 
Connection block 
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Ball screw nut 
Servomotor 
Housing 
Ball screw 
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piston pump 
Pivot mount 
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the project it was chosen instead because implementing it required very little 
manufacturing and it represented no direct expenses. The electric cylinder used was a 
SEW CMS50M with 150mm stroke (CMS50M/KY/RH1M/SM1, SEW Eurodrive GmbH & Co 
KG, Bruchsal, Germany) controlled by a SEW MoviDrive MDX61B. 
 
Table 3.2: Summary of concept comparison. 
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Weight 3 1 3 2 2 3 42 
Swash plate Low High Low Med Low Med 
21 
Weighted 3 3 3 4 2 6 
Ball screw High Med High Med Med Med 
34 
Weighted 9 2 9 4 4 6 
E-cylinder High Med High Med High High 
33 
Weighted 9 2 9 4 6 3 
 
3.2.2.2 Aortic root compliance chamber and optical access 
A new aortic root compliance chamber was designed in order to facilitate better flow and 
avert the pressure wave reflections created between the piston and the viewing window. 
The new design eliminated the aortic valve chamber and modified the flow pattern inside 
the compliance chamber with the aim of solving some of the problems highlighted in 
Section 3.1.2. The internal diameter of the chamber was kept the same as the original 
compliance chambers so that the tube and plunger could be reused. To control the 
volume of air within the compliance chamber a hand pump from a blood pressure arm 
cuff was installed on the plunger, making it easy to introduce or release air. Pressure taps 
were positioned on the ventricular and aortic sides of the valve and connected to Wika A-
10 1 bar pressure transducers (WIKA Alexander Wiegand SE & Co. KG, Klingenberg, 
Germany). The pressure taps were positioned at a distance of 50 mm from the valve to 
avoid taking measurements in potentially turbulent flow regions existing near the valve. 
See Figure 3.6 for a sectioned view of the compliance chamber and LVOT. The surgical 
aortic valve holder was designed in collaboration with Mr Kyle Davis of the BERG. 
 
Since at the time of redesigning this part of the CPD ventricular compliance was not being 
considered, the geometry of this section was specifically designed to reduce pressure 
wave reflections in the original layout of the CPD. This geometry resulted in difficult 
optical access to the valve being tested and in order to see the valve in operation a 
correction lens had to be designed and manufactured. 
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Figure 3.6: Section view of the new left ventricular outflow tract and aortic root compliance chamber. 
 
The constraints for the lens design, which included a fixed radius for one of the faces, 
dissimilar indexes of refraction and space limitations, posed some unique challenges 
which led to certain compromises in the design. Each of the faces of the lens, which was 
made from polycarbonate, was cut on a computer numerically controlled (CNC) milling 
machine as a separate process and then polished by hand. Figure 3.7 shows the finished 
lens and the corrective optical effect. Note that in panels b) and c) the camera is very close 
to the face of the lens and the edge of the lens is not visible at all.  
 
   
Figure 3.7: Optical effect of the corrective lens. a) the manufactured lens; b) view through the lens, the 
compliance chamber is empty; c) view through the lens, the compliance chamber is filled with blood 
analogue fluid. 
 
3.2.2.3 Resistor 
Since the original ball valve could not be operated accurately or with good repeatability, 
the device shown in Figure 3.8 was designed and manufactured to regulate flow. The 
design of the new resistor device is based on a needle valve and is such that when fully 
open the flow area is larger than the diameter of the tube on which the test valve is 
mounted (3.8 cm2). The area open to the flow can be controlled by turning the needle 
until the flow is completely obstructed. This makes it possible to easily set the resistance 
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pressure tap 
Aortic 
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Lens Compliance 
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in a repeatable manner. Since the compliance chamber was designed not to reflect 
pressure waves, care was taken to ensure that the area of the resistor exposed to the 
compliance chamber did not present any surfaces against which waves could reflect 
directly. The design also considered the potential for future automation of the resistance 
setting so it provides an easy way to attach a motor to the needle. 
 
 
Figure 3.8: Resistor assembly.  a) sectioned 3D model showing the internals of the resistor; b) the  
manufactured resistor mounted in position. 
Krynauw recommended that the inertance be lowered and this was achieved by mounting 
the resistance control directly on the compliance chamber, eliminating the fluid volume 
of the pipes connecting the compliance chamber to the resistor. This has the greatest 
effect at low resistance values. Since the reservoir follows the resistor in this hydraulic 
loop, any flow after the resistor is considered venous so it does not have a significant 
influence on arterial pressure.  
 
3.2.2.4 Fluid isolation and ventricular compliance 
Fluid isolation was achieved by creating a flexible diaphragm from silicone. The shape of 
the diaphragm was modelled after the anatomy of the human ventricle, following 
guidelines from literature [92, 93] but scaled to fit to the piston pumps’ end plates (refer 
to Figure 3.9 for dimensions). The dimensions were chosen to accommodate the piston 
pump’s maximum safe stroke of 133 mL and care was taken to ensure that the end systolic 
volume, based on physiological values reported by Lang et al [93], also scaled 
appropriately.  
 
Figure 3.9: Ventricle dimensions. 
 
The silicone ventricle was housed in a length of acrylic tube from an old compliance 
chamber contained between two end plates from old piston pump assemblies. One of the 
80mm 
 
   
a) b) 
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old aortic valve chambers was repurposed as the ventricular compliance chamber and 
connected to the piston pump. The second outlet from the piston pump was connected 
to the ventricle through a ball valve to add resistance. Figure 3.10 depicts the physical 
installation. 
 
The piston pump applies pressure to the outside of the ventricle causing it to collapse and 
eject the test fluid through the LVOT once the mitral valve is closed. The ventricular 
compliance is controlled by adjusting the volume of air in the chamber using two syringes 
connected to the chamber via three way valves. The working fluid is a solution of 20% 
glycerol and 80% distilled water, by volume. Glycerol is used as a lubricant for the pump 
seals. 
 
 
Figure 3.10: View of the ventricular section of the CPD. 
 
3.2.3 Mechanical overview 
Figure 3.11 is a diagrammatic representation of the CPD’s new layout while Figure 3.12 
shows the final embodiment of the CPD (in the image a PIV system is set up to visualise 
flow through the aortic tube). One of the old compliance chambers was repurposed as 
the reservoir. This greatly reduced the required test fluid volume (from approximately 
26 L to 3 L) and heating time (from approximately 35 minutes to 18 minutes for a 
temperature change of 17 ºC with the system running). This solution also allows the height 
of volume within the reservoir to be changed easily which can be used to adjust the mean 
atrial pressure. The number of heaters was reduced to one and since it is placed in an area 
of constant flow, the agitators were eliminated completely. 
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Figure 3.11: Physical layout of the CPD. F = flowmeter; P = pressure sensor. 
 
 
Figure 3.12: Final state of the redesigned CPD. 
 
An atrium fashioned from a conventional latex balloon was positioned immediately 
before the mitral valve assembly. This acts as a buffer by quickly collapsing and supplying 
the ventricle with test fluid during diastole, reducing the inertial effects of the volume of 
fluid between the reservoir and the mitral valve. While the mitral valve is closed, the 
atrium fills at a rate determined by the height of fluid in the reservoir (mean atrial 
pressure). The mean atrial pressure can also be used to alter ventricular preload. 
 
The electric cylinder’s rod drives the original piston pump which pumps the working fluid. 
The pressure generated by the pump is manipulated through the ventricular compliance 
settings before it acts on the outer surface of the silicone ventricle. The volume by which 
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the ventricle collapses is the effective SV. The volume ejected through the aortic valve is 
dependent on the efficiency of the mechanical mitral valve (St Jude Regent 25AGFN-756, 
St Jude Medical, Minnesota, USA) so it may differ from the demanded SV. To compensate 
for this, a magnetic flowmeter (Siemens Sitrans Mag 5100W DN15 with a Siemens Mag 
5000 signal converter, Siemens AG, Berlin, Germany) located between the ventricle and 
the aortic valve measures flow rate from which the actual volume ejected is calculated. 
After circulating through the aortic valve, aortic root compliance chamber and resistor the 
test fluid returns to the reservoir where the heater and temperature sensor reside. 
 
3.2.4 Control strategy and software 
Using an electric cylinder provided the opportunity to gain full control of the heart rate, 
SV and the shape of the ventricular discharge waveform so that the behaviour of different 
valve sizes under various operating conditions could be investigated. Modifying the 
ventricular discharge waveform not only allows a more realistic simulation of arbitrary 
cardiac conditions but also extends the functionality of the CPD beyond PHV testing to 
investigate, for example, the repercussions of some ventricular pathologies such as 
fibrillation or other types of arrhythmias. 
 
To achieve the requirements set out in Section 3.2.1 it was decided to use National 
Instruments (NI) LabVIEW 2015 Full Development System (National Instruments, TX, USA) 
as the development software. The reason for this choice is manifold: 
 LabVIEW integrates control, logging and process visualisation functions very well so 
it is ideal for this application which requires immediate visual feedback for tuning, 
logging of various process variables for analysis and fine control over a highly 
dynamic process demanding complex calculations. 
 LabVIEW provides efficient communication mechanisms to facilitate interaction 
between the computer and the real time controller used for controlling the electric 
cylinder. From the available real time controllers a NI myRIO-1900 running LabVIEW 
RT (real time) was selected. 
 LabVIEW has been used numerous times as the software platform for CPDs, both 
academically [89, 94, 95] and commercially [62, 96]. 
 
LabVIEW is a graphical programming language created and maintained by National 
Instruments which has been designed to enable easy interaction with data capturing and 
control devices as well as the creation of rich user interfaces. A program created in 
LabVIEW consists, in its most basic form, of a front panel and a block diagram. The block 
diagram is used to graphically code the processing by intuitively wiring functional nodes 
while the front panel serves as the user interface allowing the display of relevant data and 
user input. The front panel and the block diagram are intended to replicate a hardware 
instrument (for example, an oscilloscope) which has a front panel and internal processing 
hardware components connected by wires so LabVIEW programs are called virtual 
instruments (VIs). The software developed for controlling the CPD consists of a number 
of VIs residing both in the real time controller and a personal computer (PC).  
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3.2.4.1  Software Overview 
Figure 3.13 gives an overview of how information flows between the various devices and 
helps understand the software architecture described in the following sections. The 
general design principle from a user point of view is PC based control so the PC runs the 
main user interface. 
 
 
Figure 3.13: Information flow between the physical components of the system. 
 
The PC and the real time controller communicate over a virtual Ethernet network using 
LabVIEW’s Shared Variable Engine (SVE). This engine facilitates efficient and guaranteed 
data transfer thanks to both network and real time first-in-first-out (FIFO) buffers. The 
parameters used to describe the cylinder’s motion, among other things, are transferred 
to the RT controller using this facility. The primary function of the RT controller is to 
coordinate motion timing and handle hardware controls. The software has been broken 
down into functional components for the purposes of discussion and each one is 
described in more detail in the following sections. 
 
3.2.4.2 Ventricle pump control 
The ventricle pump’s motion was achieved through a cascaded feedback control loop 
approach consisting of two control loops: a speed control loop executed by a SEW 
MoviDrive (SEW MDX61B0015-5A3-4-00) following a position control loop developed for 
a NI myRIO7 (myRIO 1900, National Instruments, TX, USA). The user can graphically design 
the motion pattern that the position control loop will perform. In the following 
subsections the software architecture related to the motion control is discussed.  
Figure 3.14 provides the framework for the discussion and highlights the data exchange 
that takes place to enable the ventricular pump motion. Each thick rectangle represents 
a hardware entity while the thin rectangles represent VIs running within those entities. 
Each major loop running inside a VI was assigned a descriptive name according to its 
function and is listed within its corresponding thin rectangle. The flow of data within and 
between loops is represented by arrows. Data communication crossing the boundaries of 
VIs was achieved through the SVE. 
 
                                                          
7  The NI myRIO is a real time (RT) embedded controller incorporating an FPGA (Field 
 Programmable Gate Array). The RT operating system has direct access to the FPGA which 
 controls all hardware inputs and outputs. This facilitates the development of high speed, 
 complex control applications as well as high speed data acquisition tasks. 
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Figure 3.14: Data exchange pertinent to motion control. 
 
Motion design 
Motion design takes place on the PC through a graphical user interface. Here the user can 
describe the electric cylinder’s motion profile by adjusting 16 sliders (refer to Figure 3.15 
and Appendix E for a more detailed image) or loading a cam profile file. The resting 
position of the pump’s piston (zero displacement) corresponds to a ventricle in complete 
diastolic state. Thus, the beginning of motion marks the start of the systolic phase of the 
cardiac cycle and the sliders control the displacement of the piston in a positive direction 
(generating positive pressure inside the pump). To ensure the piston’s motion always 
begins and ends at the same position, one zero is inserted at the beginning of the array of 
values from the 16 sliders and another at the end. The motion described by cam profile 
files must adhere to this philosophy. 
 
The values of the sliders (or those read from a cam profile file) represent discrete positions 
separated by a constant time period that define the travel of the piston for one heartbeat. 
These values are normalised so they affect only the morphology of the control waveform. 
A control for SV defines the maximum amplitude of the waveform and the array is scaled. 
When using the sliders, the array is then interpolated into a waveform with a number of 
positions selected by the user. The interpolation is done using a spline method, ensuring 
a continuous and smooth waveform. The enforcement of continuity means that this 
operation can result in an interpolated waveform with values that exceed those stipulated 
by the user which would result in larger SVs than requested. In order to guarantee the SV, 
the error between the requested and maximum volume resulting from the interpolation 
operation is calculated. The waveform is then rescaled by this error. Prior to rescaling, the 
waveform is checked for negative values and positive displacement is enforced by means 
of substitution. The graph at the bottom of the user interface shows both the sliders array 
and the fully processed waveform that is sent to the real time controller. Two buttons 
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allow the user to save and retrieve previously configured waveforms providing the ability 
to switch waveforms instantly, even while running. This feature provides the ability to 
easily expand the functionality of the CPD by automating the loading of motion profiles 
from cycle to cycle to perform tests where heartbeats are not identical to previous ones, 
as in the case of missing heartbeats. 
 
 
Figure 3.15: Main user interface showing motion design controls. 
A control allowing the user to set the heart rate dictates the time period over which the 
complete waveform must be executed. The selected heart rate, together with the number 
of points into which the waveform is discretised, determines the rate at which the 
individual positions are fed to the position controller (hereafter called time resolution). 
An option to switch from a fixed number of interpolation points to a fixed time resolution 
is included. Having direct control over the time resolution can lead to improved motion 
controller accuracy and smoother response, overcoming some limitations of the SEW 
MoviDrive related to sampling time (see Section 5.1). Cam profile files are not 
interpolated and the extracted array is sent to the RT controller after scaling it for SV so 
the time resolution is determined by the number of positions in the file and the selected 
heart rate. The above design philosophy means that heart rate, SV and the ventricle 
discharge profile are completely independent of each other and can be adjusted in any 
order or at any time. Also, all parameters can be adjusted during motion allowing for real 
time fine tuning of the ventricular action while monitoring its effect on pressure and flow. 
Figure 3.16 shows the flow diagram for the algorithm used in generating the control 
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waveform for the manual user input; this algorithm only runs when the parameters 
describing motion are modified. 
 
An important feature of the user interface is a graphical display of the piston’s theoretical 
linear speed derived from the fully described motion control waveform (SV and time). This 
is a valuable tool when fine tuning the motion and is useful to detect high accelerations 
which may lead to pressure spikes. These data are further used to ensure that a control 
waveform containing instantaneous speeds in excess of 275 mm/s cannot be sent to the 
controller. The pump’s theoretical flow rate, which is closely related to the linear speed, 
is indicated in the same graph. A button for enabling motion also forms part of the motion 
design window. Figure 3.15 shows the graphical user interface where motion design takes 
place. 
 
 
 
Figure 3.16: Flow diagram for waveform generation in the CPD. 
 
Speed controller 
The speed of the electric cylinder’s servomotor is directly controlled by the SEW 
MoviDrive which was configured for servo speed control, with the setpoint based on a  
-10 V – 10 V analog input. The analog input is read every 1 ms and the setpoint it 
represents passed onto the speed control loop, which iterates every 0.5 ms. The 
MoviDrive’s speed control loop was configured with aggressive parameters aiming to 
optimise tracking of a rapidly changing setpoint (see Section 3.4.1.1 for details related to 
the tuning of the speed controller). Speed feedback is provided to the MoviDrive by the 
servomotor’s built-in 2-pole resolver. In order to perform external position control, the 
MoviDrive was configured to digitise this signal and instead output it as an emulated 1024 
lines per revolution incremental rotary encoder signal. This emulated output was 
connected to the NI myRIO and interpreted as a quadrature encoder signal yielding a 
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resolution of 4096 pulses per revolution. With the electric cylinder’s screw pitch of 5 mm 
this results in a linear resolution of 1.22 μm per pulse. Both the MoviDrive and the NI 
myRIO have a resolution of 12 bits on their analog interfaces and both were configured 
with a range of -10 V – 10 V, translating to a linear speed resolution of 0.183 mm/s. In 
order to successfully exchange these two sensitive signals, filtering capacitors (10 nF) 
needed to be installed at the receiving end of the signals to absorb electrical noise created 
by the high frequency (16 kHz) pulsing of the MoviDrive. 
 
Position controller 
The NI myRIO computes the position of the cylinder from the emulated encoder signal 
and uses this information as the feedback input to the position PID control loop it executes 
every 1 ms, in the PIDloop VI. The speed of the loop was limited to 1 ms due to this being 
the MoviDrive’s sampling speed of its analog inputs. The setpoint for the PID control loop 
is provided by the setpoint writer loop, which runs in the RIOorquestrator VI and iterates 
at a variable rate, equal to the control waveform’s time resolution. The main purpose of 
the setpoint writer loop is to feed the correct position setpoint extracted from the control 
waveform to the PID control loop at the right time. However, it also performs other 
functions related to motion, including: 
 ensuring that an entire heartbeat cycle is completed before committing changes 
made by the user mid-cycle. This prevents sudden and unpredictable changes of 
the control output. 
 handling the starting and stopping of motion, as commanded by the user from the 
PC’s user interface. This function is related to first point above in that the loop will 
ensure the cycle is completed before stopping the motion, thus preventing a dead 
stop and returning the cylinder to its home position. 
 controlling the firing of a configurable synchronisation pulse, which is useful to 
synchronise external measuring equipment such as high speed cameras, pressure 
and flow transducers or any other instrumentation that needs to acquire data at an 
exact point of the heartbeat. This pulse can be configured to fire at the start of the 
heartbeat (once per cycle), for each position in the displacement array or at a 
specified multiple of positions. 
 detecting internal errors and having the ability to set the output of the PID control 
loop to zero. This is important because the output of the position controller maps 
to a speed so if an internal error occurs in the PID loop, its output may be left set 
to a non-zero value which will cause the cylinder to continue moving at a constant 
speed and crash. 
 
The PIDloop VI runs two synchronised timed loops: one for the controller itself and one 
to report the control data to the PC which allows the monitoring and logging of both 
controller performance and process status without burdening the real time controller 
with graphics or saving data. Separating these two functions was done to remove the 
burden of communications from the controller loop. Data are passed from the controller 
loop to the reporting loop using fast, local variables. The reporter loop then compiles the 
variables into a single package that is posted to the SVE from where the PC collects it. This 
package includes the controller loop’s iteration count which, since the iteration period is 
deterministic, can be used to ensure that no data points are missed during transfer 
between loops or devices. 
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The controller loop includes all the functions necessary to run the positioning PID 
controller as well as for self-monitoring (the generation of a heartbeat or stay-alive signal 
reported to the RIOorquestrator VI every loop). The implemented PID controller is of the 
academic type, described by Equation 2: 
 
 
𝑢(𝑡) = 𝐾𝑝 (𝑒 +
1
𝑇𝑖
∫ 𝑒𝑑𝑡
𝑡
0
+ 𝑇𝑑
𝑑𝑒
𝑑𝑡
) ( 2 ) 
where 
 u = controller output 
 e = error 
 Kp = Proportional gain 
 Ti = Integral action time constant 
 Td = Derivative action time constant 
The output of the controller was scaled to the range of the analog interfaces so that it 
could be written directly to the output of the NI myRIO and easily mapped to the 
servomotor’s maximum speed. Provision was made to run the controller in both 
automatic and manual modes. When in manual mode the PID constants are automatically 
adjusted to enable smooth, slower positioning as the parameters used during normal 
operation are too aggressive, resulting in overcurrent errors in the MoviDrive. 
 
An important part of the controller loop is the PID constants scheduling feature. This 
enables the controller to operate optimally over a wide range of conditions, in this case 
cardiac output. The reason for using cardiac output as a reference is that the velocity of 
the cylinder for a given waveform is a product of heart rate and stroke volume. Running 
the CPD at 3.5 L/min with constants that provide satisfactory performance at 20 L/min 
results in jerky operation. Conversely, when the controller is configured with constants 
that enable smooth operation at 3.5 L/min, it cannot track the steep speed gradients 
introduced by the rapidly changing setpoint at 20 L/min. To ensure optimal performance 
through the entire range of cardiac output, a linear PID constant scheduling system was 
implemented. Since the heart rate used for most tests is 70 bpm (termed the base), the 
controller was tuned for best performance using a sine wave with this frequency and a 
peak to peak amplitude of 11.23 mm, corresponding to a cardiac output of 5 L/min (see 
Section 3.4.1.1 for details related to the tuning of the position controller). The 
proportional gain (Kp) and integral time constant (Ti) obtained from this tuning point were 
regarded as the base constants. The process was then repeated but with a cardiac output 
corresponding to 24.2 L/min, the maximum designed combination of heart rate and 
stroke volume. The constants recorded from these two tuning points were used to 
calculate the optimal performance gradient for Kp and Ti. Equation 9 and Equation 11 are 
used within the controller loop to calculate the effective constant values whenever the 
heart rate is adjusted. These equations arise from a linear function (Equation 3). The result 
of Equation 3 is added to the base constant allowing Kp_eff to be adjusted proportionally 
such that 𝐾𝑝_𝑒𝑓𝑓@𝐶𝑂<𝐶𝑂𝑏𝑎𝑠𝑒 < 𝐾𝑝_𝑏𝑎𝑠𝑒 < 𝐾𝑝_𝑒𝑓𝑓@𝐶𝑂>𝐶𝑂𝑏𝑎𝑠𝑒 < 𝐾𝑝_𝑚𝑎𝑥 (Equation 6). 
Figure 3.17 helps to understand the variables used in the equations. It also shows the 
recorded optimal Kp and Ti values at 5 L/min and 24.2 L/min. Although all the equations 
reflect variables labelled for Kp, they apply to Ti as well. 
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Figure 3.17: Values used in the determination of the optimal performance gradient for constants Kp and Ti. 
 
 𝑦 = 𝑚𝑥 + 𝑐  =>   𝐾𝑝_𝑎𝑑𝑑 = 𝑚. 𝐶𝑂 + 𝑐 ( 3 ) 
where 
 𝑐 = −𝑚𝑥𝑏𝑎𝑠𝑒 = −𝑚. 𝐶𝑂𝑏𝑎𝑠𝑒 ( 5 ) 
 
where  
 Kp_add = the proportional part of the Kp gain that must be added to Kp_base 
 Kp_max = Kp gain for best performance at 24.2 L/min 
 Kp_base = Kp gain for best performance at 5 L/min 
 
 
 𝐾𝑝_𝑒𝑓𝑓 = 𝐾𝑝_𝑏𝑎𝑠𝑒 + (𝑚𝐶𝑂 + 𝑐) ( 6 ) 
 
 
𝐾𝑝𝑒𝑓𝑓 = 𝐾𝑝𝑏𝑎𝑠𝑒 + [(
𝐾𝑝𝑚𝑎𝑥 − 𝐾𝑝𝑏𝑎𝑠𝑒
19.2
) 𝐶𝑂 − (
𝐾𝑝𝑚𝑎𝑥 − 𝐾𝑝𝑏𝑎𝑠𝑒
19.2
) 𝐶𝑂𝑏𝑎𝑠𝑒] ( 7 ) 
 
𝐾𝑝_𝑒𝑓𝑓 = 2 +
1
19.2
𝐶𝑂 −
1
19.2
𝐶𝑂𝑏𝑎𝑠𝑒 ( 8 ) 
 
𝐾𝑝_𝑒𝑓𝑓 = 1.73958 +
1
19.2
𝐶𝑂 ( 9 ) 
where 
Kp_eff = effective proportional gain  
 
Following from Equation 7, for Ti: 
 
𝑇𝑖 = 0.15 −
0.12
19.2
𝐶𝑂 +
0.12
19.2
𝐶𝑂𝑏𝑎𝑠𝑒 
 
( 10 )  
 
𝑚 =
∆𝑦
∆𝑥
=
𝐾𝑝_𝑚𝑎𝑥 − 𝐾𝑝_𝑏𝑎𝑠𝑒
𝐶𝑂𝑚𝑎𝑥 − 𝐶𝑂𝑏𝑎𝑠𝑒
=
𝐾𝑝_𝑚𝑎𝑥 − 𝐾𝑝_𝑏𝑎𝑠𝑒
19.2
 ( 4 ) 
K
p
  
; 
T
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𝑇𝑖_𝑒𝑓𝑓 = 0.18125 −
0.12
19.2
𝐶𝑂 ( 11 ) 
where 
Ti_eff = effective integral time constant 
 
It should be noted that while the derivative term is implemented in this controller, in 
practice its constant is normally kept to zero so it was not incorporated in the scheduling 
system. The flow diagram for the PIDloop VI is shown in Figure 3.18. The front panel of 
the PIDloop VI (refer to Appendix E) makes the controller’s parameters available to the 
user although in general these parameters do not need to be changed and are used for 
development or tuning. 
 
 
Figure 3.18: Flow diagram for the PIDloop VI. 
 
Stroke volume controller 
When ventricular compliance is introduced, the requested SV may no longer be an 
accurate indication of the volume ejected through the aortic valve due to the 
compressibility of air in the ventricular compliance chamber. Since the working fluid’s 
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pressure is not monitored, there is no way of establishing the effective SV. To maintain an 
accurate cardiac output, a closed loop system (using the flow meter reading as feedback) 
was implemented to automatically adjust the piston pump’s stroke to match the effective 
SV to the requested SV. The algorithm described below is presented as a flow diagram in 
Figure 3.19. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.19: Flow diagram for the stroke volume controller’s algorithm. 
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The system works on a cycle by cycle basis and is activated for an adjustable number of 
cycles after any changes to the motion descriptors are detected, allowing the system to 
settle. The volume discharged during the previous cycle is calculated by integrating the 
positive region of the instantaneous flow rate curve. The controller compares this volume 
to the requested SV, computes percentage and volume errors and uses these values to 
rescale the control waveform for the next cycle. The algorithm is designed in such a way 
that the original requested volume is never affected and the PC supplying the control 
waveform is unaware of any modifications to it. Prior to modifying the control waveform, 
the controller checks if the initial error is within acceptable limits. If the initial error is 
beyond the defined limit, the ventricular compliance settings or the limit must be 
adjusted. The limit is pre-set to a safe value that will prevent the piston from being driven 
too far in an attempt to reach the correct SV, should the ventricular compliance chamber 
contain too much air or volume measurement errors arise. 
 
To prevent sudden changes which could destabilise the controller when errors are large, 
the maximum volume by which the controller can increase or decrease the control 
waveform is limited for each cycle, allowing a progressive change. Further, in order to 
enable steady state measurements, the volume error is checked against a dead zone value 
and if the error is smaller than the dead zone value the controller does not make any 
adjustments. The dead zone value represents a convergence tolerance and prevents the 
controller from making adjustments indefinitely, which could result in cycle to cycle 
variations for pressure and flow measurements. To illustrate the above-mentioned 
functions, if the total error to be corrected is 9 mL and the cycle to cycle volume change 
is limited to 2 mL, the controller will increase the volume by 2 mL one cycle at time until 
the error is below this limit and then continue to adjust the volume proportionally until 
the error is within the dead zone.  
 
3.2.4.3 Data acquisition 
The NI myRIO was found to have insufficient resolution on its analog inputs to meet the 
ISO5840:2005 specifications stipulated in Table 2.2 for pressure and flow measurements. 
This led to the need for a separate data acquisition (DAQ) card (National Instruments USB-
6009) to record the data. 
 
The variables measured by the DAQ card are ventricular, aortic and atrial pressures as 
well as aortic flow rate. All transducers were set up for current output and each is 
measured by the DAQ via a 500 Ω precision resistor (PAPTF56500R00BYEK, Vishay 
Intertechnology, Inc., PA, USA). A facility to input calibration data for the pressure 
transducers has been included in the acquisition window, making it possible to 
automatically calibrate all measurements as they are acquired. By default, data from all 
transducers is acquired at 1000 Hz although this can be changed in the data acquisition 
window. 
 
The data acquisition window (refer to Appendix E) provides graphical feedback of the 
variables being measured, valve performance indicators, options for logging acquired data 
and controls for the acquisition parameters. Both raw and filtered plots of pressure and 
flow measurements are displayed as they are acquired. 
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 Reproduction of cam profile 
One of the main challenges encountered during preliminary tests with the CPD in its 
original configuration was determining the source of abnormal pressure waveforms. After 
ruling out other factors such as the geometry of the hydraulic loop, it was suspected that 
the shape of the ventricular discharge waveform was not appropriate because there was 
no numerical information available for the cam being used. 
 
To obtain a numerical profile for the cam, the experiment shown in Figure 3.20 was set 
up. It consisted of a vertically mounted HBM 1-WA/50MM-L (Hottinger-Baldwin-
Messtechnik GmbH, Darmstadt, Germany) linear variable differential transformer (LVDT) 
(a) contacting the cam (b) which was mounted on the shaft of a SEW DT90S4 motor (e). 
On the other side of the motor’s shaft, a shaft encoder (f) with 1024 pulses per revolution 
(SEW ES1R) was attached and used to trigger the readings of the LVDT. The LVDT was 
connected to a NI USB-6212 data acquisition card (d) via an instrumentation amplifier 
(HBM Clip A501) (c). A SEW MoviDrive (SEW MDX61B0015-5A3-4-00) (g) was used to 
rotate the motor at 2 rpm. Two separate LabVIEW programs were used to acquire and 
post process the data. 
 
 
Figure 3.20: Experimental setup used to obtain cam profile. a) LVDT; b) cam; c) instrumentation 
 amplifier; d) data acquisition card; e) motor; f) encoder; g) SEW MoviDrive motor controller. 
 
A number of steps were taken to help minimise measurement errors: 
 A tip cut at 20º was attached to the end of the LVDT core to help eliminate errors 
while measuring the steep gradients of the cam. 
 The axis of displacement of the LVDT was aligned with the centre of the motor 
shaft’s diameter to prevent errors due to the cosine effect. 
 The LVDT was calibrated using gauge blocks. Only 20 mm of the LVDT were 
calibrated (because the cam’s maximum displacement was measured at 
15.55 mm) but this was the only part of the LVDT’s core that was used in the 
experiment and this section was chosen because it was identified as having the 
lowest electrical error in the factory calibration certificate (see Appendix A). 
a 
b 
c 
d 
e 
f 
g 
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 For every encoder pulse, 20 measurements were taken at a sampling frequency 
of 1000 Hz. These measurements were then averaged, eliminating errors caused 
by electromagnetic interference (EMI) because a single data point was measured 
over an entire period of mains power frequency (50 Hz). 
 Five full rotations of the cam were recorded and the data smoothed using a 
moving average filter with a half-width of five data points. 
 The point-by-point average of the five rotations was used to produce a curve 
representative of the cam profile (each data point in the final curve represents 
the average of the corresponding points in the five rotations). 
 
The final combined curve generated by this process was interpolated into an array with a 
user-defined number of data points and saved to a file. This file could then be directly 
read by the CPD’s control program and used to simulate the original cam profile (with any 
SV) in the hydrodynamic tests (see Section 3.4.3). 
 
 Calibration and testing 
This section describes the methods used for calibration of the various components of the 
CPD as well as tests carried out to validate the accuracy and overall performance of the 
CPD as a complete system. For details related to the calibration of the instrumentation, 
refer to Appendix A. Thanks to the design approach, calibration and assessment of the 
motion control system could be done independently of the rest of the CPD. The rest of 
the performance aspects of the CPD (Section 3.4.2) needed to be assessed by means of 
testing a reference valve and commercially available PHVs were used for this. Finally, as 
part of this project, the hydrodynamic performance of two PHVs was investigated 
following the procedures recommended in ISO5840:2005 as proof that the CPD can 
achieve all the required test conditions. The details of the tests used for this purpose are 
presented in Section 3.4.2.4.  
 
3.4.1 Ventricular motion control 
3.4.1.1 MoviDrive servomotor speed controller 
Owing to the electric cylinder’s limited range of motion the MoviDrive’s speed controller 
could only be tuned using a sine wave as speed input. To measure actual speed, the 
servomotor’s encoder pulses were counted and differentiated using the sampling 
frequency. The measured speed was plotted together with the speed setpoint wave and 
the position of the cylinder. The speed controller’s parameters were adjusted with the 
process running so that the effect of changes in the parameters could be seen 
immediately in graphical form. 
 
The sine wave was initially configured with an amplitude of 1 V and a frequency of 1.16 Hz 
(70 bpm), resulting in a displacement of 10.3 mm which corresponds to a CO of 
approximately 4.5 L/min. The controller was then tuned at this operating point. When 
configured for servo speed control the MoviDrive uses a mixed feedback/feedforward 
control scheme which improves setpoint tracking and regulation. Thanks to this, the 
MoviDrive can maintain the servomotor’s speed to within 0.01% error of a stationary 
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setpoint, provided that both the motor and the MoviDrive are correctly sized for the load 
demands of the application [97]. From the position controller’s point of view, this means 
that the speed is essentially guaranteed regardless of the load applied to the motor. 
Nevertheless, to verify the accuracy of the speed controller, its response was tested by 
configuring the sinusoidal wave with various maximum speeds and frequencies. This 
exercise also served to assess the operational range (frequency and magnitude response) 
of the system. Table 3.3 shows the operating points that were verified and indicates the 
equivalent CO. The maximum speed tested was 300 mm/s. While many of the operating 
points tested represent non-physiological conditions they were tested regardless to verify 
the behaviour of the system at that speed since the control waveform could cause the 
position controller’s output to contain such velocity values. 
 
Table 3.3: Operating points tested during speed calibration. 
Frequency 
Max 
amplitude 
1 Hz 
(60 bpm) 
1.167 Hz 
(70 bpm) 
1.5 Hz 
(90 bpm) 
2 Hz 
(120 bpm) 
3 Hz 
(180 bpm) 
3.333 Hz 
(200 bpm) 
1 V (37.5 mm/s) ~4.6 L/min 
2 V (76 mm/s) ~9.25 L/min 
3 V (112.5 mm/s) ~13.85 L/min 
5 V (187.5 mm/s) ~23.88 L/min 
7 V (262.5 mm/s) ~32.16 L/min 
8 V (300 mm/s) ~36.85 L/min 
 
3.4.1.2 LabVIEW position controller 
The position controller was tuned once the speed controller was considered to be 
performing optimally. To safely obtain a controller that was stable but responsive to step 
inputs, the PID constants were initially adjusted by loosely following the Ziegler-Nichols 
ultimate sensitivity method of PID tuning as well as guidelines provided by Franklin et al 
[98]. The controller’s parameters were subsequently fine-tuned experimentally using a 
control waveform derived from the cam profile obtained through the experiment 
described in Section 3.3. The amplitude and frequency of the control waveform were set 
to simulate physiological conditions using data from Table 3.4 as a reference, to 
realistically match HR to SV. 
 
Table 3.4: Cardiovascular response to exercise in adults.  (Adapted from [99]). 
 Rest 
Exercise 
(moderate) 
Exercise 
(maximal) 
HR (bpm) 71 ±15 146 ±12 189 ±12 
SV (mL) 81 ±23 119 ±22 128 ±23 
CO (L/min) 5.72 ±2.22 17.61 ±3.28 24.26 ±4.62 
 
In order to implement the PID constant scheduling system discussed in Section 3.2.4.2, 
the system needed to be tuned at two operating points. A frequently used point (70bpm) 
and the upper limit of the speed range (200 bpm) were chosen. The optimal PID constants 
were first determined for the rest conditions by adjusting them until the tracking error 
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could no longer be improved. The process was then repeated for the operating point 
corresponding to maximal exercise, using the same control waveform.  
 
The stroke volume controller could not be tested due to the poor performance of the 
flowmeter used. In order to fulfil its purpose the controller requires accurate feedback, 
especially in terms of determining flow reversal, and this could not be achieved with the 
available instrumentation. The algorithm was presented as part of this project’s 
contribution to the field but it should be noted that its performance is untested. The 
limitations experienced as a result of the flowmeter’s performance are summarised under 
Section 4.5.  
 
3.4.1.3 Ventricle pump accuracy and resolution 
Evaluation of the overall ventricular motion performance was carried out once both 
controllers were tuned. This involved assessing the resolution, accuracy and effective 
tracking error of the controller. While performing analyses of the system’s positioning 
ability it is important to note that due to the type of controller used and the nature of the 
system the process will always lag the control signal by a small amount. Part of the 
objective of this section was to establish this lag time. However, in this application, the 
ability to closely reproduce the control signal is more important than the lag time. 
Therefore, emphasis is placed on analysing the morphology and magnitude of the process 
value instead of phase so when performing analyses related to tracking, the process value 
and the control signal are time aligned. Further, for this application accuracy does not 
only refer to magnitude but it also contains a time component: for the controller to be 
accurate it has to attain a position at the correct time. Given this and the fact that the 
process lags the setpoint by a certain amount of time, the measurable accuracy is 
dependent on motor speed because of the fixed sampling rate (at high speeds the 
setpoint may be attained but not picked up during sampling). Nevertheless, accuracy is 
evaluated at a given practical speed as described below. 
 
The system’s theoretical linear displacement resolution is 1.22 μm but while this is 
achievable with a step input, it does not necessarily reflect the controller’s ability to go 
through a position of this multiple during motion. Preliminary testing showed that 
pressures are highly sensitive to even minute changes in the control waveform so it was 
deemed relevant to know the smallest change in position that the system can achieve 
because this would help to fine tune pressure curves. To test resolution and accuracy a 
500 point, 60 bpm control waveform was setup with a stroke of 10 mm and the electric 
cylinder’s displacement was recorded as a baseline. One control point was then modified 
to effect a change of +0.1 mm. Subsequent tests were carried out, reducing the amount 
of change until it became imperceptible. The difference in position between the baseline 
and modified cylinder displacements were computed and plotted together. 
 
Tracking ability was quantified by computing the root mean square error (RMSE) between 
the control waveform and the electric cylinder’s measured position. This was done beat-
to-beat for five consecutive heartbeats and the standard deviation for the individual 
RMSEs calculated. Using this approach instead of calculating a single RMSE for five beats 
provides a more reliable indication of random beat fidelity. Three operating points, based 
on Table 3.4, were verified using this process. 
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3.4.2 Hydrodynamic verification 
Tests intended to validate the CPD’s hydrodynamic performance were done using 
commercially available aortic PHVs, described in Table 3.5. Note that there are two 
identical St Jude Medical Epic 21 mm PHVs and they are referred as SJME V1 or SJME V2. 
PHVs of different designs were used to demonstrate that the CPD can produce the 
required test conditions irrespective of the sample being assessed. The valves tested are 
aortic models and were tested in the aortic position.  
 
To allow comparisons between two separate measurements, the recordings were 
synchronised using the closing of the aortic valve as the reference event. For the purposes 
of these tests compliance is characterised by the volume of air present in the respective 
chamber once the system reached steady state. All measurements were recorded once 
the system had settled (reached steady state) which was regarded to have been achieved 
once changes in the systolic pressure trace were no longer observable from cycle to cycle. 
The settling time was dependent on cardiac output and the extent of changes in lump 
parameter controls but steady state was typically achieved within five to 25 heartbeats. 
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Table 3.5: Commercially available aortic PHVs used for the verification of the CPD’s hydrodynamic performance. 
Valve 
SJME V1/V2  SJME V3 SJMR 
St Jude Medical Epic 21 mm 
(SJM E100-21A; St Jude Medical, Inc., 
Minnesota, USA) 
St Jude Medical Epic 23 mm 
(SJM E100-23A; St Jude Medical, Inc., 
Minnesota, USA) 
St Jude Medical Regent Aortic 25 mm 
(SJM 25AGFN-756, St Jude Medical, Inc., 
Minnesota, USA) 
Tests 
V1: 
 ISO tests (all) 
 Comparison to original CPD 
V2: 
 ISO tests (all) 
 Adjustment of lump parameter controls 
 Effect of changes in control waveform on 
pressure 
 Repeatability and fidelity 
 Tests for comparison to published data  ISO Test 1 
 Ventricular compliance 
 
Description Bioprosthetic stented trileaflet from porcine aortic valve cusps Mechanical bileaflet from pyrolytic carbon 
Dimensions8 
(mm) 
Nominal size: 21 Nominal size: 23 Nominal size: 25 
 
 
 
 
 
  
Image 
   
                                                          
8 All dimensions are measured, except for the geometric orifice area of the SJMR PHV which is quoted from the manufacturer. 
Geometric orifice 
area: 1.94cm2 
Geometric orifice 
area: 4.02 cm2 
Internal diameter: 15.7 Internal diameter: 23.0 
Tissue annulus diameter: 26.4 
Internal diameter: 17.9 
Geometric orifice 
area: 2.52 cm2 
Tissue annulus diameter: 21.1 Tissue annulus diameter: 23.1 
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3.4.2.1 Adjustment and effect of compliance and resistance controls 
Aortic root compliance and peripheral resistance 
The principle of operation of these controls has been described and the tests performed 
in this section serve the purposes of verifying that the design being presented behaves as 
expected and is capable of producing the operating conditions required for testing of 
PHVs according to ISO5840:2005 guidelines. As such, this section is not intended to 
present exhaustive tests to investigate the effect of compliance and resistance at various 
combinations of HR and SV but rather to evaluate the design of the controls. Achieving all 
the required test conditions set out in Section 3.4.2.4 represents the ultimate test of 
performance. 
 
The SJME V1 PHV was used for these tests. Aortic compliance was initially set to 
approximately 650 mL, based on the recommendation for the Vivitro CPD [46]. Sufficient 
fluid was introduced into the compliance chamber to ensure that air would not enter the 
aorta or the resistance element during pumping, which was set to 70 bpm with 
CO = 5 L/min. Based on widely accepted physiological values, a target of 120/80 mmHg 
was set for the arterial pressure. The effect of the controls is demonstrated by comparing 
the pressures and flow before any adjustments were made and once the target values 
were reached, quantifying the changes made at the controls. No changes related to the 
ventricular action were made and no ventricular compliance was used. 
 
Ventricular compliance 
The effect of ventricular compliance on pressures (ventricular, aortic and atrial), as well 
as flow rate was investigated by means of the two tests described in Table 3.6, using the 
SJMR PHV. A mechanical valve was used for this test as its rigidity makes it easier to 
demonstrate the effect of ventricular compliance. The conditions for Test 2 were chosen 
based on the fact that PHVs are seldom studied in vitro at cardiac outputs exceeding 
7 L/min. Laske et al [100] present a review of eight in vitro studies for the SJM bileaflet 
PHV, none of which exceed 7.5 L/min for the 25 mm model. For tests involving other PHV 
sizes where the cardiac output is above 7.5 L/min, the heart rate is above 70 bpm. This 
led to the decision of using a heart rate of 90 bpm and a cardiac output of 7.5 L/min since 
physiologically it is more plausible to reach 7.5 L/min at 90 bpm than at 70 bpm. 
 
To perform these tests, first arterial pressure was stabilised through the adjustment of 
the aortic root compliance and peripheral resistance controls. Initially no ventricular 
compliance was used. After recording baseline pressure and flow variables, the 
ventricular compliance controls were manipulated to eliminate as much as possible of the 
high frequency oscillations highlighted in Figure 2.7. Measurements were taken again 
once the system had settled. All other variables were kept constant for the duration of 
this process. 
 
Table 3.6: Test conditions for the ventricular compliance experiment. (HR: heart rate; CO: cardiac output; SV: 
stroke volume; Psys: arterial systolic pressure; Pdias: arterial diastolic pressure; MAP: mean arterial pressure)..... 
Test HR CO SV Psys/Pdias MAP 
T1 70 bpm 5 L/min 71.43mL 120/80 mmHg 100 mmHg 
T2 90 bpm 7.5 L/min 83.33mL 140/80 mmHg 110 mmHg 
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3.4.2.2 Effect of changes in control waveform on pressure 
The ability to modify the control waveform during operation and observe the effects of 
the change on the process through immediate graphical feedback greatly simplifies the 
task of fine tuning the system for pressure, the main variable being controlled. This section 
presents a set of tests devised to demonstrate how the cylinder’s path affects pressure, 
with all other settings (HR, SV, ventricular compliance, aortic compliance, peripheral 
resistance and mean atrial pressure) being equal. All tests in this section were performed 
using the SJME V1 PHV. 
 
Response to changes in a single control point 
The effect of changes to one control point was investigated with the aim of better 
understanding how to tune the pressure profile. Using a control waveform of 500 
positions the chosen control point, affecting the waveform at location 140 (of 500), was 
increased by 0.1 mm per heartbeat for 7 heartbeats. The test was performed at a HR of 
60 bpm and a SV of 63.62 mL (this combination results in a stroke of 10 mm and 2 ms per 
position). Arterial pressure was set to 120/80 mmHg with a MAP of 100 mmHg.  
 
Tuning the pressure profile 
The aim of this test was to improve the shape of the pressure profile by changing only the 
control waveform. A pressure profile produced by a given 500 position control waveform 
and exhibiting systolic pressure spikes was used as the base for the comparison. All 
parameters were identical to those used in the previous test. 
 
3.4.2.3 Repeatability and fidelity 
Repeatability 
Basic cylinder repeatability is indirectly proved and presented in Section 4.1.4. 
Repeatability of the CPD as an instrument was assessed hydrodynamically rather than 
from the perspective of a controller’s response. Two repeatability notions are employed: 
intra-test and inter-test repeatability. Intra test repeatability is based on pressure 
measurements of 5 consecutive heartbeats. It is established by calculating the standard 
deviation (SD) of the RMSEs between the differential pressures of a baseline heartbeat 
and the following five individual heartbeats. To evaluate inter-test repeatability it is 
necessary to perform another test, a large number of heartbeats after the first test 
(without adjusting any parameters) and determine a second intra-test repeatability value 
using the original baseline heartbeat as reference. Inter-test repeatability is then 
determined by the average of the two standard deviations. Therefore, an inter-test 
repeatability value of zero indicates perfect repeatability. Repeatability within a group of 
consecutive heartbeats can be ascertained from the individual SD values. Figure 3.21 
explains the concept diagrammatically. 
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The repeatability experiment was performed with the SJME V2 PHV. Arterial pressure was 
set to 120/80 mmHg with HR = 70 bpm and CO = 5 L/min. Two measurements were taken, 
approximately 30 minutes apart, without having modified any test parameters. 
 
Fidelity 
As repeatability cannot account for accuracy, the idea of fidelity is introduced in an effort 
to provide a single metric that can be used to judge the CPD’s performance in terms of 
both of these properties. This is a challenge due to the fact that accuracy contains an 
element of time (the correct amplitude must be generated at the correct time within a 
cycle) and this must then be evaluated over multiple cycles. Since pressure is not 
controlled directly, there is no setpoint to which measurements can be compared so 
certain features of the arterial pressure trace were chosen as reference: systolic 
(maximum), diastolic (minimum) and mean values. The systolic and diastolic pressures are 
used in conjunction with the theoretical time at which they should occur within a 
heartbeat. Together, these five measurements provide a good indication of arterial 
pressure conditions and morphology. The theoretical time, in terms of arterial pressure, 
where a maximum or minimum pressure should occur was estimated from the piston 
speed (derived from the control waveform) and phased by using the beginning of systole 
as a reference. 
 
The following equations were constructed to quantify fidelity: 
 
F𝑃𝑠𝑦𝑠𝑡 =
|𝑃𝑠𝑦𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡 − 𝑃𝑚𝑎𝑥|
𝑃𝑠𝑦𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡
 +  
|𝐼𝑛𝑑𝑒𝑥𝑃𝑠𝑦𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡 − 𝐼𝑛𝑑𝑒𝑥𝑃𝑚𝑎𝑥|
𝐼𝑛𝑑𝑒𝑥𝑃𝑠𝑦𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡
2
 
( 12 ) 
 
 
F𝑃𝑑𝑖𝑎𝑠𝑡 =
|𝑃𝑑𝑖𝑎𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡 − 𝑃𝑚𝑖𝑛|
𝑃𝑑𝑖𝑎𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡
 + 
|𝐼𝑛𝑑𝑒𝑥𝑃𝑑𝑖𝑎𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡 − 𝐼𝑛𝑑𝑒𝑥𝑃𝑚𝑖𝑛|
𝐼𝑛𝑑𝑒𝑥𝑃𝑑𝑖𝑎𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡
2
 
( 13 ) 
 
 
F𝑃𝑀𝐴𝑃 =
|𝑃𝑀𝐴𝑃_𝑡𝑎𝑟𝑔𝑒𝑡 − 𝑃𝑀𝐴𝑃|
𝑃𝑀𝐴𝑃_𝑡𝑎𝑟𝑔𝑒𝑡
 
( 14 ) 
 
 
Figure 3.21: The concept used to evaluate repeatability of the CPD. 
T1 T2 x beats 
(Intra-test repeatability 1) (Intra-test repeatability 2) Inter-test repeatability 
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where:  
F𝑃𝑠𝑦𝑠𝑡  
F𝑃𝑑𝑖𝑎𝑠𝑡  
F𝑀𝐴𝑃 
 
= 
Fidelity value for systolic, diastolic and mean 
pressures, respectively. 
𝑃𝑠𝑦𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡 
𝑃𝑑𝑖𝑎𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡 
𝑀𝐴𝑃𝑡𝑎𝑟𝑔𝑒𝑡 
 
= 
Target systolic, diastolic and mean  
pressures, respectively. 
𝑃𝑚𝑎𝑥 
𝑃𝑚𝑖𝑛 
MAP 
 
= 
Measured systolic, diastolic and mean  
pressures, respectively. 
𝐼𝑛𝑑𝑒𝑥𝑃𝑠𝑦𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡  
𝐼𝑛𝑑𝑒𝑥𝑃𝑑𝑖𝑎𝑠𝑡_𝑡𝑎𝑟𝑔𝑒𝑡  
= 
Theoretical location within heartbeat when systolic and  
diastolic pressures, respectively, should occur (sample number). 
 
To prevent negative values (which could bias the results towards zero when calculating 
the difference between the target and the measurement) the absolute value of the 
difference is used before normalising the result. This ensures that the error is centred on 
the target and negative values do not skew the result. Summing both terms ensures that 
if the target for one of the measurements is achieved but the other is not, an error is still 
registered. Equation 12 and Equation 13 contain two normalised terms so they are divided 
by 2 to give a range of 1, where 1 means that the magnitude of each of the errors is as 
large as the target itself and 0 indicates perfect fidelity. 
 
Equation 12 to Equation 14 yield a fidelity value for each heartbeat. To obtain a fidelity 
figure over time, the single heartbeat fidelity values for each type of pressure are 
accumulated in an array, resulting in three arrays. The fidelity figure for each type of 
pressure is expressed as the 90th percentile. Finally, the average of the three percentiles 
yields a single value expressing the overall fidelity of the CPD. This method can be applied 
to any measurement (arterial pressure, ventricular pressure or flow rate) provided that 
target locations can be established for the measurement in question.  
 
The fidelity test was carried out with the SJME V2. Standard operating conditions were 
used: HR = 70 bpm, CO = 5 L/min and arterial pressure set at 120/80 mmHg (MAP = 
100 mmHg). 100 heartbeats were recoded and analysed. 
 
3.4.2.4 ISO testing 
The hydrodynamic testing protocol was based on Annex L.4 of the ISO5840:2005 standard 
which provides guidelines for pulsatile flow testing procedures. All tests were performed 
for the two SJME 21 mm PHVs. The reason for using this valve was not only due to two 
identical samples being available but also because it is from a manufacturer with a long 
history of PHV development and it has FDA approval [101]. Test 1 was also performed for 
the SJM Regent PHV. 
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For each of the tests in Table 3.7, ten cycles were analysed and results reported in SD 
format (mean, range and SD). Table 3.7 indicates the operating conditions for each test, 
as stipulated in ISO5840:2005. 
 
Table 3.7: Test matrix for the assessment of valve hydrodynamic performance. (CO: Cardiac Output (L/min); 
HR: heart rate (bpm); MAP: Mean arterial pressure (mmHg); -ΔPmean: mean back pressure (mmHg);  
ΔP: differential pressure; Reg vol: regurgitant volume; Rep Wave: representative pressure and  
flow waveforms; T1-T7: test number). 
 MAP = 100 -ΔPmean = 80 -ΔPmean = 120 -ΔPmean = 160 
HR 
CO 70 45 70 120 
2 T2: ΔP     
3,5 T3: ΔP      
5 T1: Rep Wave; ΔP T5: Reg vol T6: Reg vol T7: Reg vol 
7 T4: ΔP    
 
 Representative wave: Pressure and flow waveforms, representative of normal 
operating conditions, intended to graphically present an overall picture of the PHV’s 
performance. A systolic fraction of 35% is used. EOA is calculated based on the 
measurements from this test.  
 Differential pressure: Performed at a fixed heart rate and MAP, the CO is increased 
by altering the SV. This test evaluates the performance of the PHV in terms of the 
pressure drop across it during the forward flow phase. 
 Regurgitant volume: Performed at a fixed CO, these tests are used to measure 
regurgitant volume at three mean back pressures corresponding to a range of heart 
rates. Mean back pressure refers to the differential pressure measured across a 
closed valve. 
The pressure drop across the open PHV (tests 1-4) is denoted as ΔP while the differential 
pressure across the closed PHV (tests 5-7) is denoted as -ΔP. Crucial to many of the 
measurements presented in the sections concerning ISO testing is establishing when the 
valve opens and closes. The opening and closing events were determined using landmark 
features on the pressure trace, indicated in Figure 3.22. 
 
  
Figure 3.22: Heart valve events. 
 
5: Aortic valve closes 
4: Aortic valve 
starts to close 
3: Aortic valve opens 
6: Mitral valve opens 
1: Mitral valve closes 
2: Aortic valve 
starts to open 
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The following expands on the events highlighted in Figure 3.22: 
1. Ventricular pressure overcomes atrial pressure and rises rapidly. 
2. Reversal of pressure on aortic trace, momentary dip in ventricular trace. 
3. Ventricular pressure overcomes aortic pressure, forward flow is established. 
4. Ventricular pressure falls below aortic pressure, flow is reversed. 
5. Closure of the aortic valve is signalled by a slight momentary increase in pressure 
due to fluid inertia (the dichrotic notch). 
6. Ventricular pressure falls below atrial pressure. 
 
Using the data obtained from the above tests, the following variables were calculated:  
 Duration of the forward flow phase: The amount of time taken by the systolic phase 
expressed as a percentage of the heartbeat period. Also known as systolic fraction. 
 Mean flow rate: The average flow rate measured over a heartbeat. 
 Effective Orifice Area: EOA should not be confused with the geometric area of the 
valve orifice. It is a performance based indication of a PHV’s flow area which is 
calculated from flow rate and pressure data under pulsatile conditions as per Test 
1 above. The ISO5840:2005 suggests using the following equation to calculate EOA 
based on the volumetric flow rate and Bernoulli equations: 
 𝐸𝑂𝐴 =
𝑞𝑣𝑅𝑀𝑆
51,6 × √
∆𝑃𝑚𝑒𝑎𝑛
𝜌
 
( 15 ) 
where 
 EOA = effective orifice area (cm2) 
ΔPmean = mean positive pressure difference during the forward flow 
phase (mmHg) 
ρ = test fluid density (g/cm3) 
and  
 
𝑞𝑣𝑅𝑀𝑆 =
√
∫ 𝑞𝑣(𝑡)2𝑑𝑡
𝑡2
𝑡1
𝑡2 − 𝑡1
 ( 16 ) 
 𝑞𝑣𝑅𝑀𝑆  = root mean square forward flow (mL/s) 
 qv(t) = instantaneous flow rate 
 t1 = time at start of forward flow (s)9 
 t2 = time at end of forward flow (s)9 
 Total regurgitant volume, discretised into closing and leakage volumes: 
 𝑉𝑟𝑒𝑔_𝑡𝑜𝑡𝑎𝑙 = 𝑉𝑐𝑙𝑜𝑠𝑖𝑛𝑔 + 𝑉𝑙𝑒𝑎𝑘𝑎𝑔𝑒 ( 17 ) 
 MAP: arterial pressure, averaged over the entire heartbeat 
 
3.4.3 Comparative tests 
3.4.3.1 Comparison to original CPD 
Having obtained the pump’s discharge profile given by the original cam, it was tested on 
the new CPD to compare the pressure measurements against those obtained with the old 
                                                          
9  Due to the flowmeter’s poor performance during pulsatile conditions, the times used  
 correspond to the positive differential pressure period, which is as recommended in  
 ISO5840-1:2015. 
Stellenbosch University  https://scholar.sun.ac.za
54 
setup. To enable comparisons to be made as directly as possible the heart rate and 
pressure conditions were matched to the available data, which had been acquired at 
72 bpm. For tests that were run using the CPD in its final state the stroke volume was set 
to 100mL to match the cam’s discharge. 
 
3.4.3.2 Comparison to published data 
ViVitro SuperPump 
ViVitro Labs’ SuperPump is at the core of the ViVitro Pulse Duplicator System and it is the 
most popular commercial pump for generating cardiac flows [102]. The most important 
performance criterion quoted in the SuperPump’s datasheet is the waveform accuracy. 
To be able to make a direct comparison, two tests were carried out since values are 
quoted for two different heart rates: 70 bpm and 200 bpm with a stroke volume of 75 mL. 
The control waveform was the same as that used for the ISO tests. 
 
The accuracy for the BERG CPD was calculated based on the RMSE between the setpoint 
and the measured waveforms (as described in Section 3.4.1.3). The RMSE was then 
multiplied by the area of the piston pump to obtain a volumetric error indicative of 
accuracy throughout the entire heartbeat. The error was derived from the accuracy and 
expressed as a percentage of the stroke volume at a given heart rate. 
 
Commercial CPD 
Testing of commercial PHVs was done in order to prove the CPD’s capabilities. However, 
it is also important to compare the results obtained with the CPD to those published in 
the scientific literature so as to establish how this apparatus performs in relation to its 
ISO-certified counterparts. To make direct comparisons to the data available for the 
equivalent model and size of PHV, the tests described in Table 3.8 were performed using 
the SJME 23 mm PHV. 
 
Table 3.8: Tests for comparison to published data. (HR: heart rate; CO: cardiac output; SV: stroke volume; 
Psys: arterial systolic pressure; Pdias: arterial diastolic pressure). 
Test HR (bpm) CO (L/min) SV (mL) Psys/Pdias (mmHg) 
1 70 2 28.57 120/80 
2 70 4 57.14 120/80 
3 70 5 71.43 120/80 
4 70 7 100.00 120/80 
 
The measurements of interest were the pressure readings across the valve during the 
forward flow phase of the systolic period. An auxiliary measurement is the stroke work 
loss (SWL) which is expressed as a percentage of the ratio between mean systolic arterial 
pressure and mean systolic ventricular pressure: 
 
 
𝑆𝑊𝐿 = (1 −
𝑃𝑠𝑦𝑠_𝑚𝑒𝑎𝑛_𝑎𝑟𝑡
𝑃𝑠𝑦𝑠_𝑚𝑒𝑎𝑛_𝑣𝑒𝑛𝑡
) × 100 ( 18 ) 
where  
 Psys_mean_art = mean systolic arterial pressure 
 Psys_mean_vent = mean systolic ventricular pressure 
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Together with the peak and mean systolic pressure difference, SWL represents a good 
metric of valve performance during the forward flow period. As with the previous tests, 
ten cycles were recorded, analysed and the results reported as mean, range and SD. 
 
  
Stellenbosch University  https://scholar.sun.ac.za
56 
4 Results 
 Cylinder and controller performance 
4.1.1 Speed controller 
Figure 4.1 presents the results of the magnitude/frequency speed tests for the electric 
cylinder (as set out in Table 3.3). Each bar represents the difference between the setpoint 
and the measured speed for each frequency (equivalent to HR) for one maximum speed 
at a time. The error is positive when the cylinder extends and negative when it retracts. 
 
 
Figure 4.1: Dynamic speed tracking error. 
 
4.1.2 Position controller 
Figure 4.2 (CO = 5 L/min) and Figure 4.3 (CO = 24.2 L/min) depict the controller’s 
behaviour after experimental fine tuning for two vastly different operating conditions 
(although the control waveform is morphologically identical for both cases). The tuning 
parameters determined through this experiment and used in each case are recorded in 
Table 4.1 which is related to Figure 3.17. To highlight the drastic difference in the demands 
of the setpoint and how the controller behaves in these situations, the span of all the 
graphs’ axes has been kept equal for corresponding graphs across both figures. A total of 
three plots are displayed per graph: the setpoint, the measured position and the 
measured position phased in post-processing. The phasing time is highly dependent on 
the PID constants. Further details about phasing time and error are presented in Section 
4.1.4. 
 
Table 4.1: Tuning parameters used in the PI position controller. 
CO HR (bpm) SV (mL) Kp Ti 
5 L/min 70 71.43 2 0.15 
24.2 L/min 189 128 3 0.03 
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Figure 4.2: Position controller response at HR = 70 bpm and SV = 71.43 mL. 
 
 
 
 
 
 
 
Figure 4.3: Position controller response at HR = 189bpm and SV = 128mL. 
 
4.1.3 Accuracy and resolution 
The results of these tests are presented graphically in Figure 4.4. The plotted difference is 
with respect to a baseline measurement (bottom graph) where the red circle indicates 
the area upon which the modified control point has the largest effect on the control 
waveform. The velocity shown in the figure is included to provide an indication of the 
range at which the tests took place. Although the quoted repeatability accuracy for the 
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electric cylinder is ±0.05 mm [103], only changes below 0.005 mm did not produce a 
noticeable difference. 
 
 
Figure 4.4. a) Extract of the measured positions plotted as the difference to the 
baseline. b) Overview of the baseline measured position. 
 
4.1.4 Tracking 
Table 4.2 presents the results of the tracking tests with “RMSE, phased” indicating the 
effective tracking error. “Lag” is the amount of time by which the position feedback was 
shifted to obtain the phased RMSE. 
 
Table 4.2: Results for overall tracking tests. 
Operating 
point 
 
Beat 
HR = 70 bpm, 
SV = 71.43 mL 
HR = 140 bpm, 
SV = 120 mL 
HR = 189 bpm, 
SV = 128 mL 
RMSE 
(mm) 
RMSE, 
phased 
(mm) 
Lag 
(ms) 
RMSE 
(mm) 
RMSE, 
phased 
(mm) 
Lag 
(ms) 
RMSE 
(mm) 
RMSE, 
phased 
(mm) 
Lag 
(ms) 
Beat 1 0.405 0.016 
13 
1.059 0.064 
10 
1.334 0.044 
9 
Beat 2 0.403 0.016 1.064 0.063 1.327 0.048 
Beat 3 0.406 0.016 1.068 0.059 1.326 0.049 
Beat 4 0.404 0.018 1.067 0.069 1.330 0.049 
Beat 5 0.403 0.029 1.065 0.095 1.328 0.052 
Mean  0.404 0.019 1.065 0.070 1.329 0.048 
±SD 0.001 0.006 0.003 0.014 0.003 0.003 
a) 
b) 
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 Cam profiling 
The results of the cam profiling experiment can be seen in Figure 4.5. The upper graph 
indicates the recorded raw voltage from the LDVT for each encoder pulse. The lower graph 
is the average of the first five revolutions and shows scaled values representing the 
displacement of the cam. In this case the selected number of points for the output curve 
is 500. Using the scanned image of the cam shown in the inset of Figure 4.5 as reference, 
the lower graph corresponds to the profile of the cam starting approximately at 12 o’clock 
and moving clockwise. To generate a basic control waveform that could be easily modified 
from the motion design interface of the CPD’s control program, a 16 point curve was also 
generated. Each interpolated data point could then be used as the value for the respective 
control point. The 16 point output is shown in Table 4.3. 
 
Analysis of the 500 point numerical model enabled the extraction of the cam’s basic 
parameters. The maximum displacement (lift) recorded was 15.57 mm, corresponding to 
a SV of 99.07 mL. Assuming a combined error of 1% arising from manufacture, wear and 
measurement, it can be deduced that Krynauw most likely designed the cam to produce 
a SV of 100 mL which makes this cam useful only for one of the ISO tests. The profile 
yielded a systolic fraction of 38% with 1% (3.6º) dwell at full lift and 13% (46.8º) dwell at 
base circle. Appendix B contains a 500 point numerical model of the cam and a 6th order 
polynomial fit function describing the same experimental results. The polynomial function 
achieves a summed square error of 3.786 and a RMSE of 0.087. 
 
 
Figure 4.5: Interface of the processing program used to extract the cam profile. The upper graph displays 
experimental raw data and the lower graph the resultant cam profile. Inset: processed scan of the actual 
cam. 
 
Table 4.3: Control points used to describe the original cam’s profile. 
Control point 1 2 3 4 5 6 7 8 
Value (scaled to mm) 0.017 0.614 3.085 7.050 10.528 13.312 15.080 15.719 
Control point 9 10 11 12 13 14 15 16 
Value (scaled to mm) 15.159 13.511 10.912 8.191 5.411 2.825 1.103 0.216 
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 Hydrodynamic results 
4.3.1 Adjustment of lump parameter controls 
Aortic root compliance and peripheral resistance 
The target pressure was achieved by setting the resistor at approximately 90º from its fully 
closed position. The area open to flow for this position is 16.4 mm2 at the entrance of the 
resistor. An increase in peripheral resistance increases overall arterial pressure while 
increasing the aortic root compliance volume raises only the diastolic pressure. Diastolic 
pressure was found to be directly proportional to the volume of air in the compliance 
chamber for a given heart rate. Figure 4.6 shows pressure and flow plots of the three steps 
in this test. Table 4.4 contains the lump parameter control values used to achieve the 
target pressures as well as numerical results of the test. Note the systolic pressure listed 
in Table 4.4 for the centre and right plots indicates the maximum arterial pressure before 
the dichrotic notch. All pressures are arterial. 
 
Table 4.4: Effect of aortic root compliance and peripheral resistance on pressure. (C: compliance; R: 
resistance; Psys: systolic arterial pressure; Pdias: diastolic arterial pressure; MAP: mean arterial pressure.) 
 Figure 4.6, left Figure 4.6, centre Figure 4.6, right 
Test 
conditions 
C and R unspecified 
R changed to achieve 
target (Psys = 
120 mmHg) 
C changed to achieve 
target (Pdias = 
80 mmHg) 
C (mL air) ~650 ~650 ~1208 
R (qualitative) Unrestrictive ~90º from fully closed ~90º from fully closed 
Psys (mmHg) 23.48 121.62 117.91 
Pdias (mmHg) -11.81 43.71 78.01 
MAP (mmHg) 2.30 80.45 99.00 
 
 
 
Figure 4.6: Pressure response to lump parameter adjustments. a) No resistance set; b) resistance  
set for target systolic pressure; c) aortic root compliance set for target diastolic pressure 
 
Ventricular compliance 
Adjustment of the ventricular compliance controls produced acceptable results for the 
first test. Under these conditions, the controls were effective in reducing ventricular 
pressure oscillations after closure of the aortic valve (this is made evident in Figure 4.7 
between 0.4 s and 0.5 s). A portion of these oscillations’ amplitude can be seen to be 
a) b) c) 
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transmitted to the arterial pressure, especially immediately after the aortic valve closes. 
It was found that 6 mL of air in the ventricular compliance chamber was the ideal volume 
and any further increase in volume had a detrimental effect regardless of the resistance 
setting. Resistance only had an evident effect when using a high setting. To demonstrate 
the effects of compliance and resistance separately, an extra set of data was acquired 
after having adjusted the controls. This set of data was recorded with the final compliance 
volume but with no resistance and it corresponds to the centre panel on Figure 4.7. Table 
4.5 contains the most relevant pressure values related to each panel of Figure 4.7. 
 
Table 4.5: Effect of ventricular compliance controls on pressure. HR = 70 bpm, CO = 5 L/min. (C: compliance; 
R: resistance; Psys: systolic arterial pressure; Pdias: diastolic arterial pressure; MAP: mean arterial 
pressure; -ΔPmean: mean back pressure. 
  Figure 4.7, left Figure 4.7, centre Figure 4.7, right 
 C (mL air) 0 6 6 
 R (qualitative) Unrestrictive Unrestrictive 
ball valve 7/10 
closed 
A
rt
e
ri
al
 
Psys (mmHg) 12.32 118.48 121.16 
Pdias (mmHg) 79.63 77.90 76.86 
MAP (mmHg) 99.79 99.14 97.93 
V
e
n
t Pmax (mmHg) 363.14 189.14 163.48 
Pmin (mmHg) -50.73 -49.09 -42.05 
 -ΔPmean 
(mmHg) 
83.87 86.13 95.68 
 
 
 
Figure 4.7: Pressure response to ventricular compliance adjustments for test 1. a) No resistance or 
compliance; b) compliance only; c) compliance with resistance. 
 
The performance of the ventricular compliance feature was not satisfactory for the 
second test. Any volume of air in the ventricular compliance chamber, up to 50 mL, 
resulted in an increased peak ventricular pressure during diastole. Various resistance 
settings were tested with no significant changes being observed. The measurements in 
Table 4.6 show an overall decrease in arterial pressure as a result of the reduced effective 
SV caused by the air in the ventricular compliance chamber being compressed. This agrees 
with the findings from the test at 70 bpm. However, the peak to peak amplitude of the 
ventricular pressure oscillations increased. Figure 4.8 shows a trend of increased diastolic 
a) b) c) 
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peak pressure with increased compliance volume, suggesting a resonance or reflecting 
wave problem (see Section 5.1.2). 
 
Table 4.6: Effect of ventricular compliance controls on pressure. HR = 90 bpm, CO = 7.5 L/min. (C: 
compliance; R: resistance; Psys: systolic arterial pressure; Pdias: diastolic arterial pressure; MAP: mean arterial 
pressure; -ΔPmean: mean back pressure. 
  Figure 4.8, left Figure 4.8, centre Figure 4.8, right 
 C (mL air) 0 12 24 
 
R (qualitative) Unrestrictive ball valve 7/10 closed 
ball valve 7/10 
closed 
A
rt
e
ri
al
 
Psys (mmHg) 142.22 140.106 137.39 
Pdias (mmHg) 83.29 77.10 75.79 
MAP (mmHg) 112.44 111.15 109.08 
V
e
n
t Pmax (mmHg) 320.85 405.08 512.91 
Pmin (mmHg) -47.15 -52.92 -60.22 
 -ΔPmean 
(mmHg) 
96.86 95.10 85.31 
 
 
 
Figure 4.8: Pressure response to ventricular compliance adjustments for test 2. a) No resistance or 
compliance; b) compliance only; c) compliance with resistance. 
 
Based on these results, it was concluded that the current ventricular compliance model is 
inadequate for the desired quality of data at elevated heart rates. The ventricular 
compliance model used, with a single compliance chamber, did not provide the ability to 
control systolic and diastolic pressure features independently. A simple modification to 
incorporate an extra compliance element is proposed in Section 6.2. 
 
4.3.2 Response to changes in a single control point 
Figure 4.9 shows the resultant ventricular pressure for each of the changes made to the 
control point. This panel also demonstrates the effect of the interpolation method used: 
notice the small decrease in path around locations 100 and 175. A well-defined 
relationship between ventricular pressure and the control waveform can be observed. 
The results of this test highlighted how a small change in the path of the cylinder affects 
fluid inertia and consequently pressure, supporting the findings in Section 4.1.3. 
a) b) c) 
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Figure 4.9: a) Control waveform used for each heartbeat. b): Corresponding ventricular pressure. 
 
4.3.3 Tuning the pressure profile 
This experiment illustrates the practical application of the tests carried out in Section 4.1.3 
and Section 4.3.2, demonstrating the fine control offered by the system. Through subtle 
manipulation of the first five control points the systolic pressure spikes were eliminated. 
Table 4.7 contains the scaled values of the control points that describe the two waveforms 
used in this test. Grey values were unchanged. Figure 4.10 shows the resultant changes in 
pressures as well as a depiction of the control waveform. It can be seen that the 
displacement difference (blue line in the right panel) closely resembles the original 
pressure spikes and as a result has a direct counteracting effect upon them. 
 
Table 4.7: Control points used for tuning the pressure profile. Scaled values are in mm.  
Original 
control 
waveform 
Control point 1 2 3 4 5 6 7 8 
Value (scaled) 0.209 1.335 3.101 5.211 7.241 8.961 10.000 9.879 
Control point 9 10 11 12 13 14 15 16 
Value (scaled) 8.981 7.561 5.911 4.241 2.631 1.230 0.381 0.060 
Modified 
control 
waveform 
Control point 1 2 3 4 5 6 7 8 
Value (scaled) 0.519 1.345 3.071 5.121 7.421 8.961 10.000 9.879 
Control point 9 10 11 12 13 14 15 16 
Value (scaled) 8.981 7.561 5.911 4.241 2.631 1.230 0.381 0.060 
a) 
b) 
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Figure 4.10: Measurements before tuning (black) and after tuning (red) for a) ventricular pressure, b) aortic  
pressure and c) control waveform. 
 
 Repeatability and fidelity tests 
4.4.1 Repeatability 
Intra-test and inter-test results are presented in Table 4.8 which is organised in the same 
fashion as Figure 3.21 to help in visualising the flow of data leading to the inter-test 
repeatability value. The baseline heartbeat used to obtain these results is part of the first 
test (T1). The second set of data (T2) was acquired 2500 heartbeats after the initial 
recording.  
 
Table 4.8: Hydrodynamic repeatability results. All values are in mmHg. 
 T1  T2 
Beat 1 Beat 2 Beat 3 Beat 4 Beat 5  Beat 1 Beat 2 Beat 3 Beat 4 Beat 5 
ΔP RMSE 3.375 1.638 1.257 2.193 1.139  2.776 1.968 3.087 1.789 2.467 
Intra-test mean 1.921  2.417 
Intra-test ±SD 0.911  0.542 
Inter-test mean 2.169 
Inter-test ±SD 0.727 
 
4.4.2 Fidelity 
To analyse fidelity it helps to visualise the history of the entire process rather than 
concentrate on a single point of interest. The left panel in Figure 4.11 depicts arterial 
pressure for 100 heartbeats. The XY view on the right panel is useful to visualise how the 
location of a specific area of pressure (systolic or diastolic) changes in magnitude and 
phase from one heartbeat to the next.  
 
b) a) c) 
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Figure 4.11: a) Surface plot of arterial pressure for 100 heartbeats. b) XY plane view (with contour lines) of the 
surface plot showing the location of highest pressure (red) and lowest pressure (purple) for 100 heartbeats. 
 
While Figure 4.11 provides an easier way to display the whole dataset and is more 
effective at visually presenting the results over time, the combination graph in Figure 4.12 
shows only information pertinent to the variables of interest. Table 4.9 complements the 
combination graph with statistical results. This constitutes supporting information that 
leads to the quantification of fidelity. 
 
 
Figure 4.12: Graphical results for the variables of interest. 
 
Table 4.9: Statistical results to supplement Figure 4.12. 
 Systolic Diastolic 
MAP 
(mmHg) 
 Pressure 
(mmHg) 
Location 
(ms) 
Pressure 
(mmHg) 
Location 
(ms) 
Target 120 356 80 58 100 
Max 121.14 378 83.70 68 101.75 
Min 119.25 352 81.84 37 100.13 
Mean 120.25 367 82.88 57 100.99 
SD 0.46 5.5 0.39 5.7 0.37 
b) a) 
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Table 4.10 shows the individual fidelity values leading to the final statement of fidelity for 
the machine. These results indicate that the combination of pressure and its location 
(where applicable) is within 4.6% of the individual targets for 90% of the heartbeats. 
 
Table 4.10: Fidelity description of the CPD. 
 F𝑃𝑠𝑦𝑠𝑡  F𝑃𝑑𝑖𝑎𝑠𝑡  F𝑀𝐴𝑃 F𝑷𝒂𝒓𝒕𝒆𝒓𝒊𝒂𝒍  
90th percentile 0.028 0.094 0.015 0.046 
 
 ISO5840:2005 tests 
Table 4.11 to Table 4.17 contain statistical results for each of the ISO tests. These results 
are derived from the analysis of ten consecutive heartbeats (refer to Appendix C for the 
complete dataset). Columns in bold are the measurements requested by each test, as per 
Table 3.7. The rest of the columns are supporting measurements included as proof of the 
test conditions under which the main measurement was obtained.  
 
The flowmeter was found the have very poor performance during pulsatile flow 
conditions. Measurements were always under the expected value but the error was partly 
dependant on heart rate and stroke volume. In an effort to overcome this problem, an 
attempt was made to produce a calibration map for a combination of HRs and SVs by 
connecting the flowmeter directly to the pump and although results were better, they 
were variable. One major problem was that the flowmeter could not accurately identify 
flow reversal and this was exacerbated when valves were included in the flow loop. Most 
of these problems were attributed to the flowmeter’s integral time constant which could 
not be removed from the software (it was set to its minimum value of 0.1 s) and the 25 Hz 
(40 ms) update rate which for this application is very slow. Unfortunately, no suitable 
flowmeters were available. Therefore, the flow and volume measurements presented in 
the following sections are not representative of actual conditions but are included as they 
can still show trends. 
 
4.5.1 Pressure drop 
This section presents the results of the pressure drop tests with Table 4.11 to Table 4.14 
showing statistical information for each test. Effective orifice area (EOA) was calculated 
for all pressure drop tests. The representative wave (part of Test 1) of each PHV can be 
seen in Figure 4.13. 
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Figure 4.13: Representative waves showing ventricular, aortic and atrial pressures, as well as aortic 
flow rate. a) SJM Epic valve 1; b) SJM Epic valve 2; c) SJM Regent valve. 
 
Table 4.11: Statistical results for Test 1. (HR = 70 bpm; CO = 5 L/min; MAP = 100 mmHg). 
 EOA 
(cm2) 
ΔPmean 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys  
(ms) 
SJ
M
E 
V
1
 Mean 0.86 17.47 98.86 4.69 36.1 309.8 
SD ± 0.01 ± 0.33 ± 0.32 ± 0.04 ± 0.4 ± 3.0 
Max 0.87 18.20 99.38 4.76 36.6 314 
Min 0.85 17.16 98.22 4.63 35.4 304 
SJ
M
E 
V
2
 Mean  0.81 20.04 100.59 4.69 35.2 301.8 
SD ± 0.01 ± 0.21 ± 0.34 ± 0.03 ± 0.2 ± 1.2 
Max 0.82 20.34 101.40 4.76 35.5 304 
Min 0.80 19.56 100.18 4.65 35.0 300 
SJ
M
R
 
Mean  1.83 3.57 98.08 3.97 37.1 317.7 
SD ± 0.03 ± 0.08 ± 0.45 ± 0.05 ± 0.6 ± 5.2 
Max 1.88 3.71 98.57 4.00 38.0 326 
Min 1.78 3.43 97.27 3.84 36.1 309 
 
  
b) 
c) 
a) 
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Table 4.12: Statistical results for Test 2. (HR = 70 bpm; CO = 2 L/min; MAP = 100 mmHg). 
 EOA 
(cm2) 
ΔPmean 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys  
(ms) 
SJ
M
E 
V
1
 Mean 0.56 7.36 100.23 1.92 34.8 298.6 
SD ± 0.01 ± 0.17 ± 0.41 ± 0.03 ± 0.5 ± 4.3 
Max 0.57 7.57 100.72 1.95 35.6 300 
Min 0.55 7.10 99.47 1.87 34.3 294 
SJ
M
E 
V
2
 Mean  0.50 5.49 100.22 1.43 34.9 298.9 
SD ± 0.01 ± 0.10 ± 0.24 ± 0.04 ± 0.3 ± 2.9 
Max 0.51 5.65 100.74 1.49 35.6 305 
Min 0.48 5.32 99.96 1.37 34.3 294 
 
 
Table 4.13: Statistical results for Test 3. (HR = 70 bpm; CO = 3.5 L/min; MAP = 100 mmHg). 
 EOA 
(cm2) 
ΔPmean 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
TSys  
(ms) 
SJ
M
E 
V
1
 Mean 0.70 11.10 99.08 3.05 35.4 303.5 
SD ± 0.01 ± 0.12 ± 0.47 ± 0.03 ± 0.3 ± 2.8 
Max 0.71 11.28 99.62 3.08 36.1 309 
Min 0.69 10.93 98.30 3.00 34.9 299 
SJ
M
E 
V
2
 Mean  0.71 11.23 98.46 3.10 35.5 304.2 
SD ± 0.00 ± 0.10 ± 0.32 ± 0.02 ± 0.4 ± 3.2 
Max 0.71 11.42 98.99 3.13 36.2 310 
Min 0.71 11.03 97.86 3.08 35.1 301 
 
 
Table 4.14: Statistical results for Test 4. (HR = 70 bpm; CO = 7 L/min; MAP = 100 mmHg). 
 EOA 
(cm2) 
ΔPmean 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
TSys  
(ms) 
SJ
M
E 
V
1
 Mean 0.93 29.53 101.13 6.98 36.2 310.1 
SD ± 0.01 ± 0.80 ± 0.25 ± 0.05 ± 0.50 ± 4.4 
Max 0.94 30.88 101.52 7.09 37.0 317 
Min 0.91 28.72 100.69 6.91 35.5 304 
SM
JE
 V
2 Mean  0.91 31.26 96.48 6.97 35.7 306.2 
SD ± 0.01 ± 0.40 ± 0.21 ± 0.07 ± 0.30 ± 2.9 
Max 0.92 31.87 96.81 7.06 36.3 311 
Min 0.90 30.63 96.01 6.86 35.00 300 
 
4.5.2 Regurgitation 
This section presents the results for the regurgitation volume tests. Table 4.15 to Table 
4.17 contain statistical results for the two PHVs that underwent these tests. Bearing in 
mind the limitations of the flowmeter, these results are included to show trends rather 
than actual values. 
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Table 4.15: Statistical results for Test 5. (HR = 45 bpm; CO = 5L/min;–ΔPmean = 80 mmHg). 
 Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
SJ
M
E 
V
1
 Mean 25.91 13.27 12.63 4.39 79.21 93.11 
SD ± 0.81 ± 0.53 ± 0.72 ± 0.03 ± 0.61 ± 0.64 
Max 26.88 14.00 14.28 4.44 80.04 94.11 
Min 24.37 12.39 11.38 4.34 78.40 92.43 
SJ
M
E 
V
2
 Mean  25.11 12.62 12.49 4.40 80.15 93.81 
SD ± 0.86 ± 0.42 ± 1.10 ± 0.03 ± 0.50 ± 0.25 
Max 26.18 13.29 14.22 4.44 80.81 94.19 
Min 23.92 11.96 11.10 4.35 79.16 93.38 
 
 
Table 4.16: Statistical results for Test 6. (HR = 70 bpm; CO = 5L/min; –ΔPmean = 120 mmHg). 
 Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
SJ
M
E 
V
1
 Mean 22.87 9.61 13.26 3.92 119.59 142.10 
SD ± 1.02 ± 0.37 ± 0.90 ± 0.06 ± 0.38 ± 0.28 
Max 23.99 10.27 14.50 3.99 120.18 142.61 
Min 21.64 9.17 11.79 3.84 118.84 141.75 
SJ
M
E 
V
2
 Mean  23.65 9.86 14.06 4.10 118.34 131.53 
SD ± 1.22 ± 0.525 ± 1.19 ± 0.07 ± 0.41 ± 0.74 
Max 25.21 10.26 15.58 4.19 119.01 132.22 
Min 21.55 8.68 12.13 4.00 117.80 130.45 
 
 
Table 4.17: Statistical results for Test 7. (HR = 120 bpm; CO = 5L/min; –ΔPmean = 160 mmHg). 
 Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
SJ
M
E 
V
1
 Mean 16.37 5.91 10.44 3.04 154.18 194.51 
± SD ± 0.960 ± 0.191 ± 0.799 ± 0.119 ± 0.759 ± 0.70 
Max 17.95 6.29 11.65 3.21 155.25 195.64 
Min 14.95 5.63 9.30 2.86 152.68 193.83 
SJ
M
E 
V
2
 Mean  12.89 5.06 7.83 2.35 156.68 193.94 
SD ± 0.94 ± 0.26 ± 0.90 ± 0.13 ± 1.10 ± 0.99 
Max 14.14 5.67 9.22 2.53 157.96 194.90 
Min 11.30 4.73 6.18 2.10 153.85 191.47 
 
 Comparative results 
4.6.1 Comparison to original CPD 
This section presents results in such a way as to allow comparisons to be made between 
results obtained at the various stages of the CPD starting from the initial design, followed 
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by its second iteration, then by improvements made as part of this work and eventually 
by the final state of the apparatus. In the left panel of Figure 4.14 are results obtained by 
Krynauw at 72 bpm. This is compared to unfiltered data recorded in the original 
configuration of the CPD under similar conditions (right panel), in order to establish the 
similarities. Although the measurements shown correspond to dissimilar PHVs, a good 
correlation can be observed between the two, particularly in terms of the morphology of 
the arterial pressure traces during systole, which do not exhibit physiological 
characteristics. It should be noted that Krynauw did not use the same valve chamber that 
was used for obtaining the measurements on the right panel (which constitutes part of 
the second iteration of the CPD, implemented prior to the start of this project) and this 
could be the reason for the high pressure differential seen in the ventricular trace 
between 0.2 s and 0.3 s. The remainder of the ventricular pressure profile follows the 
same tendency, notably the pressure spike at the beginning of systole at 0.05 s.  
 
 
 
Figure 4.14: a) Pressure measurements obtained by Krynauw (adopted from [28]). b) Pressure 
measurements obtained with the original CPD configuration. 
 
Figure 4.15 displays the results obtained after implementing the new compliance 
chamber and LVOT but still using the mechanical cam and the old resistance ball valve. 
The trends remain the same as with the old configuration for both ventricular and arterial 
pressure traces but the amplitude of the ventricular pressure spikes was reduced. Further, 
the large rise in ventricular pressure during the systolic phase was no longer present, 
suggesting smoother flow through the PHV. 
 
 
 
Figure 4.15: Pressure measurements obtained using the new compliance chamber and LVOT. 
b) a) 
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Results obtained with the system in its final configuration are shown in Figure 4.16. The 
left panel shows the pressures produced by the cam profile discussed in Section 4.2 
(numerically described in Table 4.3). The ventricular trace still exhibits a systolic 
ventricular pressure spike (between 0 and 0.1 s) with the same features as those seen in 
Figure 4.14 and Figure 4.15, consistently affecting the arterial pressure trace. However, 
the frequency of the oscillations is drastically reduced as an effect of the compliant 
ventricle. The right panel shows the pressure produced by a modified control waveform. 
Only the first four control points were adjusted to eliminate the pressure spike (see Table 
4.18); the remainder of the control points were as per Table 4.3. Eliminating the systolic 
pressure spike had the effect of making the arterial pressure rise more progressively and 
as a result, the pressure drop across the PHV is more constant, indicating smoother flow. 
The mean systolic pressure difference produced by the original cam was 31.46 mmHg and 
23.33 mmHg after adjusting the control waveform. This pressure drop is characteristic of 
a stenotic valve presenting moderate stenosis. 
 
 
 
Figure 4.16: Results obtained from the system in its final state with a) unmodified cam profile showing 
systolic ventricular pressure spike between 0 and 0.1 s and b) modified cam profile showing reduced peak 
systolic ventricular pressure. 
 
Table 4.18: Control points used to eliminate the ventricular pressure spike during systole. 
 Control waveform (original cam) Control waveform (modified cam) 
Control point 1 2 3 4 1 2 3 4 
Value (scaled to mm) 0.017 0.614 3.085 7.050 1.297 2.704 4.689 7.427 
 
4.6.2 Results used for comparison to published data 
This section only reports results obtained from the tests intended to produce data to be 
compared against that of a commercial CPD (see Table 5.1 in Section 5.2.2 for the ViVitro 
Labs SuperPump comparison). The results presented here are for parameters that provide 
useful points of comparison against the data in the available literature. Thus, the 
outcomes of the test were the following: peak systolic pressure difference (ΔPpeak), mean 
systolic pressure difference (ΔPmean) and stroke work loss. Table 4.19 presents the results 
for all the relevant parameters, including the systolic fraction which is reported as proof 
of the test conditions.  
 
a) b) 
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Table 4.19: Statistical results for SJME 23 mm PHV.  (CO: cardiac output; ΔPpeak: peak systolic pressure 
difference; ΔPmean: mean systolic pressure difference; SWL: stroke work loss) 
CO Parameter Mean SD Max Min 
2
 L
/m
in
 ΔPmean (mmHg) 5.91 ± 0.15 6.19 5.6 
ΔPpeak (mmHg) 11.17 ± 0.90 13.56 10.34 
SWL (%) 6.03 ± 0.14 6.30 5.81 
Systole (%) 33.0 ± 0.2 33.1 32.4 
4
 L
/m
in
 ΔPmean (mmHg) 12.48 ± 0.23 12.7 12.05 
ΔPpeak (mmHg) 24.92 ± 0.63 25.81 23.53 
SWL (%) 11.62 ± 0.19 11.87 11.26 
Systole (%) 34.6 ± 0.2 35.1 34.4 
5
 L
/m
in
 ΔPmean (mmHg) 14.49 ± 0.21 14.92 14.1 
ΔPpeak (mmHg) 24.39 ± 0.47 25.62 23.81 
SWL (%) 13.41 ± 0.19 13.79 13.06 
Systole (%) 35.8 ± 0.2 36.1 35.5 
7
 L
/m
in
 ΔPmean (mmHg) 19.17 ± 0.29 19.54 18.68 
ΔPpeak (mmHg) 45.16 ± 1.68 49.48 44 
SWL (%) 16.95 ± 0.23 17.22 16.48 
Systole (%) 37.3 ± 0.4 37.9 36.3 
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5 Discussion 
Previous sections described the development, testing and performance of the CPD. In 
particular, Section 4 presented the results of the tests designed to evaluate specific 
aspects of the CPD. Some points related to these results are worth noting and are 
discussed in the section that follows. Section 4 also presented results obtained from tests 
stipulated by the ISO5840:2005 which were performed using commercially available 
PHVs. In contrast, Section 5.1 aims to assess the CPD beyond these isolated tests by using 
these data and comparing it to the results published in the literature, thus placing the CPD 
in context with similar devices described in scientific publications. Owing to the poor 
performance obtained from the flowmeter, this section will not discuss flow or volume 
measurements in detail but rather concentrate on pressure readings. 
  
 Hydrodynamic analysis 
The hydrodynamic analysis is founded on the proven performance of the motion control 
system, whose accuracy compares favourably against ViVitro Labs’ SuperPump, the pump 
regarded as the gold standard for producing cardiac flows. A comparison is made in Table 
5.1 for the conditions for which data is available from the SuperPump’s datasheet [102]. 
The “Phased” column indicates the error obtained after shifting the position feedback 
waveform to align it with the setpoint waveform. The quoted error and accuracy 
correspond to a stroke volume of 75 mL. Note that the accuracy and error values refer to 
displaced volume. 
 
Table 5.1: Comparison of waveform accuracy for BERG CPD and ViVitro Labs SuperPump at SV = 75 mL. 
HR 
BERG CPD ViVitro Labs  
SuperPump [102] 
Unphased Phased 
Error Accuracy Error Accuracy Error Accuracy 
70 bpm < 3.56 % ± 2.67 mL < 0.15 % ± 0.11 mL < 4 % ± 3 mL 
200 bpm < 6.71 % ± 5.04 mL < 0.27 % ± 0.21 mL < 5 % ± 3.8 mL 
 
The repeatability and accuracy of the pressure readings were demonstrated in Section 4.4 
and this, combined with the above mentioned performance,  gives good credibility to the 
data produced by the BERG CPD and allows meaningful comparisons to be made based 
on pressure. However, while a great deal of data is available for the SJME PHVs, most of 
it relates to in vivo studies published in medical journals as post-implantation follow up 
investigations. Given the nature of these studies, the conditions under which the 
measurements are taken are difficult to control. This means that the range of testing 
conditions is very limited which has the added disadvantage of reducing the results to a 
very narrow band. Further, echocardiography continues to be the method of choice to 
assess PHV performance post-implantation and there is evidence showing that pressure 
values obtained through in vivo studies do not match the data acquired in vitro [100]. A 
factor contributing to this may be the fact that valve replacements often take place in the 
presence of comorbidities which affect the hydrodynamics around the PHV. The 
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combination of all these facts means that it is not possible to compare the data acquired 
from the CPD to in vivo data and reputable in vitro studies for the PHVs that were available 
were found to be scarce. Gerosa et al [88] used the well-known Sheffield Pulse Duplicator 
(D’Avenio et al [104] provide a description) to perform an in vitro assessment of the SJM 
Epic Supra 21mm PHV. Thanks to an improved mounting style, the orifice area of the SJM 
Epic Supra model corresponds to that of a standard SJM Epic model one size larger for a 
given tissue annulus diameter [105]. Thus, a 21 mm SJM Epic Supra corresponds 
(hydrodynamically) to a standard 23 mm SJM Epic. Consequently, Table 5.2, which 
summarises Table 4.19, is a comparison of pressure data between measurements 
obtained for the SJM Epic 23 mm PHV and data published by Gerosa et al for the 21 mm 
SJM Epic Supra. 
 
Table 5.2: Measured and published pressure data for the SJME 23 mm PHV.  (CO: cardiac output; ΔPmean: 
mean systolic pressure difference; ΔPpeak: peak systolic pressure difference; SWL: stroke work loss). 
CO Parameter Measured SJME Gerosa et al [88] 
2 L/min 
ΔPmean (mmHg) 5.91 ± 0.15 7.41 ± 1.80 
ΔPpeak (mmHg) 11.17 ± 0.90 13.50 ± 2.32 
SWL (%) 6.03 ± 0.14 9.36 ± 2.70 
4 L/min 
ΔPmean (mmHg) 12.48 ± 0.23 13.06 ± 1.50 
ΔPpeak (mmHg) 24.92 ± 0.63 24.90 ± 2.30 
SWL (%) 11.62 ± 0.19 14.75 ± 2.16 
5 L/min 
ΔPmean (mmHg) 14.49 ± 0.21 17.37 ± 1.80 
ΔPpeak (mmHg) 24.39 ± 0.47 36.20 ± 4.60 
SWL (%) 13.41 ± 0.19 19.10 ± 2.80 
7 L/min 
ΔPmean (mmHg) 19.17 ± 0.29 27.50 ± 1.37 
ΔPpeak (mmHg) 45.16 ± 1.68 50.50 ± 3.80 
SWL (%) 16.95 ± 0.23 27.13 ± 2.50 
 
 
 
Figure 5.1: Graphical comparison between measured and published hydrodynamic data. a) Mean  
systolic pressure difference; b) peak systolic pressure difference; c) stroke work loss. 
It can be seen from Figure 5.1 that the values obtained by Gerosa’s group are consistently 
higher than those measured. Starting in very close agreement at 2 L/min, the results from 
the two studies tend to converge at 4 L/min. However, they diverge at higher cardiac 
outputs, with the peak systolic pressure difference (Figure 5.1 (b)) exhibiting a crucial 
difference at 5 L/min. Although the two sets of data follow the same general trend, some 
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points need to be considered to identify the reasons for the deviations and these will be 
discussed in the sections that follow. It should be noted that since the SJME is a 
bioprosthetic valve, some variation in hydrodynamic performance is to be expected from 
sample to sample and Gerosa et al tested three identical PHVs to account for this. 
However, only one sample was available for this study. 
 
5.1.1 The sinuses of Valsalva 
D’Avenio et al [104] noted that the same PHV produces different flow fields in different 
CPDs. Differences in the flow field have the potential to alter the perceived characteristic 
resistance of the PHV which would lead to differences in pressure values. The flow field 
and perceived characteristic resistance can be affected by the presence and geometry of 
the sinuses of Valsalva10 (see Figure 5.2). Bottio et al [106] speculated that the sinuses of 
Valsalva have a significant effect on the hemodynamic behaviour of the PHV during both 
the systolic and diastolic phases, suggesting that a lack of sinuses could impact valve 
durability due to higher stresses. Recently, Salica et al [107] proved that the presence of 
sinuses of Valsalva lead to improved flow through a reduced pressure drop across the 
PHV, especially at higher flow rates, confirming that the sinuses are responsible for 
minimising energy losses. 
 
 
Figure 5.2: The sinuses of Valsalva. a) Schematic longitudinal section of the aortic valve, showing the 
location of the sinuses. b) Aortic root cut lengthwise with leaflets removed to show the sinuses  
of Valsalva, defined by the basal leaflet attachment (marked by the dotted orange line). 
Taking the above into consideration, the divergence seen in Figure 5.1 for both mean 
pressure drop and SWL at higher cardiac outputs could be attributed to the differences in 
the geometry of the aortic root immediately after the valve. The CPD used in Gerosa’s 
study has a glass aorta with anatomically modelled sinuses of Valsalva whereas the 
surgical aortic valve holder used for this study (refer to Figure 3.6) uses a 28 º taper as 
pseudo sinuses (due to the cost and manufacturing complexity of including sinuses of 
Valsalva in the design this consideration was outside the scope of this project). Pisani et 
al [108] present clear evidence that the sinuses modify the leaflets’ movement resulting 
in reduced pressure gradients during the systolic phase. To explain this they hypothesise 
that flow past the valve creates an area of low pressure within the sinuses allowing the 
leaflets to open wider, effectively increasing the geometric orifice area. Following this 
rationale, it is likely that having a ring of low pressure around the leaflets, instead of three 
                                                          
10 A sinus of Valsalva is an enlargement of the aortic root defined by the basal attachment of a  
    leaflet, forming an oval cavity between the aortic wall and the leaflet. 
Sinuses of 
Valsalva 
a) 
Leaflets (closed) 
Aortic wall 
LVOT 
b) 
Coronary arteries 
Sinuses of Valsalva 
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distinct sinuses, is the cause for lower pressure differences across the PHV since the effect 
would be magnified. 
5.1.2 Pulse wave velocity 
Pulse wave velocity (PWV) refers to the speed at which the pressure wave generated by 
the ventricle travels through the arterial system. PWV is dependent on both the 
compliance of the system and the arterial pressure. Achieving the same arterial pressure 
at various cardiac outputs demands modifications to the resistance and compliance, in 
turn affecting PWV. PWV also contributes to the shape of the arterial pulse because the 
latter is influenced by the pressure wave reflected from the periphery of the arterial 
system [109, 110]. Since the location where the pressure wave is reflected back to the 
source is constant in a CPD, the overall time taken by it to return to a given measurement 
point can be affected through PWV without changing the heart rate. This means that the 
peak systolic pressure difference is susceptible to resonance which would manifest itself 
at different cardiac outputs for a given heart rate. Burattini et al [44] studied this 
phenomenon using a viscoelastic model and experimental data from dogs, concluding 
that the viscoelasticity of the aorta and nearby arteries is key in governing the magnitude 
of resonance. Therefore, a logical explanation for the peak systolic pressure difference 
obtained at 5 L/min being significantly lower than Gerosa’s measurements is that the 
reflection points of the two CPDs are at different distances from the source of the 
pressure wave and that the compliance required for achieving the correct pressure at 
5 L/min in the BERG CPD minimises the effects of resonance. Figure 5.3 is useful to explain 
the effect of this phenomenon. 
 
 
Figure 5.3: a) Pressure components of the arterial pressure curve. b) Effect of reduced compliance on  
arterial pressure due to age. (Adapted from [109]) 
Analysis of five heartbeats yielded an average PWV of 9.35 m/s during the systolic phase 
for a CO of 5 L/min (see Appendix C: SJM Epic 23 mm, for graphical results). This fits well 
into the 50-59 years of age category within the normal population [111] indicating that, 
although towards the upper limit (likely due to the rigid tubes comprising the LVOT), the 
PWV is within physiological limits. Since the reflected wave contributes to the 
characteristic shape of the arterial waveform, the distance between the source and 
reflection point of the pressure wave should be physiological too. This is necessary in 
order for the reflected wave to contribute to the forward wave at the right time. 
Deviations will cause the shape of the arterial pressure wave through different heart rates 
and mean pressures to not follow a physiological response. 
 
b) a) 
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5.1.3 Nature and operation of the CPD 
The phenomena described in the previous two sections relate to the physical design and 
operating conditions of the CPD. The diameter, length and path, as well as the choice of 
material for the hydraulic loop play an important role in shaping the pressure wave. 
Sugawara et al [110] used a dog model to explain how fluid inertia affects ventricular 
pressure, especially at the end of the systolic period. They hypothesise that, due to its 
inertia, blood can continue moving forward for longer than the ventricle is in systole. 
Therefore, the ventricle must stop blood flow by going into diastole (before the aortic 
valve closes), rather than diastole starting after blood flow has decayed significantly. Their 
theory explains the negative pressure spike observed at 0.38 s in all panels of Figure 4.13, 
suggesting that this feature is likely linked to the large volume of fluid subject to pulsatile 
flow after the ventricle. Nonetheless, this feature also has been observed, in varying 
degrees, in commercial devices such as the ViVitro CPD [46]. 
 
In terms of the material used for the hydraulic loop, interaction between the pressure 
wave and its surroundings creates or eliminates certain features in the pressure and flow 
measurements. The stiffness of the wetted material influences the magnitude of the 
reflected pressure wave, affecting how the observed wave is constructed. Furthermore, 
the locations where these variables are measured also influence the perceived test results 
since the formation of the observed pressure wave has a time component due to 
interaction with the reflected pressure wave.  
 
Section 4.3.3 demonstrated that small changes to the control waveform (small enough to 
be unperceivable without precise measuring aids) can effect significant changes in 
pressure measurements that directly affect a PHV’s commonly reported performance 
indicators. This highlights the need for the motion control system to be highly dynamic 
and accurate. However, it also proves the susceptibility of the tests to manipulation (for 
example, adjusting the control waveform when testing the same PHV sample in different 
CPDs, to reduce the peak systolic pressure difference that arises due to different inertance 
characteristics). In the comparison between the Sheffield Pulse Duplicator and the BERG 
CPD, the CPDs’ different abilities to track a control waveform could also account for the 
disparities observed at 5 L/min, given the dynamic nature of the pressure wave and the 
components that contribute to its formation (the forward pressure wave and the reflected 
pressure waves from all possible reflection points). 
 
Through the above observations it becomes apparent that every aspect of the CPD, 
including its fundamental design, contributes to the perceived performance of a PHV 
raising the need to establish well defined performance criteria covering all systems 
involved: electrical, mechanical, hydraulic and software (control, data acquisition and 
analysis). Without appropriate CPD performance quantification it is impossible to 
accurately reproduce results of PHV performance tests for comparison or independent 
analysis. Although the CPD performance assessment methods developed for this project 
have limitations, they should provide valuable information about a CPD’s abilities that can 
be used to establish to what extent the CPD influences PHV performance. It should be 
noted that to obtain a CPD’s performance baseline a universal valve (such as a simple 
spring loaded disc valve) should be used as this will provide consistent performance 
regardless of the test platform. 
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 Limitations affecting system performance 
A few limitations played a role in the development of the CPD. This section discusses the 
compromises that had to be made during the design process, the rationale behind the 
decisions made and the measures taken to mitigate the effects on performance. 
 
5.2.1 Mechanical 
The main constraint governing mechanical design was that all modifications and upgrades 
had to be backwards compatible with the existing setup which required the new design’s 
dimensions to be adjusted, particularly at the subsystem interfaces. This resulted in the 
CPD’s hydraulic loop being larger than necessary. The flowmeter also contributed to the 
size of the hydraulic loop due to the length of its flow tube. The electromagnetic probe is 
housed at the middle of a flow tube which is used to form laminar flow and ensure 
consistent readings. This flow tube has a length of 200 mm and installation is by means of 
flanges integral to the tube. Besides the space required to accommodate the instrument’s 
overall length, the diameter of the flanges (95 mm) also demanded that the left 
ventricular outflow tract be extended. The need for this additional length can be seen in 
Figure 3.12, where it is evident that the mitral valve assembly and atrium prevent the 
flowmeter from being mounted closer to the ventricle due to the size of its inlet flange. 
The size of the hydraulic loop plays an important role on the hydrodynamic behaviour of 
the system since the inertial effects of the increased volume of fluid that the ventricle 
must set in motion affect the dynamics of the entire system (see Section 5.1.3). Although 
the above-mentioned constraints meant that the volumetric size of the hydraulic loop was 
largely out of the control of the design, every effort was made to keep the volume of the 
section experiencing pulsatile flow within a realistic limit. 
 
5.2.2 Motion control 
One of the limitations in terms of controller performance was hardware related. The 
electric cylinder that was used was a general purpose actuator instead of one tailored 
specifically for the application of the CPD. This means it is larger than necessary which 
results in higher inertia, reducing dynamic response. While the electric cylinder can easily 
achieve its maximum speed of 375 mm/s during longer strokes, the sudden acceleration 
and deceleration to which it is subjected in order to track the control waveform precisely 
within such short strokes can damage the screw assembly. Therefore, following the 
general architecture of the system, a three layered approach was taken to protect the 
electric cylinder: 
1. at the motion design level, the maximum speed component that a control 
waveform can contain in order to be sent to the position controller was limited to 
275 mm/s, 
2. at the position controller level, the maximum transient output (the maximum 
speed the controller can request) was limited to 300 mm/s (equivalent to 8 V out 
of a maximum of 10 V) and, 
3. at the speed controller level, the peak current to the motor was limited to 100 %, 
effectively limiting torque (a value of 150 % is typical for this type of servomotor). 
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The MoviDrive itself imposed some limitations on the control system due to its fixed 
maximum sampling rate of 1 kHz for its analog inputs. This means that to prevent aliasing 
the maximum rate at which the position control loop can send speed values to the 
MoviDrive is limited to 1 ms. Sending speed values at a rate faster than 1 ms introduces 
jitter as some of the values may be completely missed by the MoviDrive causing the 
position controller to overreact during the following iteration. This happens because the 
MoviDrive will continue moving the electric cylinder at a constant speed for longer than 
the position controller expects, undershooting or overshooting the target position. A 
similar situation arises when the position controller sends speed values at a rate slower 
than the MoviDrive reads them. In this case the MoviDrive has too much time to attain 
the requested speed between speed commands from the position controller, again 
overshooting or undershooting the target position, causing the controller to 
overcompensate during subsequent iterations. Figure 5.4 shows the behaviour of the 
position controller at a heart rate of 70 bpm and a stroke volume of 71.43 mL using (a) a 
fixed time resolution  of 1 ms (857 positions) and (b) a fixed number of positions (500 
positions resulting in a time resolution of 1.71 ms). It can be seen that the main areas 
affected by jitter are those characterised by high velocity while the piston is half way 
through its travel.  
 
 
Figure 5.4: Controller response when writing setpoints using (a) fixed time  
resolution and (b) fixed number of positions. 
It should be noted that the behaviour observed in Figure 5.4 (b) is still that of a PI 
controller, with an inactive Td term which is notorious for introducing this type of high 
frequency oscillation. The oscillation introduced by the position controller’s 
overcompensation manifests itself on the motor both audibly and tangibly and at heart 
rates above 180 bpm it translates to large changes in instantaneous speed values between 
iterations, causing the MoviDrive to experience overcurrent errors. To avoid this 
instability and take full advantage of the benefits of smooth operation, the control 
waveform’s time resolution is normally kept fixed to 1 ms but this has two drawbacks: 
1. To enforce a period of 1 ms for writing the setpoint value, the heartbeat duration 
must be rounded off to the nearest millisecond. This means that Figure 5.4 (b) has 
a heart rate of exactly 70 bpm because it was produced with a fixed number of 
positions in the control waveform which allows for adjustment of the time 
resolution. However, Figure 5.4 (a) has a heart rate of 70.011 bpm because a fixed 
time resolution was used. This difference tends to increase together with the heart 
rate: at 192 bpm, where it would be necessary to have a smooth controller output 
to prevent overcurrent errors, the actual heart rate is 191.69 bpm. 
a) b) 
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2. As the heart rate increases, the number of points in the control waveform must 
decrease, resulting in a reduction of temporal resolution of the control waveform. 
To provide the determinism of control with a fixed number of points per heartbeat or the 
better performance offered by a fixed time resolution, both functions were coded and 
can be switched while the CPD is running. 
 
Table 4.2 shows that the typical RMSE for setpoint tracking under the operating conditions 
used in Figure 5.4 is below 0.02 mm. To complement this, the RMSE for the position 
waveform between the two heartbeats shown in Figure 5.4 (a) is 0.001 mm, indicating 
excellent repeatability and controller behaviour. By comparison, the same analysis 
yielded an RMSE of 0.009 mm for Figure 5.4 (b). While 0.009 mm does not represent a 
significant error, it is 9 times more than with a well-timed controller and it serves to show 
how jitter can introduce variability to the process. The effect of jitter becomes more 
pronounced as cardiac output increases because higher speeds increase the amplitude of 
the oscillations. In contrast, a fixed time resolution of 1 ms results in smooth controller 
behaviour across the full range of operating conditions. Thus, despite the afore-
mentioned limitations, the CPD performs on par with commercial systems. 
 
 Cost overview 
A detailed breakdown of the hardware and manufacturing costs for the CPD is available 
in Appendix D. Table 5.3 provides a summary of these costs, given in 2015 South African 
Rand (ZAR). The costs shown represent retail prices and exclude Value Added Tax. Other 
costs excluded from the estimation are those related to assembly, programming, testing 
and tuning of the apparatus.  
 
While this CPD has certain limitations and would benefit from some improvements 
beyond the scope of this project, the overall estimated cost of R 161 000 is approximately 
8 times less than the retail price of a leading commercial device, depending on the 
selected hardware and software features of the latter. Therefore, the functionality 
offered by this custom-built CPD has a good cost-to-benefit relationship when compared 
to commercial devices. Understandably, a large component of the cost of commercially 
available CPDs relates to recovering development costs. The costs reported for this 
project include only hardware, raw materials and manufacturing but this project fulfils 
one of its aims by detailing the architecture of the system (for both hardware and 
software) so that these costs can be reduced to a minimum. A further benefit of the 
custom-built CPD is that its software is customisable since the source code is accessible. 
Modifying or expanding the software can lead to greater flexibility during testing and 
more in-depth real-time analysis of PHV performance. 
 
Table 5.3: Summary of hardware and manufacturing costs. 
 BERG CPD Commercial CPD 
Instrumentation and control R 113 651 
~R 1 250 000 
Materials R 10 200 
Manufacturing R 37 100 
TOTAL R 160 951 
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6 Conclusion and Recommendations 
 Conclusion 
A CPD was redesigned, constructed and tested following ISO5840:2005 
recommendations. This thesis represents a collection of information intended to aid those 
wishing to develop a custom-built CPD to produce a successful design, based on the good 
results obtained from the apparatus presented in this work. This investigation resulted in 
an in-house CPD that produces performance measures on par with commercial 
equivalents. 
 
The need for the above follows from the rationale that PHVs are most needed in areas of 
the world that cannot afford them. Reducing development costs to encourage local PHV 
development is an effective way to increase the availability of PHVs in resource 
constrained areas. One of the means to accomplish this is through the use of developing 
and testing equipment built in-house. One such piece of equipment is a CPD and the 
literature review was used, among other things, to describe their theory of operation, role 
in the development of PHVs and challenges surrounding their design and implementation. 
The key areas presenting the major challenges related to the development of CPDs were 
discussed and later shown to have a direct impact on the performance of the machine. 
While this project started off with an existing apparatus, the extent of the modifications 
actually gave birth to a new device, the design of which is documented in this text. A 
number of tests were devised and carried out to evaluate the performance of the 
machine. The tests worked well to highlight both its good characteristics and certain flaws. 
 
With the exception of the limitations imposed by the flowmeter, overall performance of 
the CPD was found to be satisfactory. Pressure measurements obtained from reputable 
PHVs under a range of operating conditions showed expected trends and good agreement 
with published data. Achieving the specified test conditions which allowed comparison of 
results to values found in literature was made possible through a series of hardware 
improvements as well as extensive software development. Despite these good outcomes, 
some aspects of the CPD require further work and the section that follows provides some 
advice on how to overcome the problems encountered during testing. 
 
While many works present methods and data for the validation of CPDs, no reference 
could be found in the literature in terms of approaches to quantify CPD performance. 
Further, no literature could be found that directly compares two CPDs to each other by 
using the same PHV samples and test parameters. The lack of a standardised assessment 
for the performance of CPDs means that the evaluation of a few specific parameters (such 
as Psys/Pdias and MAP) could allow a CPD to pass a simple validation test. However, it is 
thoroughly proven, overall CPD performance (perceived only through more subtle 
parameters, or their combination), that yields credible and unbiased PHV performance 
results. As a consequence, skewed or biased PHV performance results could go unnoticed 
without the use of more complex CPD performance indicators (such as those discussed in 
Section 3.4.2.3). This leaves a gap in the domain of heart valve testing and led to the 
development of new techniques to evaluate and present performance metrics which 
should prove useful in assessing and comparing CPDs, irrespective of design. In 
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connection to this contribution, a proposal for a standardised system of evaluating CPD 
performance is made and the approach discussed in this document is presented as a first 
step toward this goal. 
 
 Recommendations 
As the CPD is expected to be used in further investigations, future work is needed to 
address the main drawbacks encountered during testing. The recommendations 
presented here should contribute not only towards maximising the functionality but also 
the reliability of the CPD. 
 
The sourcing and installation of a flowmeter capable of measuring pulsatile flow more 
accurately is of highest importance and necessary to perform detailed analyses on the 
PHVs being tested. However, widely cited modern flowmeters (Carolina Medical 
Electronics CME 500 Series [67, 95], Transonic Systems ultrasonic probes [79, 89]) are not 
affordable in the local context, making this a challenging task. An unrestrictive and low 
profile probe will be greatly advantageous as it will eliminate a significant volume of fluid 
between the ventricle and the aortic valve. Beyond the aortic valve, it is highly 
recommended that sinuses of Valsalva be included. The original design of the LVOT is 
meant to accept sinus inserts so that the effect of different size sinuses can be studied. 
 
The integration of an accurate means of measuring the peripheral resistance setting is 
recommended. While this will not have a direct effect on the performance of the CPD, it 
will make inter-test repeatability more accurate and easily achieved. This could be 
accomplished by attaching a graded dial to the resistor’s shaft and referencing it to the 
housing of the resistor. 
 
Fabrication of a thinner (~1 mm thick) and more elastic moulded ventricle is advised, 
primarily for durability reasons. Having a mould will allow easy manufacture of identical 
replacement parts. The CNC-machined PVC mould in Figure 6.1 (left panel) produces a 
silicone ventricle with a wall thickness of 1mm. In relation to ventricular compliance, a 
more effective system to improve the performance at elevated HRs should be 
implemented. The diagrams on Figure 6.1 (right panel) depict the old and proposed 
configurations. The proposed model is similar in design to a commercially available system 
[84] and the current configuration of the CPD’s ventricular section can easily 
accommodate this modification. 
 
             
Figure 6.1: a) Ventricle mould to be manufactured and resultant silicone model. b) Current  
ventricular compliance setup; c) proposed ventricular compliance setup. 
~ 
  
~ 
 
 
a) b) 
c) 
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A Appendix A: Calibration data 
 
A.1 Pressure sensors 
The setup for the calibration procedure was identical to that used during normal tests. 
The pressure port of the transducer under calibration (Wika A-10 1 bar, WIKA Alexander 
Wiegand SE & Co. KG, Klingenberg, Germany) was connected to the Druck DPI 610 
pressure calibrator (GE Measurement & Control Solutions, MA, USA; S/N: 61011739). The 
output of the transducer, configured for current output mode, was connected to the 
National Instruments USB-6009 data acquisition card (National Instruments, TX, USA; S/N: 
302BF3B) through a 500 Ω precision resistor (Vishay Intertechnology, Inc., PA, USA; P/N: 
PAPTF56500R00BYEK). 
 
Three calibration runs were performed for each sensor. For each calibration run, the 
sensor was loaded from 0 bar to 1 bar in steps of 0.2 bar. The current reported by the data 
acquisition card for each pressure value was noted after the calibrator indicated that the 
pressure had settled on the target. This normally required adjustment of the pressure 
source, taking care to not overshoot the target. After reaching 1 bar, the same procedure 
was followed in reverse, unloading the sensor.  
 
The excellent linearity of all three sensors throughout their range became evident once 
all calibration data were available. Therefore, a linear function was used to convert from 
mA to bar, using the average of the calibration points (six values for each pressure step: 
three load points and three unload points).  
The following sections detail the calibration parameters for each sensor. 
 
A.1.1 Ventricular pressure transducer 
Table A.1 shows the results of the calibration process for the ventricular pressure 
transducer while Table A.2 summarises the results of the three runs into the average of 
each pressure point. The values presented in Table A.2 were used to plot the calibration 
curve shown in Figure A.1 and to calculate the linear calibration function (included in 
Figure A.1). 
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Table A.1: Calibration data for the ventricular pressure transducer. 
S/N: 00126108YS T1 T2 T3 
Data point Papplied (bar) Imeasured (mA) Imeasured (mA) Imeasured (mA) 
1 0 4.070 4.078 4.079 
2 0.2 7.258 7.258 7.259 
3 0.4 10.455 10.446 10.446 
4 0.6 13.654 13.654 13.653 
5 0.8 16.832 16.832 16.830 
6 1 20.009 20.000 19.998 
7 0.8 16.832 16.833 16.832 
8 0.6 13.653 13.655 13.655 
9 0.4 10.457 10.456 10.458 
10 0.2 7.261 7.262 7.268 
11 0 4.076 4.080 4.079 
 
 
Table A.2: Averaged calibration data for each pressure point (ventricular pressure transducer). 
Papplied (bar) Iaverage (mA) 
0 4.077 
0.2 7.261 
0.4 10.453 
0.6 13.654 
0.8 16.832 
1 20.002 
 
 
Figure A.1: Calibration curve for the ventricular pressure transducer. 
 
A.1.2 Aortic pressure transducer 
Table A.3 shows the results of the calibration process for the ventricular pressure 
transducer while Table A.4 summarises the results of the three runs into the average of 
each pressure point. The values presented in Table A.4 were used to plot the calibration 
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curve shown in Figure A.2 and to calculate the linear calibration function (included in 
Figure A.2). 
 
Table A.3: Calibration data for the aortic pressure transducer. 
S/N: 001260UH1A T1 T2 T3 
Data point Papplied (bar) Imeasured (mA) Imeasured (mA) Imeasured (mA) 
1 0 4.074 4.075 4.048 
2 0.2 7.253 7.254 7.254 
3 0.4 10.446 10.446 10.447 
4 0.6 13.636 13.637 13.638 
5 0.8 16.827 16.823 16.821 
6 1 20.013 20.016 20.016 
7 0.8 16.827 16.821 16.819 
8 0.6 13.647 13.648 13.649 
9 0.4 10.447 10.448 10.448 
10 0.2 7.264 7.263 7.264 
11 0 4.075 4.075 4.075 
 
 
Table A.4: Averaged calibration data for each pressure point (aortic pressure transducer). 
Papplied (bar) Iaverage (mA) 
0 4.070 
0.2 7.259 
0.4 10.447 
0.6 13.643 
0.8 16.823 
1 20.015 
 
 
Figure A.2: Calibration curve for the aortic pressure transducer. 
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A.1.3 Atrial pressure transducer 
Table A.5 shows the results of the calibration process for the ventricular pressure 
transducer whileTable A.6 summarises the results of the three runs into the average of 
each pressure point. The values presented in Table A.6 were used to plot the calibration 
curve shown in Figure A.3 and to calculate the linear calibration function (included in 
Figure A.3). 
 
Table A.5: Calibration data for the atrial pressure transducer. 
S/N: 001260UH18 T1 T2 T3 
Data point Papplied (bar) Imeasured (mA) Imeasured (mA) Imeasured (mA) 
1 0 4.084 4.076 4.078 
2 0.2 7.258 7.261 7.271 
3 0.4 10.448 10.449 10.449 
4 0.6 13.651 13.653 13.653 
5 0.8 16.824 16.832 16.828 
6 1 19.979 19.98 19.991 
7 0.8 16.829 16.831 16.838 
8 0.6 13.657 13.669 13.664 
9 0.4 10.464 10.472 10.472 
10 0.2 7.281 7.274 7.283 
11 0 4.073 4.084 4.078 
 
 
Table A.6: Averaged calibration data for each pressure point (atrial pressure transducer). 
Papplied (bar) Iaverage (mA) 
0 4.079 
0.2 7.271 
0.4 10.459 
0.6 13.658 
0.8 16.830 
1 19.983 
 
 
Figure A.3: Calibration curve for the atrial pressure transducer.
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A.2 Flowmeter 
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A.3 Linear variable differential transformer 
The calibration of the linear variable differential transformer (LVDT) (HBM 1-WA/50MM-
L, S/N: 173410237, Hottinger-Baldwin-Messtechnik GmbH, Darmstadt, Germany) was 
performed with the same setup that was used to measure the cam. An HBM Clip AE501 
instrumentation amplifier (S/N: 801177327, Hottinger-Baldwin-Messtechnik GmbH, 
Darmstadt, Germany) was used to excite and amplify the output of the LVDT and a 
National Instruments USB-6212 data acquisition card (S/N: 18C7531, National 
Instruments, TX, USA ) was used to read the output of the instrumentation amplifier. To 
maximise the resolution of the measurement, the instrumentation amplifier’s variable 
sensitivity was set up to produce the highest possible output when the LVDT measured 
the cam’s maximum lift. Therefore, the calculated sensitivity is related to the amplified 
value and does not match the calibration certificate (included in page 99), which was used 
only to decide which section of the LVDT to calibrate. Since only 20mm were to be 
calibrated, the section showing the lowest average deviation (from 0 mm to 20 mm) was 
calibrated using gauge blocks. 
 
Table A.7 contains all the data relevant to the calibration process. The applied 
displacements correspond to the sizes of the available gauge blocks. To minimise linearity 
errors, the sensitivity was calculated for each interval and the average used to convert the 
raw voltage value to a displacement measurement. Figure A.4 shows the acquired 
calibration data to depict linearity. 
 
Table A.7: Calibration data for the LVDT. 
Measure-
ment 
(i) 
Applied 
displacement 
(mm) 
Measured 
Voltage 
(V) 
Displi - Displi-1 
(mm) 
Vi - Vi-1 
(V) 
Calculated 
sensitivity 
(V/mm) 
1 0 0.58673 - - - - - - - - - 
2 1 0.83942 1 0.25269 0.25269 
3 2 1.08665 1 0.24723 0.24723 
4 3 1.33761 1 0.25096 0.25096 
5 5 1.83441 2 0.49680 0.24840 
6 10 3.08079 5 1.24638 0.24928 
7 15 4.32442 5 1.24363 0.24873 
8 20 5.55932 5 1.23490 0.24698 
    Average 0.24918 
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Figure A.4: Raw calibration data used to determine the sensitivity of the LVDT. 
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B Appendix B: Cam’s numerical profile 
 
Table B.1 contains the cam’s numerical profile in the form of 500 measurement points. 
The profile presented was obtained using the process described in Section 3.3.  
 
Table B.1: Numerical description of the cam. 
Point Lift (mm) Point Lift (mm) Point Lift (mm) Point Lift (mm) Point Lift (mm) Point Lift (mm) 
1 0.017 46 1.580 91 7.465 136 12.548 181 15.322 226 15.026 
2 0.017 47 1.666 92 7.598 137 12.647 182 15.350 227 14.987 
3 0.017 48 1.756 93 7.733 138 12.745 183 15.377 228 14.944 
4 0.017 49 1.850 94 7.870 139 12.843 184 15.402 229 14.900 
5 0.017 50 1.946 95 8.007 140 12.937 185 15.424 230 14.855 
6 0.017 51 2.047 96 8.142 141 13.026 186 15.446 231 14.807 
7 0.018 52 2.151 97 8.276 142 13.116 187 15.467 232 14.760 
8 0.019 53 2.261 98 8.406 143 13.200 188 15.484 233 14.711 
9 0.020 54 2.376 99 8.532 144 13.285 189 15.500 234 14.660 
10 0.023 55 2.496 100 8.657 145 13.369 190 15.512 235 14.609 
11 0.025 56 2.619 101 8.779 146 13.444 191 15.522 236 14.556 
12 0.029 57 2.742 102 8.900 147 13.525 192 15.533 237 14.500 
13 0.035 58 2.865 103 9.023 148 13.601 193 15.543 238 14.443 
14 0.044 59 2.990 104 9.143 149 13.675 194 15.554 239 14.383 
15 0.056 60 3.116 105 9.264 150 13.754 195 15.562 240 14.319 
16 0.070 61 3.244 106 9.384 151 13.829 196 15.568 241 14.256 
17 0.086 62 3.374 107 9.503 152 13.898 197 15.573 242 14.193 
18 0.105 63 3.508 108 9.621 153 13.969 198 15.573 243 14.130 
19 0.126 64 3.645 109 9.738 154 14.038 199 15.573 244 14.068 
20 0.151 65 3.785 110 9.854 155 14.104 200 15.572 245 14.005 
21 0.179 66 3.929 111 9.968 156 14.172 201 15.569 246 13.942 
22 0.208 67 4.074 112 10.081 157 14.237 202 15.569 247 13.876 
23 0.239 68 4.222 113 10.194 158 14.302 203 15.566 248 13.810 
24 0.272 69 4.371 114 10.307 159 14.363 204 15.558 249 13.741 
25 0.307 70 4.519 115 10.420 160 14.426 205 15.549 250 13.672 
26 0.346 71 4.669 116 10.536 161 14.486 206 15.536 251 13.602 
27 0.386 72 4.816 117 10.649 162 14.540 207 15.524 252 13.529 
28 0.429 73 4.964 118 10.763 163 14.594 208 15.513 253 13.457 
29 0.473 74 5.114 119 10.876 164 14.643 209 15.500 254 13.384 
30 0.519 75 5.264 120 10.987 165 14.689 210 15.484 255 13.307 
31 0.569 76 5.416 121 11.095 166 14.736 211 15.465 256 13.229 
32 0.621 77 5.567 122 11.200 167 14.782 212 15.446 257 13.146 
33 0.678 78 5.717 123 11.300 168 14.826 213 15.425 258 13.061 
34 0.736 79 5.864 124 11.399 169 14.870 214 15.406 259 12.974 
35 0.797 80 6.009 125 11.496 170 14.913 215 15.386 260 12.884 
36 0.860 81 6.150 126 11.593 171 14.955 216 15.362 261 12.791 
37 0.925 82 6.288 127 11.690 172 14.997 217 15.335 262 12.696 
38 0.991 83 6.423 128 11.786 173 15.039 218 15.304 263 12.599 
39 1.059 84 6.555 129 11.881 174 15.081 219 15.272 264 12.504 
40 1.128 85 6.685 130 11.976 175 15.121 220 15.239 265 12.411 
41 1.197 86 6.815 131 12.070 176 15.160 221 15.206 266 12.316 
42 1.268 87 6.944 132 12.164 177 15.195 222 15.172 267 12.224 
43 1.342 88 7.073 133 12.259 178 15.229 223 15.137 268 12.130 
44 1.418 89 7.203 134 12.354 179 15.260 224 15.101 269 12.033 
45 1.498 90 7.333 135 12.450 180 15.291 225 15.065 270 11.937 
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Table B.1: Numerical description of the cam. (Continued) 
Point Lift (mm) Point Lift (mm) Point Lift (mm) Point Lift (mm) Point Lift (mm) Point Lift (mm) 
271 11.841 316 7.464 361 3.138 406 0.565 451 0.024 496 0.020 
272 11.746 317 7.364 362 3.055 407 0.532 452 0.006 497 0.019 
273 11.654 318 7.263 363 2.971 408 0.500 453 0.006 498 0.019 
274 11.560 319 7.163 364 2.888 409 0.469 454 0.006 499 0.018 
275 11.465 320 7.063 365 2.806 410 0.440 455 0.005 500 0.017 
276 11.369 321 6.962 366 2.727 411 0.411 456 0.006   
277 11.272 322 6.860 367 2.651 412 0.384 457 0.006   
278 11.176 323 6.757 368 2.576 413 0.359 458 0.006   
279 11.079 324 6.654 369 2.504 414 0.336 459 0.006   
280 10.981 325 6.552 370 2.432 415 0.313 460 0.006   
281 10.884 326 6.451 371 2.364 416 0.292 461 0.006   
282 10.787 327 6.352 372 2.298 417 0.271 462 0.006   
283 10.692 328 6.254 373 2.234 418 0.252 463 0.007   
284 10.598 329 6.158 374 2.171 419 0.236 464 0.006   
285 10.504 330 6.063 375 2.107 420 0.222 465 0.006   
286 10.411 331 5.969 376 2.044 421 0.210 466 0.006   
287 10.317 332 5.875 377 1.982 422 0.199 467 0.007   
288 10.225 333 5.781 378 1.920 423 0.188 468 0.008   
289 10.134 334 5.684 379 1.861 424 0.179 469 0.008   
290 10.043 335 5.587 380 1.802 425 0.168 470 0.008   
291 9.954 336 5.489 381 1.742 426 0.157 471 0.008   
292 9.864 337 5.392 382 1.683 427 0.143 472 0.008   
293 9.774 338 5.294 383 1.624 428 0.128 473 0.009   
294 9.683 339 5.196 384 1.564 429 0.112 474 0.010   
295 9.592 340 5.097 385 1.505 430 0.097 475 0.010   
296 9.502 341 4.997 386 1.447 431 0.083 476 0.010   
297 9.407 342 4.897 387 1.391 432 0.071 477 0.010   
298 9.311 343 4.795 388 1.337 433 0.060 478 0.010   
299 9.212 344 4.694 389 1.284 434 0.049 479 0.010   
300 9.109 345 4.593 390 1.233 435 0.039 480 0.010   
301 9.007 346 4.493 391 1.183 436 0.030 481 0.011   
302 8.903 347 4.396 392 1.134 437 0.024 482 0.011   
303 8.798 348 4.300 393 1.086 438 0.018 483 0.012   
304 8.692 349 4.206 394 1.039 439 0.013 484 0.013   
305 8.584 350 4.113 395 0.994 440 0.009 485 0.013   
306 8.478 351 4.021 396 0.950 441 0.005 486 0.014   
307 8.374 352 3.928 397 0.907 442 0.003 487 0.013   
308 8.271 353 3.836 398 0.865 443 0.001 488 0.013   
309 8.170 354 3.745 399 0.824 444 0.001 489 0.012   
310 8.067 355 3.655 400 0.784 445 0.000 490 0.012   
311 7.964 356 3.567 401 0.746 446 0.000 491 0.013   
312 7.863 357 3.479 402 0.709 447 0.000 492 0.015   
313 7.761 358 3.392 403 0.672 448 0.001 493 0.017   
314 7.662 359 3.306 404 0.636 449 0.002 494 0.019   
315 7.563 360 3.221 405 0.600 450 0.010 495 0.019   
 
A polynomial was fitted to the above numerical data using a least squares method (the 
original dataset has five digits of precision). A 6th order polynomial yields a coefficient of 
determination R2 = 0.99978 indicating a very good fit.  
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After having found the correct order for the polynomial, the fitting routine was run again 
on the same dataset after it was normalised. This is useful because the profile produced 
by this polynomial can be scaled easily. Further, although the polynomial is based on 500 
data points, the tool shown in Section 4.2 makes it easy to generate a dataset of any 
length. Equation B.1 is the polynomial for the normalised data and Figure B.1 shows the 
experimental data and the fitted curve superposed for comparison. Although the 
polynomial fitting the original dataset is not presented, Table B.2 contains the parameters 
indicating the goodness of fit for both. 
 
 𝑦 =  0.0077564 − ( 0.002912 × 𝑥 ) +  (0.0001562 × 𝑥2) 
                   − (8.5816918 × 10−7 × 𝑥3 ) +  (1.4658378 × 10−9 ×
𝑥4 ) 
                   − (3.1147732 × 10−13 × 𝑥5 ) − (7.8220802 × 10−16 ×
𝑥6) 
( B.1 ) 
 
 
 
Figure B.1: Graphical comparison of measured and fitted data. 
 
Table B.2: Measures of fit for the respective polynomials. (RMSE: root mean square error;  
SSE: sum of square errors; R2: coefficient of determination.) 
Parameter Original dataset Normalised dataset 
RMSE 0.08728 0.0056 
SSE 3.7862 0.01561 
R2 0.99978 0.99978 
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C Appendix C: ISO test data 
 
The tables in this appendix contain the full set of data for the 10 heartbeats that were 
analysed for each test for each valve. The statistical summary at the end of each table was 
included in Section 4.5. Figure C.1 to Figure C.4 represent a single heartbeat, related to 
the comparative tests performed on the 23mm St Jude Epic Supra PHV, and complement 
Table C.16 to Table C.19, respectively. The figures were included to allow the reader to 
observe the progression of the pressure and flow curves as the stroke volume increases 
and to allow the graphical visualisation of features which cannot be accounted for 
numerically but that contribute to the results that were reported. 
 
The following nomenclature and abbreviations apply to the tables, listed in the order of 
the column headers: 
 Table C.1 to Table C.8 and Table C.15: 
EOA: Effective orifice area 
ΔP: Pressure drop across the open valve 
MAP: Mean arterial pressure 
Qmean: mean flow rate 
Systole: Systolic fraction 
Tsys: Systolic time 
 
 Table C.9 to Table C.14: 
Vreg_total: Total regurgitant volume 
Vclosing: Closing volume 
Vleakage: Leakage volume 
Qmean: Mean flow rate 
-ΔPmean: Mean back pressure across the closed valve 
MAP Mean arterial pressure 
 
 Table C.16 to Table C.19: 
PSPD: Peak systolic pressure difference 
MSPD: Mean systolic pressure difference 
MSAP: mean systolic arterial pressure 
MSVP mean systolic ventricular pressure 
SWL: Stroke work loss 
Systole Systolic fraction 
Tsys: Systolic time 
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SJM Epic 21 mm Valve 1 
 
Table C.1: ISO Test 1 results for SJM Epic 21 mm Valve 1. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys 
(ms) 
1 0.85 17.46 99.17 4.63 36.4 312 
2 0.86 17.18 98.50 4.65 36.4 312 
3 0.86 17.39 98.96 4.73 36.4 312 
4 0.85 18.00 98.97 4.67 35.8 307 
5 0.86 17.34 98.67 4.67 36.2 310 
6 0.86 17.17 98.81 4.66 36.6 314 
7 0.87 17.40 98.81 4.72 35.8 307 
8 0.86 17.16 98.22 4.65 36.4 312 
9 0.86 18.20 99.13 4.76 35.4 304 
10 0.86 17.47 99.38 4.72 35.9 308 
Mean 0.86 17.48 98.86 4.69 36.1 309.8 
SD ± 0.01 ± 0.33 ± 0.32 ± 0.04 ± 0.4 ± 3.0 
Max 0.87 18.20 99.38 4.76 36.6 314 
Min 0.85 17.16 98.22 4.63 35.4 304 
 
Table C.2: ISO Test 2 results for SJM Epic 21 mm Valve1. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole  
(%) 
Tsys 
(ms) 
1 0.55 7.49 99.69 1.87 34.3 294 
2 0.57 7.12 99.47 1.92 35.4 303 
3 0.56 7.30 99.97 1.92 35.6 305 
4 0.57 7.10 100.15 1.94 35.2 302 
5 0.57 7.18 100.23 1.91 35.5 304 
6 0.56 7.57 100.16 1.95 34.7 297 
7 0.56 7.46 100.55 1.92 34.3 294 
8 0.56 7.40 100.72 1.93 34.8 298 
9 0.55 7.56 100.65 1.87 34.4 295 
10 0.56 7.43 100.69 1.93 34.3 294 
Mean 0.56 7.36 100.23 1.92 34.8 298.6 
SD ± 0.01 ± 0.17 ± 0.41 ± 0.03 ± 0.5 ± 4.2 
Max 0.57 7.57 100.72 1.95 35.6 305 
Min 0.55 7.10 99.47 1.87 34.3 294 
 
 
SJM Epic 21 mm Valve 2 
 
Table C.3: ISO Test 1 results for SJM Epic 21 mm Valve 2. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys 
(ms) 
1 0.81 20.34 100.74 4.76 35.4 303 
2 0.81 19.93 100.97 4.69 35.5 304 
3 0.81 20.25 100.43 4.69 35.1 301 
4 0.82 19.56 100.46 4.69 35.2 302 
5 0.82 20.11 101.40 4.73 35.0 300 
6 0.80 20.11 100.41 4.65 35.4 303 
7 0.82 19.91 100.54 4.69 35.2 302 
8 0.80 20.10 100.18 4.65 35.1 301 
9 0.81 20.19 100.38 4.69 35.1 301 
10 0.82 19.90 100.39 4.70 35.1 301 
Mean 0.81 20.04 100.59 4.69 35.2 301.8 
SD ± 0.01 ± 0.21 ± 0.34 ± 0.03 ± 0.2 ± 1.2 
Max 0.82 20.34 101.40 4.76 35.5 304 
Min 0.80 19.56 100.18 4.65 35.0 300 
 
Table C.4: ISO Test 2 results for SJM Epic 21 mm Valve 2. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole  
(%) 
Tsys 
(ms) 
1 0.50 5.53 100.02 1.48 35.0 300 
2 0.48 5.65 99.96 1.37 34.7 297 
3 0.51 5.53 100.24 1.49 34.5 296 
4 0.49 5.62 100.57 1.40 34.3 294 
5 0.51 5.32 100.74 1.46 35.1 301 
6 0.49 5.35 100.28 1.39 35.6 305 
7 0.50 5.42 100.13 1.45 34.9 299 
8 0.49 5.57 100.10 1.41 34.7 297 
9 0.50 5.44 99.99 1.44 35.0 300 
10 0.49 5.48 100.12 1.43 35.0 300 
Mean 0.50 5.49 100.22 1.43 34.9 298.9 
SD ± 0.01 ± 0.10 ± 0.24 ± 0.04 ± 0.3 ± 2.9 
Max 0.51 5.65 100.74 1.49 35.6 305 
Min 0.48 5.32 99.96 1.37 34.3 294 
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Table C.5: ISO Test 3 results for SJM Epic 21 mm Valve1. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys 
(ms) 
1 0.71 11.02 98.33 3.06 35.4 303 
2 0.70 11.09 98.30 3.00 34.9 299 
3 0.71 11.05 98.60 3.09 35.7 306 
4 0.70 11.03 99.07 3.07 36.1 309 
5 0.70 11.19 99.45 3.07 35.2 302 
6 0.70 11.28 99.62 3.03 35.0 300 
7 0.71 10.93 99.48 3.07 35.4 303 
8 0.70 10.98 99.33 3.00 35.5 304 
9 0.70 11.25 99.41 3.08 35.4 303 
10 0.69 11.21 99.21 3.02 35.7 306 
Mean 0.70 11.10 99.08 3.05 35.4 303.5 
SD ± 0.01 ± 0.12 ± 0.47 ± 0.03 ± 0.3 ± 2.8 
Max 0.71 11.28 99.62 3.09 36.1 309 
Min 0.69 10.93 98.30 3.00 34.9 299 
 
Table C.6: ISO Test 4 results for SJM Epic 21 mm Valve1. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys 
(ms) 
1 0.91 30.88 100.69 7.00 35.5 304 
2 0.94 28.84 101.08 6.93 36.6 314 
3 0.94 28.76 100.76 6.98 36.8 315 
4 0.94 29.38 101.11 6.95 35.9 308 
5 0.94 28.83 101.08 7.02 36.4 312 
6 0.94 28.90 101.38 6.95 36.5 313 
7 0.92 30.42 101.52 7.09 35.6 305 
8 0.91 30.48 101.41 6.91 35.8 307 
9 0.93 28.72 101.11 6.99 37.0 317 
10 0.93 30.03 101.18 6.95 35.7 306 
Mean 0.93 29.52 101.13 6.98 36.2 310.1 
SD ± 0.01 ± 0.80 ± 0.25 ± 0.05 ± 0.5 ± 4.4 
Max 0.94 30.88 101.52 7.09 37.0 317 
Min 0.91 28.72 100.69 6.91 35.5 304 
 
 
SJM Epic 21 mm Valve 2 
 
Table C.7: ISO Test 3 results for SJM Epic 21 mm Valve 2. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys 
(ms) 
1 0.71 11.24 98.66 3.11 35.4 303 
2 0.71 11.29 98.80 3.13 35.2 302 
3 0.71 11.13 98.40 3.08 35.1 301 
4 0.71 11.30 98.53 3.10 35.2 302 
5 0.71 11.28 98.99 3.09 35.1 301 
6 0.71 11.28 98.61 3.11 35.7 306 
7 0.71 11.03 98.03 3.08 36.2 310 
8 0.70 11.17 97.86 3.10 35.5 304 
9 0.71 11.42 98.42 3.10 35.4 303 
10 0.70 11.16 98.32 3.11 36.2 310 
Mean 0.71 11.23 98.46 3.10 35.5 304.2 
SD ± 0.00 ± 0.10 ± 0.32 ± 0.01 ± 0.4 ± 3.2 
Max 0.71 11.42 98.99 3.13 36.2 310 
Min 0.70 11.03 97.86 3.08 35.1 301 
 
Table C.8: ISO Test 4 results for SJM Epic 21 mm Valve 2. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys 
(ms) 
1 0.90 31.56 96.37 6.93 35.8 307 
2 0.91 30.94 96.36 6.95 35.9 308 
3 0.90 31.69 96.39 6.92 35.5 304 
4 0.92 30.63 96.61 7.02 35.8 307 
5 0.90 31.87 96.71 6.90 35.0 300 
6 0.91 30.95 96.61 6.95 35.5 304 
7 0.90 31.45 96.01 6.86 35.6 305 
8 0.91 31.34 96.46 7.05 36.1 309 
9 0.90 31.43 96.48 7.05 35.8 307 
10 0.92 30.71 96.81 7.05 36.3 311 
Mean 0.91 31.26 96.48 6.97 35.7 306.2 
SD ± 0.01 ± 0.40 ± 0.21 ± 0.07 ± 0.3 ± 2.9 
Max 0.92 31.87 96.81 7.05 36.3 311 
Min 0.90 30.63 96.01 6.86 35.0 300 
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Table C.9: ISO Test 5 results for SJM Epic 21 mm Valve1. 
Beat 
Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
1 26.88 13.79 13.09 4.43 79.97 94.11 
2 24.37 12.99 11.38 4.36 79.34 93.80 
3 26.68 12.40 14.28 4.44 79.57 93.71 
4 25.65 13.17 12.47 4.42 79.89 93.82 
5 24.54 12.39 12.16 4.38 80.04 92.99 
6 26.31 13.15 13.16 4.40 78.49 92.44 
7 25.76 13.48 12.28 4.34 78.40 92.50 
8 26.27 13.69 12.58 4.38 78.66 92.43 
9 26.41 14.00 12.41 4.40 78.66 92.58 
10 26.21 13.68 12.53 4.40 79.06 92.75 
Mean 25.91 13.27 12.63 4.39 79.21 93.11 
SD ± 0.81 ± 0.53 ± 0.72 ± 0.03 ± 0.61 ± 0.64 
Max 26.88 14.00 14.28 4.44 80.04 94.11 
Min 24.37 12.39 11.38 4.34 78.40 92.43 
 
Table C.10: ISO Test 6 results for SJM Epic 21 mm Valve1. 
Beat 
Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
1 22.15 9.31 12.84 3.89 119.81 142.08 
2 23.82 9.49 14.33 3.97 119.84 141.94 
3 21.64 9.17 12.48 3.85 120.18 141.75 
4 23.99 9.49 14.50 3.99 119.92 141.92 
5 22.02 9.38 12.63 3.86 119.60 142.34 
6 23.93 9.53 14.40 3.97 119.68 141.89 
7 21.78 9.29 12.50 3.84 118.84 141.84 
8 23.85 10.27 13.58 3.98 119.09 142.16 
9 21.71 9.92 11.79 3.87 119.47 142.50 
10 23.79 10.21 13.57 3.98 119.48 142.61 
Mean 22.87 9.61 13.26 3.92 119.59 142.10 
SD ± 1.02 ± 0.37 ± 0.90 ± 0.06 ± 0.38 ± 0.28 
Max 23.99 10.27 14.50 3.99 120.18 142.61 
Min 21.64 9.17 11.79 3.84 118.84 141.75 
 
 
SJM Epic 21 mm Valve 2 
 
Table C.11: ISO Test 5 results for SJM Epic 21 mm Valve 2. 
Beat 
Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
1 24.25 12.89 11.36 4.38 79.46 93.38 
2 25.80 12.95 12.85 4.43 79.16 93.39 
3 24.10 13.00 11.10 4.38 80.51 93.68 
4 25.57 12.17 13.40 4.43 80.05 93.94 
5 23.92 12.43 11.49 4.35 80.81 93.75 
6 26.07 12.93 13.13 4.43 80.72 93.92 
7 24.50 13.29 11.21 4.37 79.99 93.96 
8 26.18 11.96 14.22 4.44 80.01 93.85 
9 24.63 12.29 12.34 4.37 80.34 94.04 
10 26.07 12.26 13.81 4.42 80.39 94.19 
Mean 25.11 12.62 12.49 4.40 80.15 93.81 
SD ± 0.86 ± 0.42 ± 1.09 ± 0.03 ± 0.50 ± 0.25 
Max 26.18 13.29 14.22 4.44 80.81 94.19 
Min 23.92 11.96 11.10 4.35 79.16 93.38 
 
Table C.12: ISO Test 6 results for SJM Epic 21 mm Valve 2. 
Beat 
Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
1 22.39 10.26 12.13 4.07 118.43 130.52 
2 24.60 9.02 15.58 4.19 117.80 130.84 
3 21.55 8.68 15.58 4.00 117.92 130.45 
4 22.33 9.86 12.48 4.00 118.86 130.70 
5 24.29 10.08 14.21 4.16 119.01 131.97 
6 24.80 10.18 14.62 4.14 118.22 132.06 
7 23.98 10.17 13.81 4.08 117.88 132.20 
8 22.65 9.94 12.71 4.03 118.30 132.22 
9 25.21 10.21 15.01 4.19 118.17 132.14 
10 24.67 10.20 14.47 4.12 118.79 132.16 
Mean 23.65 9.86 14.06 4.10 118.34 131.53 
SD ± 1.22 ± 0.52 ± 1.19 ± 0.07 ± 0.41 ± 0.74 
Max 25.21 10.26 15.58 4.19 119.01 132.22 
Min 21.55 8.68 12.13 4.00 117.80 130.45 
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Table C.13: ISO Test 7 results for SJM Epic 21 mm Valve1. 
Beat 
Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
1 16.08 5.84 10.24 3.00 154.37 194.38 
2 16.37 5.94 10.43 3.04 153.56 193.83 
3 16.66 5.86 10.80 3.07 154.52 193.94 
4 15.39 6.08 9.30 2.92 153.67 193.87 
5 17.95 6.29 11.65 3.21 153.88 194.03 
6 14.95 5.63 9.32 2.86 152.68 194.15 
7 17.61 5.97 11.63 3.21 154.92 195.25 
8 15.45 5.67 9.79 2.92 154.78 195.52 
9 16.90 5.91 10.99 3.12 155.25 195.64 
10 16.64 5.72 10.24 3.06 154.82 194.90 
Mean 16.37 5.91 10.44 3.04 154.18 194.51 
SD ± 0.96 ± 0.19 ± 0.80 ± 0.12 ± 0.76 ± 0.70 
Max 17.95 6.29 11.65 3.21 155.25 195.64 
Min 14.95 5.63 9.30 2.86 152.68 193.83 
 
SJM Epic 21 mm Valve 2 
 
Table C.14: ISO Test 7 results for SJM Epic 21 mm Valve 2. 
Beat 
Vreg_total 
(mL) 
Vclosing 
(mL) 
Vleakage 
(mL) 
Qmean 
(L/min) 
-ΔPmean 
(mmHg) 
MAP 
(mmHg) 
1 11.30 5.12 6.18 2.10 153.85 191.47 
2 14.03 5.67 8.36 2.47 156.94 192.89 
3 13.02 5.13 7.88 2.32 157.14 194.53 
4 12.79 5.22 7.57 2.35 156.75 194.87 
5 13.47 5.17 8.30 2.43 157.38 194.90 
6 11.57 4.99 6.57 2.20 157.39 194.58 
7 13.76 4.88 8.87 2.49 157.96 193.93 
8 12.62 4.73 7.89 2.33 156.89 193.89 
9 12.24 4.76 7.48 2.27 156.91 194.30 
10 14.14 4.92 9.22 2.53 155.60 194.02 
Mean 12.89 5.06 7.83 2.35 156.68 193.94 
SD ± 0.93 ± 0.26 ± 0.90 ± 0.13 ± 1.10 ± 0.99 
Max 14.14 5.67 9.22 2.53 157.96 194.90 
Min 11.30 4.73 6.18 2.10 153.85 191.47 
 
SJM Regent 25 mm 
 
Table C.15: ISO Test 1 results for SJM Regent 25 mm. 
Beat 
EOA  
(cm2) 
ΔP 
(mmHg) 
MAP 
(mmHg) 
Qmean 
(L/min) 
Systole 
(%) 
Tsys 
(ms) 
1 1.86 3.65 97.47 3.98 36.1 309 
2 1.84 3.49 97.93 3.98 37.2 319 
3 1.85 3.50 98.35 4.00 36.8 315 
4 1.84 3.54 98.52 3.98 36.6 314 
5 1.85 3.52 98.57 4.00 36.6 314 
6 1.81 3.63 98.42 3.97 37.7 323 
7 1.83 3.56 98.39 4.00 37.5 321 
8 1.78 3.71 98.27 3.96 37.7 323 
9 1.78 3.65 97.64 3.84 38.0 326 
10 1.88 3.43 97.27 3.96 36.5 313 
Mean 1.83 3.57 98.08 3.97 37.1 317.7 
SD ± 0.03 ± 0.08 ± 0.45 ± 0.05 ± 0.6 ± 5.2 
Max 1.88 3.71 98.57 4.00 38.0 326 
Min 1.78 3.43 97.27 3.84 36.1 309 
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Table C.16: Results for SJM Epic 23 mm Test 1.  
Beat 
PSPD 
(mmHg) 
MSPD 
(mmHg) 
MSAP 
(mmHg) 
MSVP 
(mmHg) 
SWL 
(%) 
Systole 
(%) 
Tsys 
(ms) 
1 11.99 6.01 92.17 98.26 6.19 32.4 278 
2 10.65 5.60 91.81 97.49 5.83 33.1 284 
3 10.60 5.90 92.39 98.33 6.04 32.8 281 
4 11.10 5.88 92.78 98.69 6.00 33.1 284 
5 10.82 5.84 92.33 98.21 5.98 33.0 283 
6 11.05 5.81 92.96 98.70 5.81 32.9 282 
7 10.34 5.83 92.65 98.56 6.00 33.0 283 
8 10.98 5.98 92.32 98.27 6.05 33.0 283 
9 13.56 6.19 92.09 98.29 6.30 32.9 282 
10 10.58 6.04 92.32 98.36 6.14 33.1 284 
Mean 11.17 5.91 92.38 98.32 6.03 33.0 282.4 
SD ± 0.90 ± 0.15 ± 0.32 ± 0.32 ± 0.14 ± 0.2 ± 1.7 
Max 13.56 6.19 92.96 98.70 6.30 33.1 284 
Min 10.34 5.60 91.81 97.49 5.81 32.4 278 
 
 
Figure C.1: Graphical results for SJM Epic 23 mm Test 1. 
 
Table C.17: Results for SJM Epic 23 mm Test 2. 
Beat 
PSPD 
(mmHg) 
MSPD 
(mmHg) 
MSAP 
(mmHg) 
MSVP 
(mmHg) 
SWL 
(%) 
Systole 
(%) 
Tsys 
(ms) 
1 25.39 12.56 95.04 107.60 11.67 34.5 296 
2 25.81 12.70 95.23 107.92 11.76 34.4 295 
3 24.89 12.32 95.33 107.72 11.50 34.7 297 
4 25.39 12.67 95.37 107.97 11.67 34.7 297 
5 24.60 12.66 94.79 107.44 11.77 35.1 301 
6 25.23 12.65 94.63 107.36 11.86 34.7 297 
7 23.53 12.05 94.94 106.99 11.26 34.4 295 
8 24.44 12.28 94.74 107.02 11.47 34.7 297 
9 25.37 12.69 94.21 106.89 11.87 34.7 297 
10 24.55 12.21 94.80 107.00 11.41 34.5 296 
Mean 24.92 12.48 94.91 107.39 11.62 34.6 296.8 
SD ± 0.63 ± 0.23 ± 0.34 ± 0.38 ± 0.19 ± 0.2 ± 1.6 
Max 25.81 12.70 95.37 107.97 11.87 35.1 301 
Min 23.53 12.05 94.21 106.89 11.26 34.4 295 
 
 
Figure C.2: Graphical results for SJM Epic 23 mm Test 2. 
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Table C.18: Results for SJM Epic 23 mm Test 3. 
Beat 
PSPD 
(mmHg) 
MSPD 
(mmHg) 
MSAP 
(mmHg) 
MSVP 
(mmHg) 
SWL 
(%) 
Systole 
(%) 
Tsys 
(ms) 
1 23.81 14.51 93.82 108.33 13.39 35.9 308 
2 24.58 14.35 93.98 108.33 13.25 35.9 308 
3 24.37 14.44 93.90 108.42 13.40 35.5 304 
4 24.18 14.50 93.34 107.83 13.44 35.7 306 
5 24.38 14.70 92.85 107.46 13.59 35.7 306 
6 24.13 14.32 93.54 107.86 13.27 35.8 307 
7 24.07 14.10 93.86 107.96 13.06 35.8 307 
8 25.62 14.92 93.25 108.17 13.79 35.9 308 
9 24.19 14.48 93.40 107.88 13.42 35.8 307 
10 24.58 14.55 93.75 108.29 13.43 36.1 309 
Mean 24.39 14.49 93.57 108.05 13.41 35.8 307.0 
SD ± 0.47 ± 0.21 ± 0.34 ± 0.29 ± 0.19 ± 0.2 ± 1.3 
Max 25.62 14.92 93.98 108.42 13.79 36.1 309 
Min 23.81 14.10 92.85 107.46 13.06 35.5 304 
 
 
Figure C.3: Graphical results for SJM Epic 23 mm Test 3. 
 
Table C.19: Results for SJM Epic 23 mm Test 4. 
Beat 
PSPD 
(mmHg) 
MSPD 
(mmHg) 
MSAP 
(mmHg) 
MSVP 
(mmHg) 
SWL 
(%) 
Systole 
(%) 
Tsys 
(ms) 
1 45.63 19.47 93.40 112.83 17.22 37.1 318 
2 44.32 19.07 93.69 112.74 16.90 37.1 318 
3 44.00 19.22 93.74 112.96 17.02 37.6 322 
4 44.34 19.06 94.11 113.15 16.83 37.3 320 
5 44.95 19.49 94.14 113.63 17.15 36.3 311 
6 44.39 19.14 94.57 113.71 16.84 37.6 322 
7 44.19 18.68 94.67 113.35 16.48 37.6 322 
8 46.50 19.54 94.19 113.73 17.18 37.3 320 
9 49.48 19.54 94.02 113.47 17.14 37.1 318 
10 44.30 18.81 93.63 112.42 16.72 37.9 325 
Mean 45.16 19.17 94.02 113.20 16.95 37.3 319.6 
SD ± 1.68 ± 0.29 ± 0.39 ± 0.43 ± 0.23 ± 0.4 ± 3.6 
Max 49.48 19.54 94.67 113.73 17.22 37.9 325 
Min 44.00 18.68 93.40 112.42 16.48 36.3 310 
 
 
Figure C.4: Graphical results for SJM Epic 23 mm Test 4. 
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D Appendix D: Cost details 
 
National Instruments, SEW and Siemens components were imported by their respective 
South African representatives and are therefore more susceptive to price fluctuations. All 
other components and materials were procured from local suppliers.  
 
The expenses taken into account relate to the hardware and manufacturing costs required 
to have the CPD in its final specification, as described in Section 3.2.3. However, this does 
not include assembly or development time which accounts for programming, calibration, 
tuning and testing. The amounts shown in Table D.1 are in 2015 South African Rand (ZAR). 
These amounts are retail prices and do not include the Value Added Tax (VAT) of 14%. 
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Table D.1: Costs for the CPD in its final specification. (VAT: value added tax). 
 Cost/unit Qty Line total Subtotal 
INSTRUMENTATION AND CONTROL     
SEW MoviDrive R 15 427 1 R 15 427  
Encoder card for SEW MoviDrive R 2 127 1 R 2 127  
SEW Electric cylinder R 25 807 1 R 25 807  
Pressure sensor R 2 010 3 R 6 030  
Flowmeter + Signal converter R 33 900 1 R 33 900  
Submersible heater R 650 1 R 650  
Temperature controller R 800 1 R 800  
Pt100 temperature sensor R 180 1 R 180  
24V Power supply (20W) R 320 1 R 320  
NI myRIO 1900 R 11 990 1 R 11 990  
NI USB-6009 R 6 420 1 R 6 420  
NI LabVIEW (Full Development System) R 10 000 1 R 10 000  
    R 113 651 
MATERIAL     
Compliance chamber R 2 000 1 R 2 000  
Resistor R 450 1 R 450  
Left ventricular outflow tract R 600 1 R 600  
Reservoir R 600 1 R 600  
Pump R 1 800 1 R 1 800  
E-cylinder support & rod connection R 300 1 R 300  
Ventricular chamber R 500 1 R 500  
Ventricular compliance chamber R 650 1 R 650  
Frame R 1 500 1 R 1 500  
Miscellaneous hardware R 1800 1 R 1 800  
    R 10 200 
MANUFACTURING LABOUR Cost/hour    
Compliance chamber R 350 18 R 6 300  
Resistor R 350 12 R 4 200  
Left ventricular outflow tract R 350 14 R 4 900  
Reservoir R 350 6 R 2 100  
Pump R 350 24 R 8 400  
E-cylinder support & rod connection R 350 6 R 2 100  
Ventricular chamber R 350 10 R 3 500  
Ventricular compliance chamber R 350 8 R 2 800  
Frame R 350 8 R 2 800  
    R 37 100 
TOTAL exVAT    R 160 951.00 
VAT @ 14%    R 22 533.14 
GRAND TOTAL    R 183 484.14 
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E Appendix E: Graphical user interfaces 
 
 
Figure E.1: Main window (motion definition and control). 
 
 
Figure E.2: RIOorquestrator front panel (stroke volume controller and parameters for external synchronisation pulse). 
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Figure E.3: PIDloop front panel (PID controller and manual positioning parameters). 
 
 
Figure E.4: PIDmonitor front panel (electric cylinder performance monitoring and logging). 
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Figure E.5: Data acquisition window (data display, analysis and calibration as well as acquisition control). 
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